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Preface 
This completed document is submitted to Western Sydney University (WSU) in fulfilment of the 
requirements of the Doctor of Philosophy (PhD) degree as a series of publications and overarching 
statement. My initial enrolment in the higher degree program was in the first semester of 2008. The 
project consisted in an initial literature review followed by a Confirmation of Candidature in 2010.  
Shortly after the confirmation of the project, the research phase commenced and included 
laboratory studies, a risk assessment study, five poster presentations, five publications arising from 
the research including a field based pilot study which was described in the fifth publication, several 
letters to the editor canvassing aspects of the research, and finally the compilation and presentation 
of this thesis.   
The requirements for awarding of a PhD by publication must include at a minimum four, full length, 
scholarly and peer reviewed publications and an overarching statement as a thesis. This PhD thesis 
includes five scholarly and peer reviewed publications as the second publication was published as a 
‘research brief’, albeit with full peer review and within a special edition on environmental hygiene 
through the journal Infection Control & Hospital Epidemiology.  
The format of this thesis generally follows the WSU guidelines found in the Higher Degree Research 
Examination Handbook (http://www.uws.edu.au/__data/assets/pdf_file/0019/ 
70822/ORS3474_HDR_Handbook_Exams_booklet_A5_LR3.pdf:doi 21st January 2016).  
There are a number of minor exceptions from the guidelines within this thesis. Firstly the order of 
inclusions is slightly varied to take account of the content, which is for a PhD thesis as a series of 
publications. Secondly, the references appear at the end of each discreet chapter, both in the 
compilation and each of the published references, published letters, and posters. At the start of each 
of the first four chapters is a short precis which takes the place of an abstract for each chapter. This 
precis outlines in a simple form the content to be appreciated through the following material. 
The page numbering has been applied as per the WSU guidelines, excepting that the five 
publications have retained their pagination as published. The page numbers applied to the section 
headings have been kept in the proper sequence throughout the thesis.    
I hope that you enjoy reading this account of the study and the published outputs arising from this 
body of original work. 
 
Greg S Whiteley 
1st August 2016 
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Abstract 
There is a problem in hospital cleaning. There is currently no scientific monitoring method that 
provides timely and reliable assurance that harmful bacteria have been removed by the cleaning 
processes.  
This PhD investigates the validation of commercially available testing devices intended for the rapid 
detection of adenosine triphosphate (ATP), which may provide a quantitative surrogate estimate of 
surface cleanliness based on ATP measurements. The findings indicate that ATP testing devices, 
despite problems with scaling and imprecision, provide immediacy in readings which enables the 
incorporation of ATP testing into an improved and integrated cleanliness monitoring process for 
applications within healthcare settings.   
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Introduction 
There is a problem in hospital cleaning. The problem is that there is no accepted and credible 
scientific measurement of the outcome resulting from the cleaning process. A monitoring approach 
is required that can reliably assess both the efficacy and efficiency of hospital cleaning and the 
standard of cleanliness of healthcare surfaces.  
There are two existing methods which are used to verify the cleaning and both are inadequate. The 
most common method of cleaning monitoring is visual inspection, which whilst it is quick and easy, is 
not overly scientific. Visual inspection in isolation cannot assess if the cleaning process has occurred, 
nor the time since the cleaning process on a particular surface was completed and the visual 
appearance does not correlate with actual surface cleanliness using microbiological methods.1  
The other existing method of cleaning monitoring is environmental or surface microbiology which 
takes too long between sampling and obtaining results, is expensive, and has sampling difficulties.2 
There are two new methods proposed to measure and monitor cleanliness.  
The first new monitoring method utilises hand held devices that rapidly measure the presence of 
adenosine triphosphate (ATP). ATP is present in all living cells and the presence of ATP is proposed as 
a proxy indicator of surface soiling with biological based materials.1  
The second new cleaning monitoring method uses a fluorescent mark (FM) to assess the efficiency of 
a cleaning process an environmental surface (FM spot removal).3  
Both of the new methods provide timely information for monitoring purposes and both may be 
integrated into cleanliness monitoring processes for hospital applications.4  
This PhD study investigates the validation of several commercially available, rapid ATP testing 
devices, which can be used to provide a quantitative estimate of surface cleanliness based on their 
ATP measurements. Rapid ATP testing devices make use of the ‘firefly reaction’ to generate and 
measure a luminescent reaction which is loosely proportionate to the level of cellular soiling present 
on a surface (ATP + Luciferase = Light). This light response is expressed in a scale known as Relative 
Light Units (RLU). 
The results from the studies in this PhD are published in the five included published papers. These 
findings indicate that rapid ATP testing, despite imprecision and scaling difficulties, can be included 
in an integrated monitoring processes, albeit with careful consideration over sampling methodology 
and the interpretation of the data/readings arising from the use of rapid ATP devices.  
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The four chapters which follow this introduction are the overarching statement that explains the 
examinable work. The first chapter outlines the evolution of the project; the second chapter reviews 
the methods used in the five papers; the third chapter provides a detailed discussion over the 
context and implications arising from each of the papers, and finally a fourth and concluding chapter 
summarises the key findings.  
The five published papers each examines a different aspect of the overall validation and integration 
of rapid ATP testing into a cleanliness monitoring process. The five papers are included after the first 
four chapters, and are described briefly as follows.    
The first paper outlines the findings of a series of studies of three commercially available ATP testing 
devices, to describe and document the dynamic range, upper and lower limits of detection, linearity 
of response and the precision of response of each ATP device. The accuracy of response which 
would normally be included in validation studies could not be conducted due entirely to the relative 
and idiosyncratic scaling used by each branded ATP device. A novel method of direct application of 
pure ATP was developed to establish device validation without interfering with the individual dose 
responses of each commercial device. The findings of this paper indicate the key features of each 
ATP device against the core validation criteria. 
The second paper (which is a short ‘Research Brief’), applied the findings from the first laboratory 
study and, using the statistical measure of Coefficient of variance (Cv), presented graphical 
information on the uncontrolled variability of the ATP devices. The measurement of Cv is obtained 
by dividing the mean into the standard deviation for each data set and allows dis-contiguous data 
sets to be normalised for comparative purposes. The results demonstrated that when challenged 
using pure ATP, all of the ATP testing devices displayed a Cv above 0.4. This was surprisingly high 
when compared to the calibrated High Performance Liquid Chromatography (HPLC) results.  
The third paper in chronological sequence considered the findings arising from the laboratory 
studies to consider the risks arising from integrating ATP testing into a cleanliness monitoring 
program. The paper used a risk assessment tool known as Failure Mode Effects Analysis (FMEA) to 
assess each of the cleaning monitoring methods (visual inspection, surface microbiology, ATP testing 
and FM). The findings indicated that by combining the four cleanliness monitoring methods into a 
single integrated monitoring process, the strengths of each method could be used to mitigate the 
weaknesses from each of the other monitoring methods. This finding is presented as a novel and 
new approach for integrating the cleanliness monitoring for use in healthcare settings.  
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The fourth paper (in the chronological sequence of publication) applies the results from the first and 
second studies and extends this analysis to include the use of bacterial species in addition to pure 
ATP. This provided a more comprehensive measure of the precision of the dose-response for each of 
the ATP testing devices. The variability of the dose-response was again examined using Cv, which is 
fully described in the paper. The experiments included a fourth ATP device and results demonstrated 
that the Cv (variability) for each of the tested ATP devices was in excess of Cv > 0.4. The high 
variability suggests that any reading taken on any of the four ATP devices has a 20% chance of being 
wrong by a factor of 2. This finding has important sampling and interpretative implications for those 
using rapid ATP testing devices in cleanliness monitoring.  
The fifth and final paper applied knowledge obtained during the earlier published studies and 
applied this learning into a field based pilot study investigating an integrated cleanliness monitoring 
approach. This paper was selected as the lead article in the December 2015 issue of the American 
Journal of Infection Control. There were a number of key findings, and importantly the use of rapid 
ATP testing applied within an integrated cleanliness monitoring process was shown to be 
significantly better than using a traditional, one dimensional, list based sampling approach.  
This PhD is the accumulation of a single and contiguous group of studies which examines the 
validation and performance of ATP testing devices. This PhD further investigates the incorporation of 
rapid ATP testing devices within an integrated cleanliness monitoring process for healthcare settings.  
The results demonstrated in this PhD underpin an enhanced scientific platform for on-going research 
to further improve the reliability of cleanliness measurements within healthcare settings. This thesis 
is submitted for the satisfaction of requirements for the awarding of a Doctor of Philosophy Degree.  
 
Goals for the study 
 
In the Confirmation of Candidature (March 2010), the overarching aim of the research was to:  
“…investigate an integrated approach to cleanliness monitoring, relying on modern scientific 
methods… that reflects a truly validated standard of cleanliness at a sub-visual level. An accurate 
appreciation of actual surface hygiene and cleanliness can then more accurately inform infection 
control practice. By demonstrating that interpretation and validation of cleaning in health care be 
improved this will remove a critical current confounding factor (validity of cleaning processes) that 
contributes to the difficulty in preventing the spread of HAI within the health care setting.” 
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The initial research goals of the project were to: 
1. Conduct a series of validation studies of the new cleanliness monitoring methods of ATP 
testing and FM spots to confirm their scientific validity for field use; and  
2. Compare the ATP and FM methods with visual inspection and microbial recovery so as to 
develop an integrated approach to cleanliness monitoring which is scientifically valid; and 
3. Complete a field based cleanliness monitoring study using an integrated model within a 
healthcare setting to demonstrate the value of improved scientific measures of cleanliness 
monitoring for use in practical infection control. 
Following the initial laboratory studies it became clear that the FM approach measured cleaning 
efficiency (i.e. the physical effort of wiping a surface – a qualitative factor) and did so with 
robustness. Validation studies published by Carling and others established FM as a reliable measure 
of cleaning effort and efficiency.  
However, ATP testing systems measure the output of cleaning effort through assessment of the 
quantitative cleanliness level achieved through the cleaning process (a quantitative factor). 
Unfortunately, it became quickly apparent that ATP testing systems required substantially greater 
laboratory experimentation in an effort to achieve a validated status upon which ATP testing could 
be used reliably for cleanliness monitoring within healthcare settings.  
The confirmed goals for the research project were to: 
1. Investigate the validation of ATP testing systems for reliable cleanliness monitoring; and, 
2. Investigate the four major cleanliness monitoring methods (ATP, FM, visual inspection and 
microbial recovery) to provide a reliable and integrated method of cleanliness monitoring 
within healthcare settings: and,  
3. Investigate the application of an integrated cleanliness monitoring process for practical 
infection prevention within a healthcare setting. 
 
The hypothesis being tested is:  
“ATP testing is a valid and reliable method of cleanliness monitoring which can be incorporated into 
an integrated cleanliness monitoring methodology for use within healthcare settings to improve 
practical infection control”.   
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Chapter 1 
The evolution of the research project 
Précis  
This PhD project was commenced in 2008 on a part time basis through the school of Science and 
Health at Hawkesbury Campus at Western Sydney University. The overall aim of the research 
program was to examine cleanliness monitoring within healthcare settings, with a particular focus 
on the validation of rapid ATP testing. The experimental goal was to validate ATP testing as a reliable 
and quantitative mechanism for the assessment of surface cleanliness prior to any practical 
verification of the use of ATP testing within a healthcare setting. 
This chapter sets out the background for the project, the development of the literature over the 
period of the project and the chronological development of the project. The stages of the project 
outlined include the validation of the rapid ATP testing systems, the development of an integrated 
framework for cleanliness monitoring arising from a risk assessment, and a final field based study 
within a healthcare setting which applied the teaching from the earlier project results.  
Chapter 1 outlines the single and focused theme of the project across each of the five research 
publications to create a single body of novel work for this PhD project.  
 
The Background to the project 
At the time of commencement of the project in 2008, the problems of multi drug resistant 
organisms (MRO), and particularly methicillin resistant Staphylococcus aureus (MRSA) were 
recognised as a significant cause of morbidity and mortality through healthcare associated infections 
(HAI) in Australian hospitals.1 There had been a dramatic increase in hospital cross-infections in 
many western countries over the past decade. In the United States, nosocomial infections of HAI 
were ranked among the top ten causes of death.2 In Australia, it is estimated that 50% of all multiple 
resistant Staphylococcus aureus (MRSA) infections are HAI, with an 11% case fatality rate.3 There is 
also extensive evidence of transmission of other bacterial pathogens such as Enterococcus species, 
including Multi Resistant Organisms (MRO) via healthcare settings, and particularly involving 
contaminated surfaces.4,5 
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Apart from morbidity and mortality, the economic impact is considerable. The annual number HAI 
cases in Australia is thought to be approximately 200,000.6 A recent study estimated that a 1% 
reduction in HAI’s should be attainable through a modest improvement in infection control and 
would free up 38,500 hospital beds annually.7 The cost associated with HAI is a significant drain on 
the health care system and is estimated in terms of billions of dollars in the USA alone.8 Equivalent 
cost data for Australia is not available, but the Australian Commission on Safety and Quality in 
Healthcare (ACSQH) acknowledges broadly that around half of all HAI are preventable through 
better infection prevention practices.9 
The first tier response to the growing burden of HAI from the global clinical community, including 
Australia, was to focus on hand hygiene as a principle infection prevention intervention, and so the 
‘5 moments of hand hygiene’ campaign (‘the 5 moments’) was developed and accepted 
internationally.10-12 ‘The 5 moments’ campaign recognised that bacteria can move via unwashed 
hands from surface to surface.13 Studies had shown that where hand hygiene compliance was 
reduced the risk of nosocomial transmission of MRO increased.14 The goal of ‘the 5 moments’ 
campaign was to increase the frequency of hand hygiene compliance amongst all health care 
workers (HCW) and particularly attending clinicians.  
In Australia, hand hygiene products with bactericidal claims which are intended for hospital or 
healthcare usage, are controlled as medicines by the Australian Government regulator, the 
Therapeutic Goods Administration (TGA). The ‘5 moments’ shifted the focus of hand hygiene onto 
the effective use of alcohol based hand rub (ABHR) products to speed up the efficiency around hand 
hygiene compliance and to allow bedside application of ABHR without need of a sink and running 
water.12 The effective use of ABHR, with proven bactericidal properties, increased the likelihood that 
MRO that had been picked up on HCW hands via unhygienic surfaces, would be killed on the hands 
by the ABHR prior to transmission to another surface or object.  
Whilst hand hygiene was the significant focus, no studies in Australia had considered the corollary 
issue of surface hygiene, and the effectiveness of cleaning and disinfecting of the patients’ surrounds 
and the hygienic standards of cleanliness for general hospital surfaces. Whilst visual inspection was 
the primary cleaning and cleanliness monitoring method, it was suggested to define cleanliness 
standards in terms of bacterial contaminants present on healthcare surfaces.15 Authors such as 
Dancer and Carling have noted that the microbes that are most frequently responsible for HAI are all 
recognised as organisms that can survive for long periods of time on environmental surfaces and 
that these surface are also the surfaces most frequently touched by healthcare workers.16,17 More 
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recent work has demonstrated that these organisms can survive within dry surface biofilms on 
common hospital surfaces and can remain viable for many years.18   
The former President of the Society of Healthcare Epidemiologist of America, Professor Robert 
Weinstein has commented that whilst a large amount is known about the genetics of organisms 
responsible for HAI, the precise mechanisms of development of antibiotic resistance and the 
interaction of these bacteria in the hospital environment continues to be poorly understood from a 
preventative perspective.2 Environmental surfaces are recognised as an important reservoir for 
infectious agents of such nosocomial infections.19  
One key study indicated that prior occupancy of the same bed or hospital room was a key indicator 
for the likelihood of a subsequent patient acquiring the same organism thus suggesting poor 
cleaning as a small but important causal link to HAI.20 The issue of prior patient infection 
transmission risk was also more recently confirmed in a meta-analysis.21 MRSA was identified as 
strongly associated with hospital surface contamination and nosocomial transmission when 
comparing environmental and patient isolates.22 Gram negative bacteria are also responsible for HAI 
and are similarly associated with environmental contamination that could be controlled by improved 
cleaning processes.5 
Some lamented modern hospital hygiene practices including disinfectant usage and harked back to 
the days of Florence Nightingale.23 The need to reconsider hygiene standards and methods for the 
monitoring of cleanliness of healthcare surfaces required urgent attention.16 
The TGA had instituted rigorous and mandated, pre-market, in-vitro testing requirements for 
hospital grade surface disinfectants since 1996.24 Despite the regulatory controls, there was a view 
that disinfectants were both undesirable and unreliable, and additionally that cleaning was the key 
issue for effective hospital hygiene and cleanliness.6 
The issue of disinfectant expertise within policy setting documents of the same period was a major 
concern. One authoritative Australian Government policy document contained poorly considered 
information on cleaning and disinfecting of instruments possibly exposed to prion contamination 
and this was criticised via a letter to the editor from this author (see Appendix A1).25 A second 
document, published shortly thereafter by another Australian Government body, made 
recommendations on surface decontamination in regards to influenza virus which ignored the 
Australian Commonwealth legislation on disinfectants (see Appendix A2).26 
Whilst disinfectants and their use were being ill-considered, it seemed that the important corollary 
issues around the hygienic status and the cleaning of surfaces (what gets touched and how to clean 
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them) were being uniformly overlooked and particularly so in Australia. The risk arising from this 
omission in approach was that disinfectant failure may have been solely as a result of the first 
chronological task of cleaning. No risk assessment was apparently conducted to identify this issue 
and even in relevant healthcare cleaning standards – such as the NSW Infection Control Policy of 
2007 – the process of cleaning prior to disinfectant usage was not defined.27   
In the 2010 Australian Infection Prevention Guidelines the cleaning process always precedes the 
disinfecting, and so to ensure that the disinfectants work correctly, it is important to understand the 
initial cleaning step as a quality assurance opportunity and eliminate cleaning as a variable for 
disinfectant performance.6 To add to the confounders, whilst the disinfectant products are regulated 
by the TGA, the cleaning products are unregulated. The process of surface disinfection is therefore a 
two-step process involving an unregulated product use (for the cleaning process) followed by the 
use of a regulated disinfectant for the disinfecting process. 
Cleaning of the environment has long been regarded as the essential first step in the major 
guidelines for Infection Control within health care settings and yet not one of these major 
documents defines the term “clean” in any quantitative manner.6,28,29 The closest to a definition of 
“clean” is with the process of “cleaning” which is defined as “the removal of soil and a reduction in 
the number of micro-organisms from a surface”.29 The primary shortfall with cleaning in hospitals in 
Australia and elsewhere is in the measurement of the efficiency and effectiveness of the cleaning 
processes due to the reliance on visual assessment alone for performance monitoring. 
The primary mechanism for monitoring both what is ‘clean’ and also the process of cleaning is visual 
inspection. No other routine monitoring has been recommended in any of the major reference 
standards. Routine microbiological examination is not recommended in Australia or the USA.6,28 If a 
surface therefore appears to be acceptably visually clean, and the audit tool developed in Victoria 
scores the surfaces as clean, then it is deemed to be clean.27,30 There is no recognised or accepted, 
quantitative standard for what constitutes a clean surface, nor how it could be measured.31 
The benefits of improved cleanliness or cleaning have been demonstrated. A study at Rush Medical 
Center in the USA with Vancomycin Resistant Enterococci (VRE) positive patients, demonstrated that 
with every 10% improvement in cleaning, there was a 6% reduction in the recovery of VRE within a 
contaminated ICU.5 In a Scottish hospital with active MRSA patients and HAI – MRSA transmissions, 
the rate of transmission dropped significantly with the addition of just a single extra cleaning staff 
member.32 Work with additional cleaning during an outbreak with a multi drug resistant 
Acinetobacter baumannii (MRAB) showed similar reductions in cross infections with cleaning 
enhancements.33 The question is how to measure the cleaning and ensure that the standard of 
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cleaning processes regularly meets the standard of quantitative cleanliness that is desirable to 
reduce the risk of cross infections or HAI. The literature provided no clear answers on how to make 
cleaning improvements and permanently implement and provide a measure of quality assurance for 
these cleaning outcomes.   
This gap in the literature around cleaning within healthcare focused the project onto the definition 
of healthcare surface cleanliness, and immediately two separate process issues became apparent. 
The first was the cleaning process itself, and the second was the outcome from the cleaning 
processes. Visual inspection and surface microbiology were insufficient to meet the requirements of 
a modern hospital. At that time, the literature suggested two new methods of cleaning validation for 
investigation. The two new methods proposed for applications within healthcare settings were the 
use of rapid ATP testing (ATP), and fluorescent marker technologies (FM), which is where the 
following description of the laboratory phase of the project commences. 
 
Some Background on ATP testing 
Adenosine Triphosphate (ATP) is present in all living cells and testing using ATP portable devices was 
first developed for the food industry.34 The first published study using ATP testing to measure 
cleanliness within healthcare settings came later.35 ATP is detected using the “firefly reaction” and 
the amount of light liberated in this reaction is roughly proportional to the amount of ATP present in 
a sample.36 
The handheld and portable ATP testing devices measure all available ATP in a swab sample by firstly 
lysing any cells to liberate the ATP present, and then measure the light output from the luciferase 
reaction using a Photo Diode Array or a Photo Multiplier.37 However, these devices do not 
distinguish between the sources of ATP and so any cells present (human, plant or bacterial cells) will 
yield a volume of ATP against which the light reaction will occur. Consequently, the use of ATP 
testing cannot be directly correlated with bacterial contamination, but only cellular contamination 
(all sources). 
So, ATP testing is proposed a surrogate of cellular soiling in general, and not specifically bacterial 
soiling. To add to complications in use, ATP testing cannot distinguish on the basis of resistance or 
susceptibility to antibiotics (MRO). Review articles on the use and abuse of ATP testing have noted 
these shortcomings, which is discussed later and within the presented papers of this thesis.38 The 
use of modern selective growth techniques and the application of modern genetics in microbiology 
(such as whole genome sequencing) are both essential for the detection and specific identification of 
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MRO as indicated later in the thesis. These improvements to specificity in microbial identification 
with MRO dramatically improve our understanding of the movement of MRO within and without the 
healthcare setting in both spatial and temporal aspects.39    
 
The Initial Laboratory Phase 
The use of rapid ATP testing had become available to the food microbiology sector in late 1998 with 
the innovation of hand held (portable) ATP testing devices and accompanying consumables. The use 
of rapid ATP testing was suggested in 2000 as a superior method to both visual inspection and 
microbial recovery methods for cleaning validation within healthcare settings.35 This application of 
rapid ATP testing was being explored with field studies on the practical implementation of rapid ATP 
testing as a surrogate method for cleaning validation within hospital settings.40-44 
The other new method of cleaning validation used a fluorescent marker (FM) and had been 
developed by Dr Philip Carling, an Infectious Diseases clinician who was concerned that critical 
cleaning required practical verification.17 This new FM technology allowed tracking of cleaning 
action, and whilst being a qualitative measurement, the FM appeared to work well as a quality 
improvement technique.45 The use of an FM was shown to aid in the reduction of Staphylococcus 
aureus nosocomial infection rates when included as part of a cleaning intervention during an 
outbreak of disease.46 
The starting point for this PhD project at the Confirmation of Candidature (COC) was a research 
proposal which included the validation of cleanliness monitoring methods by comparing the new 
methods (ATP and FM) with the two existing methods (visual inspection and microbial recovery). The 
project would move from a laboratory based validation process (focused on rapid ATP testing and 
FM usage) and then move into a risk assessment that subsequently applied the findings of validation 
studies and risk assessment and tested these findings within a healthcare setting.  
The initial studies arising from the COC project proposal quickly identified that the validation of the 
ATP testing systems required more laboratory based research than was initially anticipated. The first 
laboratory study subjected samples of the Fluorescent Marker (FM) to a range of drying studies to 
qualify the characteristics as described in the literature. A key observation was that the ATP devices 
were measurement tools (quantitative), whereas the FM was an observational (qualitative) tool.  
The initial experimental results were expressed through two Poster Presentations in 2011 at the 
International Federation of Infection Control meeting in Venice (Appendix B1 and B2). A result of the 
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early findings included a risk-based approach to cleaning monitoring which is shown on the poster 
titled “The importance of practical zero in cleaning performance indicators” (Appendix B1). The flow 
chart presented on the poster is shown as Figure 1.  
The goal of a cleaning process is soil reduction or microbial removal and there are four possible 
outcomes from any monitoring process. The four possible outcomes are also individual risk elements 
of a cleaning process being true negative, false negative, true positive and false positive. Each of 
these risk elements has implications for cleaning management and infection prevention. The 
cleaning process involves a cleaning activity that should be measurable (efficiency monitoring) and 
the cleaning outcome that should also be measurable (efficacy monitoring). Whilst ATP testing 
measures the efficacy of the process, it is the role FM to measure cleaning efficiency.  
The experimental results for FM were described on the second poster (“Validation of cleaning 
indicators for healthcare surfaces”) at the same IFIC 2011 Conference (Appendix B2).   
 
Figure 1: Cleaning Process Risk Overview (source: Whiteley Poster: Appendix B1)
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The Validation experiments with ATP testing devices and consumables 
The laboratory work examining the validation of the ATP devices used a known source of 
standardised ATP in controlled dilution series. This experimental work used a new method to 
conduct the validation by applying the diluent directly onto the swabs using a micro-pipette. The 
study was based on standard validation methods as outlined in the International Conference on 
Harmonisation (ICH) Guidelines on validation for the pharmaceutical industry which calls for 
separate validation for each of the known variables.47 
In using an ATP testing device, a pre-prepared swab (consumable) is used to wipe across the surface 
to be tested, which is then recapped, and the reagent (which is contained in the proximal end of the 
swab) is released onto the swab which allows the ATP-Luciferase reaction to initiate. There is a short 
activation time of around 15 – 30 seconds during which time the swab is inserted into the ATP 
measurement device for detection of the light arising from the reaction. The light is measured by the 
ATP testing device and the measurement is expressed as relative light units (RLU).  
The first and primary consideration in the validation process for the rapid ATP testing devices and 
their consumables is the reliability of the core chemical reaction between the Luciferase and the ATP 
and the quantification of RLU expressed as a result of the reaction. The initial validation started with 
testing the dose-response of the devices using this core chemical reaction process before any other 
variables were introduced to the validation experiments.    
The additional variables present when using a rapid ATP device and consumables as intended, 
include the swab ‘material’, which was identified as an independent variable in its own right (the 
first independent variable in addition to the core biochemical reaction). The swabbing process is a 
separate, second independent variable. The reagent containing the luciferase must also contain a 
separate chemical reagent which will induce cellular lysis to liberate the intercellular ATP, and this 
lysis process is yet another and third independent variable. So, before the essential reaction can 
occur, there are at least three separate variables which could each independently effect the results 
of the validation.   
In order to avoid confronting these variables, the decision was taken to use a calibrated micro-
pipette which would apply the ATP in quantitative volumes directly onto the swabs, thus focusing 
the testing purely on the performance of the devices/consumables against pure ATP solution in a 
quantitated dilution series. This was a previously unpublished method for this type of validation 
study and has subsequently had citations in peer reviewed publications looking into ATP studies.  
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The results of the study were therefore a more accurate indication of validation of ATP devices than 
any prior studies, all of which were either field based or subject to the combination of all four 
variables (dose response; swab material; swab technique; and lysis chemistry). The other key issue 
arising from the research was that a sufficient number of replicates at each dilution point were 
required to establish precision at each sample point which was also a previously unreported finding. 
This was an important observation due to the variability observed in the first experimental phase.  
The results from the first validation study of the three ATP bioluminometers were analysed and 
submitted for publication. The first full paper arising from the laboratory studies on the three ATP 
devices was submitted to the journal, Healthcare Infection (CSIRO publications), was accepted into 
peer review in June 2012 and was accepted for publication in July 2012.48 
The key findings of the first paper were threefold. Firstly, the scale used to express the measurement 
of ATP uses Relative Light Units. Whilst all of the commercial ATP devices make use of the same 
equation (one ATP unit plus one Luciferase Unit gives one light unit), each of the devices applies a 
different algorithm to express the measurement of light units and even the method of light 
detection varies between different branded ATP devices.37 So, whilst the same equation is used as 
the underlying technology, the expression of RLU is relative in every sense. There is no standardised 
scale and so each ATP device will express a quite different number when measuring a standardised 
ATP quantity. The lack of a standardised scale means that different brands currently have no 
interoperability. The lack of a standardised scale also means that any calibration tool is relative to 
that device only and has no universal applicability. Without a standardised measurement scale, 
accuracy of measurements cannot be assessed.  
Secondly, the ATP devices were reasonably reliable when testing against a ten-fold dilution series 
(and taking the median reading as indicative). An important contribution of the findings arising from 
the log scale dilutions was that all three ATP devices tested did demonstrate a uniform linearity of 
response over the core part of the dynamic range. However, all of the ATP devices tested were 
highly unreliable at testing a 20% dilution series. The uncontrolled variability revealed through a 
standardised laboratory validation process was both surprising and unexpected. Interestingly the use 
of medians to express a group of readings was more reliable than averages due to the frequency of 
outliers (which was also part of the novel result).   
Thirdly, there was no way for a normal user to detect the level of variability when using an ATP 
device. Therefore, the applicability of ATP devices to perform a role in validation of cleaning was 
undermined by the limitations of the devices.  
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Lord Kelvin once wrote: 
“I often say that when you can measure what you are speaking about, and express it in numbers, you 
know something about it; but when you cannot measure it, when you cannot express it in numbers, 
your knowledge is of a meagre and unsatisfactory kind; it may be the beginning of knowledge, but 
you have scarcely in your thoughts advanced to the state of Science, whatever the matter may be." 49 
The basis of measurement sciences is that the numbers produced can be relied upon to accurately 
express the underlying measurement. The first paper arising from this study demonstrated that this 
fundamental principle of reliability of measurement was seriously compromised when using rapid 
ATP devices. Further work was required to understand and quantify the level of variability.  
The work on reliability was extended in the second paper by using a simple but elegant statistical 
tool known as the Coefficient of Variance (CoV or Cv).50 Cv divides the standard deviation into the 
mean and gives a number that should be always between zero and one. The lower the number, the 
lower the variance. The Cv is the inverse of the engineering equation most frequently known as the 
signal to noise ratio (mean divided into standard deviation). 
Fortunately, the first experimental series used a large number of replicate readings at each 
concentration point, for each of the ATP devices. From this data set, the mean and standard 
deviation were calculated for each discreet concentration point with that associated sample group 
(same ATP device, same concentration and multiple readings at that concentration) and from there 
the Cv was calculated for each ATP device at each concentration.   
In this first experimental series a standardised and validated laboratory analytical tool (HPLC option 
on the Liquid Chromatograph – Mass Spectrometer, or LCMS) was also used to measure 
standardised ATP, and this provided a comparative data set. The Cv for the HPLC was very low, 
whilst the Cv for each of the commercial ATP devices was routinely high.  
Another advantage of the Cv over the more frequently used standard deviation, is that whilst the 
standard deviation is unique for each of the discreet sample groups, the merging of Cv and average 
into a single ratio, normalised all of the data from each of the discreet sample groups, thus allowing 
a true comparison. Figure 1 from the second paper is shown below in colour to illustrate the 
problems of variability observed in this first experimental series.  
The authors’ initial experimental studies on the ATP testing devices demonstrated that instrument 
performance required additional consideration in regards to validation and to practical use. A 
limitation of the first laboratory study on ATP testing devices which provided the data for the first 
and second published papers, was that the testing was limited to only pure ATP solutions. This 
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opened a reasonable opportunity for additional study using bacteria. Studies were commenced 
using bacteria to challenge the performance of ATP testing devices. 
 
Figure 2: Coefficient of Variance for three portable ATP bioluminometers (source: second 
Whiteley Paper: ICHE 2013:34:538-540) 
 
 
 
Consideration of Failure Risk arising from Cleaning Monitoring Methods 
Whilst this laboratory based research into ATP device variability was continuing, an important 
strategic question arose in regard to the findings. The initial two publications had demonstrated that 
the reliability of measurements was an underlying and uncontrolled variable for the field use of ATP 
testing within healthcare settings. The next question was to consider the impact of the published 
findings (from the first two papers) on current uses of the ATP testing devices within healthcare 
settings. The impact of this unreliability in measurement required a risk assessment.   
The earlier work outlined in one of the authors 2010 posters (“The importance of practical zero in 
cleaning performance indicators”) mapped out a risk management approach that accounted for both 
false positive and false negative interpretation risks from the data (Appendix B1). These could be 
considered as type I and type II statistical errors. This methodological approach had been used in 
studies attempting to deduce a ‘best option’ for a cleanliness threshold using ATP testing where a 
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Receiver Operating Curve (ROC) was developed to position the proposed cleaning threshold based 
on a proposed RLU level.51 
A risk-based study was undertaken to consider the impact of the variability of the ATP testing 
devices in practical use within healthcare settings.  Given that failure risk can include both false 
positive and false negative outcomes, and that failure risk applies to all of the cleaning monitoring 
methods, the study was widened to also include FM, visual inspection and microbiological recovery 
methods.   
The use of each of the monitoring methods was considered using the innovative application of 
Failure Mode and Effects Analysis (FMEA), which is a standard tool used in the medical device 
manufacturing sector.52,53 Whilst this focused the study onto the failure risks of each of the methods, 
the literature revealed that these risks were more clearly identified than any positive association 
with any of the cleaning monitoring methods.  
Far from being a negative study (as implied by the word ‘failure’), this FMEA process allowed the 
combination of the different methods to reveal a new approach and integrated use of each of the 
cleaning monitoring methods (see Figure 3 below).  
This integrated monitoring approach reflected the risk overview shown in Figure 1 from the first 
poster in 2011. In that earlier figure, the four possible outcomes from any cleaning process were 
outlined as true positive, false positive, true negative and false negative (indicated as the worst 
possible failure risk in red colouring). In this third paper, the monitoring methods were combined 
into an integrated framework so as to minimise the risks of any one method providing a false 
negative outcome (this would be an indication of cleanliness where in fact pathogenic microbes 
remained despite the cleaning processes).    
The third paper, which used the FMEA approach was submitted for publication in August 2014 and 
accepted for publication in October 2014.53  
This FMEA study linked all of the monitoring methods, including the ATP testing, and contextualised 
the application of the cleaning monitoring methods in a new and novel way. This work both built on 
the ATP validation work and extended a justification for continued use of ATP testing despite the 
risks of measurement variability. The work also demonstrated that ATP testing has a distinct role in 
cleaning monitoring that is unique in its timeliness, quantitation of cleanliness, and ease of use.  
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Figure 3: An integrated model for cleaning monitoring (source: third Whiteley paper: AJIC: 
2015:43:147) 
 
 
 
Continuing the Laboratory Phase 
Experimental work on the validation of the ATP devices was extended to also consider the detection 
and measurement of bacterial ATP. Given that the swab materials and lysis chemistry were fixed 
(each determined by each of the ATP device manufacturers) and that the swabbing techniques 
required for environmental cleaning were well reviewed by others, the focus of the remaining 
laboratory work with ATP devices was on the essential responsiveness of the ATP devices to the 
suspensions of bacterial cultures. This extended the experimental phase using several known 
bacterial species in quantitated dilution series. These experiments with suspension cultures were 
used to examine the variability of the devices ATP-Luciferase reaction and to compare this to the 
variability observed when only pure ATP had been tested. 
A number of experimental runs using different bacterial species were commenced. Bacterial cultures 
were selected on the basis of gram staining and general relevance to healthcare settings. The 
bacteria initially chosen were laboratory strains of Staphylococcus epidermidis (ATCC 12228) (S 
epidermidis), Escherichia coli (ATCC 25922) (E coli) and Pseudomonas aeruginosa (ATCC 15692) (P 
aeruginosa).  
The use of bacterial species required an extensive period of range finding and experimental 
exploration in order to develop sound techniques and approaches to underpin the microbiological 
21 
 
validity of the project. Refreshing the benchtop microbiology methods was an important personal 
feature of the journey. The preparation period was extensive and ensured that repeatability in the 
results was attained, including issues such as quantitation of the dilutions of the suspension cultures. 
The microbiological work added materially to the validation process as range finding work confirmed 
the new variables to be controlled. An example of the value of the preliminary work was that the use 
of E. coli was discontinued following what appeared to be lysis failure for both of the 3M and 
Hygiena ATP devices/consumables. Another validation issue was that the use of Triptone Soy Broth 
(TSB) as a growth media for the suspension cultures was observed to interfere with two of the 
devices/consumables (Kikkoman and 3M) whereas Phosphate Buffer Solution (PBS) had no impact. 
The use of TSB was thereafter discontinued in preparation of the bacterial dilution series for 
validation testing.   
An additional (fourth) commercially branded ATP device was made available through the University 
of Tulsa in Oklahoma and the Cleaning Industry Research Institute International in the USA. This ATP 
device (Charm Inc) added a new dimension to the work as its scaling was much higher than the 
existing three commercial devices used in the earlier studies.  
The methodological approach for the microbiological challenge to the ATP testing devices followed 
the earlier work using pure solutions of ATP as used in the first study. The statistical analysis using 
the Cv approach used in the second study was also followed and so the results of this extended 
laboratory phase of the validation work were all translated from the raw data into Cv results. 
The initial studies using pure ATP dilutions were also repeated to ensure comparability and 
completeness, although data from all of the pure ATP dilution series of studies was included in the 
full presentation of Cv analysis. Statistical advice was obtained through Mr Paul Fahey who also 
agreed to be included as co-author on the paper.  
The results from the studies using bacterial cultures demonstrated that the variability observed 
using ATP from a known source, was precisely the same variability levels seen when testing against 
bacterial species. Whilst the lysis variable was still uncontrolled, the results mirrored the earlier 
finding on variability. 
The fourth Whiteley paper was written and then in November 2014 it was submitted to the leading 
healthcare epidemiology journal, Infection Control and Hospital Epidemiology (ICHE) which is 
published on behalf of the Society of Healthcare Epidemiologists of America (SHEA).54 This paper 
confirmed the experimental findings on variability and demonstrated the importance of a thorough 
validation approach prior to any field based applications of ATP testing and interpretation of the 
data arising. This study is the first published paper to demonstrate that the variability seen when 
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challenging ATP testing devices with pure ATP solutions was exactly mirrored by the variability 
observed when testing those same devices against quantitated bacterial dilution series’.   
 
Communicating the message on ATP testing variability 
During the period of writing up this fourth paper, a study by Visrodia et al., was published (also in 
ICHE) which used ATP testing to ‘validate’ endoscope cleaning.55 The work was supported with 
funding by the commercial manufacturer whose ATP testing device was exclusively used in the 
study. The paper failed to provide validation data and used a single point sampling method, which 
overlooked potential variability, flaws in the sampling methodology and statistical analysis.  
A response was initiated by this author and a letter to the editor was submitted for publication in 
September of 2014 (accepted October 2014), which focused on two problems with the Visrodia 
paper.56  
Firstly, the issue of using a single brand and not cross correlating with a second branded unit was 
discussed to illustrate the dangers of the relative scaling and lack of unit interoperability. A 
commentary on the Visrodia paper had made a similar, albeit unreferenced remark.57  
Secondly, the Visrodia paper indicated that the sampling method used to obtain ATP readings was 
based on single point samples (not even duplicate sampling was conducted) and therefore variability 
issues were unrecognised. The statistical analysis of the raw data was done on this sample set and 
found with significant findings. This raised the significant risk of type I statistical error.  
In the reply from Visrodia et al., the most important responsive comment was “Given the imperative 
for cost containment and to improve efficiencies on the front lines, we believe it would not be 
desirable to perform duplicate or triplicate testing as suggested by Whiteley et al. Their concern 
about variability within and between ATP measuring devices deserves additional study.” 58  
The fourth Whiteley paper, which focused specifically on the issue of recurrent variability in ATP 
testing, was published just three ICHE editions later in the June 2015.53 This fourth paper set out the 
critical issue of variability and for the first time proposed a quantitated risk of misreading based on 
the high variability. Earlier mathematical work by Reed et al., had proposed that where the Cv is 
above 0.4, then there is a 20% likelihood that any one reading (in RLU) could be out by a factor of 
two.59 In this context a reading of say 100 RLU, could indicate a true reading of between 50 RLU or 
up to a true reading of 200 RLU. This gave insight into the variability observed in the first Whiteley 
paper when the 20% dilution series were undertaken.50 
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In that first study, the log scale differences had minimised the impact of this variability (difference is 
‘10-fold’ and not just ‘2-fold’).50 Whereas by using a 20% dilution series the RLU readings presented 
in figures 2 – 4 in the first published paper, showed that there was often overlap between what 
should have been clearly differentiated readings/data sets.  
This insight also goes some way to explaining why many of the statistical findings on earlier studies 
by other groups produced insignificant results, and results which did not correlate well with parallel 
measurements such as microbial recovery. Whilst the ATP testing does read a wider variety of ATP 
soils, and not just bacterial ATP, the results often obtained were incongruous.  
A good example is in the paper by Sherlock where in several instances the ATP readings go up after 
cleaning whilst the microbial results decrease.60 In Lewis et al., readings using an ATP cleanliness 
threshold of 250 RLU (a 3M ATP device) also often show failures where below threshold microbial 
growth is noted.61 
To further add to the confusion and variability difficulties with interpretation of results from ATP 
testing, there is no standardised size of sampling area for swabbing. When ATP testing was first 
suggested by Griffiths et al., the sampling area suggested was a 10x10cm (100cm2) area with a target 
level of cleanliness of 500 RLU using a Cleantrace (3M) ATP testing device.35 Following studies using 
the same branded equipment and same sampling area concluded that the cleanliness standard 
should be reassessed and suggested a cut-off of 250 RLU.61  
A study by Andersen et al., suggested that the cleanliness standard be reduced to just 100 RLU using 
a similar 10x10cm = 100 cm2 sampling area but using a different brand of ATP testing equipment 
(Hygiena).62 The swabbing area for use in ATP testing has often followed the recommendations of a 
100cm2 area (10cm x 10 cm) in both food and healthcare settings whilst using non-comparable 
equipment. 63,35,43,62 Another study selected a smaller sampling area of just 16cm2 (e.g. 4cm x 4cm = 
16cm2).64 Finally, another study using the Hygiena ATP reaffirmed the 100 RLU cleanliness threshold, 
but reduced the sampling area to a more practical 2 x 5 cm (10cm2) area.51  
The variability problems with these useful little devices could be mitigated substantially with the 
development of a unified RLU scale against which the ATP testing devices could be calibrated. This 
would allow for accuracy and improved precision. 
Another approach taken in an effort to determine a reliable RLU ‘cut-off’ is the use of an ROC curve 
correlated with bacterial recovery from similar surfaces. The work in Mulvey et al., used the ROC 
curve approach and concluded that this method provided only ‘weak support’ for the 100 RLU cut-
off.51 Similarly, in Smith et al., after application of the ROC curve approach, using a different ATP 
testing device (Cleantrace, 3M), the ROC supported an elevated RLU threshold or cutoff at 800 RLU 
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on a 10x10cm=100cm2 sample area.65 This threshold outcome was not able to be correlated 
between the three cleanliness monitoring methods used in their study. 
The issues of different RLU scales, unpredictable readings in RLU readings due to inherent variability, 
the non-standardised swabbing area used in differing studies, the poor correlation with bacterial 
presence on surfaces, the weak evidence provided through methods such as the ROC curve 
approach, and the differing performance characteristics between ATP testing device brands can all 
work together to confound practical studies using ATP testing. The practical reality is that a pre-
determined, single cleanliness threshold expressed in RLU, which is common to all ATP testing 
devices is statistically unobtainable at this point in time. Any field based study requires very careful 
consideration to mitigate these issues, which was the point made in response to Visrodia et al. 56 
 
The practical application of the findings through a (pilot) field based study  
In August and September 2014 an opportunity arose to use the ATP testing devices in a practical 
field application in a real healthcare setting. This study integrated the earlier findings with an 
existing clinical microbiological research program through the School of Medicine at Western Sydney 
University. This study – lead by Professor Iain Gosbell – was investigating the locations of MRO 
embedded within dry surface biofilms which are present within an Intensive Care Unit (ICU).66, 18 
The first sampling attempt to locate the biofilms used a list of likely sites and objects within the ICU. 
This sampling round used only microbial recovery and required a more aggressive form of surface 
swabbing based on a method originally proposed in ICHE by Corbella et al., whilst that Corbella team 
were searching for Acinetobacter baumannii.67 The biofilm research was interested in locating any 
multi drug resistant organisms (MRO) imbedded within biofilms on environmental surfaces. To 
recover the MRO a selective growth media was used, followed by further identification methods.  
However, the initial results from the first sampling round were poor with only a single sample from 
twenty three total samples returning positive growth on the selective media. 
The candidate posed the question: ‘Could the ATP testing assist in the identification of more dirty 
areas when used in combination with the microbial recovery methods as per the teaching of the 
third Whiteley paper?’ 52 The sampling methodology in this pilot study used both ATP and surface 
microbiology at matched sites within the ICU. The sampling method used two of the ATP testing 
devices at each sample location and in tandem with the aggressive biofilm swabbing approach.   
In the second sampling session – a trial run – the sampling approach using two ATP devices and 
microbial recovery. Whilst at every sampling site one of the sampling methods was used (either of 
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the ATP devices and sometimes microbial recovery), at only a limited number of the sites were all of 
the three methods used. The two ATP devices used were the Hygiena and Kikkoman devices and 
accompanying consumables. The Hygiena device was used more extensively in this initial ATP 
sampling session which followed on from teaching by Andersen et al.68 
A third sampling run was organised for early in September where all of the samples taken were fully 
matched. The collaborative approach provided excellent results. 
The statistical analysis indicated that the ATP testing did assist in identifying the surfaces with higher 
levels of microbial soil (Chi-Square P>0.025[corrected for Yates] and Fishers Exact P=0.01). The 
sampling sequence was 1/23 MRO positive samples on the first round, with 12/36 MRO positive 
samples on the combined second and third sampling rounds when the samples were fully matched. 
Importantly, the sampling locations with higher ATP readings in many instances grew MRO, although 
on the day of ATP testing and microbial sampling, it was only the ATP testing in real time which gave 
the indication of the more soiled surfaces with higher RLU readings. The microbial recovery results 
were not known for five days after the sampling, and longer for the accurate microbial identification 
of the specific MRO which were recovered. 
Whilst the more aggressive sampling method did assist in higher recovery rates than normal 
swabbing methods might have achieved, the statistically significant findings demonstrated that using 
a list and visual observation, was poorly successful (1/23). Whereas, with real time feedback via an 
ATP testing device (where the matched samples were conducted), sampling revealed a large number 
and variety of MRO on environmental surfaces available to potentially infect patients (12/36).  This 
use of a combination of the recognised cleaning monitoring methods largely followed the teaching 
of the earlier work in the third Whiteley paper.52 
The results in real time of the ATP testing, indicated that the focus of the sampling should be moved 
from the patient surrounds to the area around the clinical work station including chairs and highly 
touched devices with which staff were in frequent hand contact. This proved a decisive approach 
despite concerns over the use of ATP in healthcare settings.69 The discussion section of the published 
paper identified a number of potential flaws in interpretation of the results but also indicated 
improvements for further and on-going studies to improve infection prevention strategies focused 
on environmental surface hygiene within healthcare settings.  
The fifth paper was submitted to the American Journal of Infection Control for publication in June 
2015 and was accepted in July 2015. It was published in the December 2015 edition of the journal.70 
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This fifth paper is the first Australian study to have located such a high number and variety of 
contaminated surfaces (13 separate locations) with such a variety of MRO inside an active ICU. 
The paper was written with a clear outline of the flaws in the pilot study, but with the statistical 
findings clearly described and discussed.  
The paper also made some other very important observations. Using two ATP devices in parallel 
within a healthcare setting has been documented in only one other paper.68 The paper by Andersen 
et al., used a 3M device and a Hygiena device. Whilst the Hygiena device provided a platform of 
results that were significant for some measurements, the ‘before-and-after-cleaning’ readings from 
the 3M device were not statistically significant. Unfortunately, there was no attempt in the Andersen 
paper to correlate the ATP readings (in RLU) between the two ATP testing devices.  
In this fifth Whiteley paper the correlation between the two devices was subject to direct 
comparison. The first important finding of this paper in respect to rapid ATP testing devices and their 
variability was the almost zero correlation (r2=0.0144) between the sampling results of the two 
branded ATP devices – Hygiena and Kikkoman – that were used in the study. Whilst the 
manufacturer of one of the ATP devices used (Kikkoman) does note the capacity of the consumables 
to measure other components (including Adenosine Mono-Phosphatase = AMP) this finding 
warrants additional research in subsequent studies.71 
The second important observation made in the fifth paper relating to ATP testing, was that provided 
that the teaching of the third Whiteley paper (using FMEA) was followed with parallel/alternative 
cleanliness measurements, rapid ATP testing did contribute significantly towards indicating surface 
cleanliness. This is a very positive finding for the use of ATP testing when examining the cleanliness 
of surfaces. The use with biofilm studies also warrants additional and future research.  
This fifth paper is a neat conclusion to the work. As a pilot study the paper demonstrated the 
learning achieved through this confluent body of work. It takes the findings of the earlier validation 
and risk studies and extends them practically in a new and novel manner with outstanding results, all 
based on the findings of the four other (included) Whiteley papers.  
The essential goal of cleaning monitoring is to ensure that the cleaning is achieved both in terms of 
efficacy and efficiency. FM can play a qualitative role in efficiency monitoring as indicated in the 
posters presented from the earlier project findings. The use of rapid ATP testing as presented in this 
fifth paper provides a timely (rapid) indication of surface cleanliness that allows further intervention 
or investigation if required. The validation work achieved through this study has demonstrated both 
the problems and failure risks with commercial rapid ATP testing devices (as they are currently 
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configured). The implications arising from this observation contrast earlier critical for the use of 
rapid ATP testing within healthcare settings.72 
The validation work also contextualised these flaws when ATP testing is used within the healthcare 
setting, and outlined how the flaws can be minimised, whilst taking full advantage of the benefits of 
the ATP testing and real time readings.73 The final and fifth paper demonstrated how the variability 
was both present in the study, and yet the real time impact and cleanliness indication was 
sufficiently useful to direct microbial sampling to uncover a wide array of MRO lurking in plain sight 
and within the clinical area of an active ICU.  
 
The following chapters set out: 
a. In Chapter two, the overview of the methods used in this thematic study;  
b. In Chapter three, how the five papers demonstrate the work and meld together into a single 
PhD thesis as a complete body of novel findings; and  
c. In Chapter four, how the work has opened up a wide new pathway of further and on-going 
research. 
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Chapter 2   
Methods used within the study 
Précis  
This chapter outlines the background for the methods used within each of the five papers and 
explains how these methods interlock in a single confluent theme within the PhD. The full details of 
each of the methods are described in each of the five papers. This chapter sets out the salient 
reasoning for selection and development of each of the methods and the contextualisation for each 
application. This chapter also discusses the implications of the methods for further investigation into 
the use of ATP testing for cleanliness monitoring within healthcare settings. 
A brief outline of the methods used in the five papers 
The backbone of the study is the laboratory phase which investigated the validation issues for rapid 
ATP testing. The laboratory methods followed the applicable principles of pharmaceutical industry 
guidelines to establish the responsiveness of the ATP testing devices and their consumables.1 The 
data were generated through the novel ‘direct droplet’ method of analysis whereby ATP was directly 
applied to each of the ATP swabs using a micro-titre pipette. The data were then plotted, statistically 
analysed for association and also analysed the using coefficient of variance (Cv) method. The use of 
this approach provided a basis to normalise the data across the full array of the experimental series 
and to compare each of the branded ATP devices.  
The first, second and fourth of the papers included in the PhD study outline the methods of analysis 
for the ATP responsiveness and the results obtained from the testing program. The ability of the ATP 
devices to meet the core validation criteria of linearity, dynamic range, accuracy, precision and limits 
of detection are demonstrated in the results. The methods used demonstrate that uncontrolled 
variability is an issue for all of the ATP device brands tested in this study. A key quality assurance 
concern for any application of ATP testing within healthcare settings, is that the measurements 
provided by the ATP testing must be reliable and well understood so that interpretation of the ATP 
data is able to stimulate an appropriate quality assurance response. 
The second phase of the work, as outlined in the third paper, took the data from the ATP testing and 
considered how to integrate ATP testing into a cleanliness monitoring process. The study used the 
risk based method of ‘Failure Mode Effects Analysis’ (FMEA) to assess the impact of the hazards of 
cross infection where any of the four main methods of cleanliness monitoring are used. A novel 
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proposal for an integrated cleanliness monitoring approach within healthcare settings was a key 
finding arising directly as a result of the novel application of this FMEA method.  
The fifth paper outlines the final phase of the work where a field based pilot study was conducted. 
This study followed and applied the findings arising from firstly the ATP validation studies and 
secondly the new integrated cleanliness monitoring process. This pilot study was conducted within a 
working Intensive Care Unit (ICU) in a modern teaching hospital. The sampling method used two ATP 
devices, a novel approach to microbial sampling, and the statistical analysis compared the findings 
when using microbial sampling only, with the integrated use of visual inspection/observation, 
microbial sampling and rapid ATP testing.  
 
Table 1: The methods used in the Five Whiteley papers  
Paper 
Number 
Abbreviated Title Journal, 
Year 
Method of Analysis Statistical Analysis 
1st 
Paper 
Comparative 
performance of 3x ATP 
Bioluminometers 
HI, 2012 1. ATP analysis using 
ATP devices - using 
pure sourced ATP;                 
2. ATP analysis using 
HPLC 
1. Test of association 
(Kruskal-wallis)   
2. Linear correlation 
(HPLC)                    
3. Box and whisker 
graphs for precision 
testing  
2nd 
Paper 
ATP Device Reliability 
Testing 
ICHE, 
2013 
Used data from 1st 
paper  
Coefficient of Variance 
(CoV or Cv) 
3rd 
Paper 
FMEA & Synergies  AJIC, 
2015 
Risk analysis using 
FMEA 
Not applicable 
4th 
Paper 
The Perennial problem 
of variability of using 
4x ATP 
bioluminometers 
ICHE, 
2015 
1. ATP analysis using 
ATP devices - using 
pure sourced ATP;                 
2. ATP analysis using 
4x ATP devices using 
2x bacterial suspension 
cultures;                       
3. ATP analysis using 
HPLC 
1. Coefficient of 
Variance (Cv)                                                                
2. Box and whisker 
graphs to indicate data 
spread 
5th 
Paper 
Pilot study in finding 
the bad bugs in an ICU 
using ATP & 
Microbiology 
AJIC, 
2015 
1. ATP analysis using 
2x ATP devices in an 
active ICU setting    2. 
Microbial recovery 
using swabbing and 
selective media with ID 
specificity analysis 
(Vitek) 
1. Test of association 
using Chi-square and 
Fishers Exact Test;            
2. ROC Curve (sensitivity 
analysis);     
3. Linear correlation with 
results with the 2x ATP 
devices 
Key: Abbreviations: HPLC = High Powered Liquid Chromatography; ICU = Intensive Care Unit; ROC = Receiver Operating Curve 
Journals: HI = Healthcare Infection; ICHE = Infection Control Hospital Epidemiology; AJIC = American Journal of Infection Control 
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In each paper the methods of analysis and statistical methods were overseen and re-checked with 
supervisors and co-authors for the papers. In the first 3 papers the primary author was Whiteley plus 
two co-authors (Dr Derry and Dr Glasbey). In the 4th paper a third co-author was added (Paul Fahey). 
The 5th and final paper had the principle author (Whiteley) and one of the prior co-authors (Dr 
Derry), plus four additional co-authors (Jessica Knight, Professor Gosbell, Associate Professor Jensen, 
and Associate Professor Vickery). 
The methods of analysis and statistical and drawing tools used in each of the five papers are shown 
in Table 1 where they are briefly outlined. 
 
Methods of analysis for ATP testing devices (Whiteley Papers 1, 2 and 4) 
The method that underpins the first three of the papers used a novel approach to measuring the 
accuracy of the dose-response for the application of ATP or ATP containing soils with the various ATP 
testing devices and their associated consumables. This new approach used a calibrated pipette to 
directly and quantitatively apply the test solutions directly onto each of the ATP device swabs.  Until 
the first of the papers in this PhD, all of the studies in healthcare had used bacterial suspensions, 
either applied to a surface or dried onto surface, to assess responsiveness and other characteristics 
of the rapid ATP testing devices.  
In the period leading up to the initial study (the first paper), only one paper had been published in 
infection control journals which used a validation style of approach to ATP testing devices.2 In this 
paper by Aiken et al, the test solutions were bacteria dried onto a surface.  
The Aiken paper used only a single microorganism (Staphylococcus aureus) but tested a range of ATP 
bioluminescence tests (including rapid ATP devices) and the results indicated many inconsistencies 
in the ATP results including a large variance in results and a reported Cv of ‘133’. The results 
compared readings in RLU and ATP light emissions across a dilution series on a log scale (ten-fold 
dilutions) and concluded that ATP bioluminescence was not an accurate way to measure the number 
of bacteria on a test surface. The work also noted that the number of bacteria was frequently 
underestimated (by a factor of up to 10 times) and that the highest level of inaccuracy was at the 
lower levels of bacteria being present.  
In early 2012 a paper by Shama and Malik reviewed and strongly criticised the use of ATP testing for 
hygiene monitoring.3 The authors engaged in a series of letters  which responded to a series of 
papers on ATP which were published without suitable reference to the difficulties of using ATP 
testing and particularly in response to articles propositioning the ATP testing and use of cut-offs of 
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various RLU values.4 A paper by Heller et al., also presented data which suggested that the 250 RLU 
cut-off did not correlate well with the presence of MRO on hospital surfaces using a Neogen ATP 
testing device.5  
Another of the papers in 2012 examined the comparative reading and reliability efficiencies of three 
branded ATP devices using three microorganisms across a log scale dilution series.6 This work by 
Sciortino et al also used microorganisms dried onto surfaces. This paper also identified that 
consistency was a problem for all brands, although a ‘best brand’ was selected. A close examination 
of the results suggests that variability was a constant problem and that variables such as swab 
material, swabbing efficiency and even lysis efficiency were uncontrolled and unrecognised until 
later in the experimental phase.  
The authors also hinted that use of a direct droplet application onto the swabs may produce a 
different result from application of the swabs to a dried inoculum on a surface, but there were many 
‘random effects’ noted in the paper. The reasoning for this conclusion was based on the response of 
one organism (Candida albicans) which showed higher readings using dried inoculum rather than 
directly applied volumes of a suspension culture. As a retrospective reading of their data, the 
authors suggested that swabbing in combination with the lysis agent may in itself liberate bacterial 
ATP, however this was unproven, and somewhat questionable given the other inconsistencies in the 
various results. The important findings from the paper were that the three ATP bioluminometers all 
read on different RLU scales, and that the sensitivity of response to different bacteria was somewhat 
brand specific.   
There was an interesting exchange between Dr Malik and Dr Sciortino in a subsequent edition of the 
journal in regards to the validity of the results presented in the paper.7, 8 Dr Malik warns against 
overstating the case in favour of ATP testing and cautions explicitly against using ATP testing as “…a 
surrogate indicator of microbial burden and hence risk of infectious agents”.7 The response from Dr 
Sciortino defended their laboratory validation, but threw the issue of protocol development and 
validation for field use back onto the hospital staff thus leaving unresolved the practical issues of 
implementation for ATP testing within healthcare settings.8  
This highlighted the difficulties in the use of ATP testing for practical cleanliness monitoring 
purposes. Whilst the ATP devices are broadly and proportionately reactive to bacterial ATP in any 
series of ten-fold concentration dilutions, the practical applications require reliability on 
comparative cleanliness including detection of bacterial contamination.2,6,3-5 To move the ATP testing 
from the laboratory validation into use for cleanliness monitoring, reliability was the significant 
concern as any over-reaction in ATP readings could have cost implications (additional cleaning 
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required), whilst any under-reaction might allow infectious organisms to persist despite cleaning 
processes. Reliability in the precision of response of ATP testing devices to ATP was identified as an 
issue for exploration.  
In the work for the first Whiteley paper, the first research goal was to focus on the reliability of the 
ATP reaction response by the ATP devices to be tested. To achieve this outcome it was necessary to 
remove or minimise (as best as possible), all of the extraneous variables, including swab material 
dynamics, swabbing efficiency, lysis efficiency and even species sensitivity. It was agreed that the 
use of a pure (known and validated source of ATP) would allow the examination of just the ‘ATP + 
Luciferase’ reaction. A ten-fold dilution series of pure ATP which was directly applied onto the swab 
via a calibrated micro-titre pipette, removed the non-essential variables and focused the results on 
only the reaction dynamics.  
As an extension of this work and to test the precision of response (by the ATP devices), on a 
narrower basis, a 20% dilution series was also tested. This provided additional insight into the 
precision around smaller variances in ATP concentration.  
The use of a fully validated HPLC method, anchored the findings in terms of a “gold standard” 
against which the precision of the ATP devices could be compared.  
This novel direct application method was used as the basis for all of the ATP data in the first, second 
and fourth Whiteley papers. This included using the direct droplet method for the experiments using 
suspension cultures of bacteria.  
For each experiment, the suspension culture was diluted from a freshly grown laboratory stock of 
the selected bacteria. Confirmation of live bacterial was performed using serial ten-fold dilution onto 
agar plates. Each of the experiments were repeated on multiple separate occasions to ensure 
repeatability. The data arising from the final set of repeats using bacterial suspensions were used in 
the 4th Whiteley paper. The work using pure ATP and the four ATP testing devices was also repeated 
to ensure that all of the ATP devices available for the validation work were considered as part of the 
final validation paper (the Charm ATP device had not been used in the earlier work).   
The statistical analysis using Cv was repeated using both Microsoft Excel (2010) and box and whisker 
graphs were drawn using Sigma Plot 12.5 (2013). 
This approach using direct application for the testing and validation of the ATP devices was novel 
and this PhD study documents the first use of this method. The confluent application of the novel 
direct application method, and then the use of coefficient of variance for statistical analysis was a 
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comprehensive approach to the validation which allowed a uniform understanding to be developed 
on the reliability of the ATP devices across the various branded platforms.  
One important finding through this comprehensive methodology (both the ATP analysis and the 
statistical methods) was that the outliers shown in the box and whisker plots were both above and 
below the 10th and 90th percentile whiskers. This was a regular event and not just a single time 
incident. This was observed with all of the ATP devices tested, and was observed in all of the tests 
including pure ATP and both bacterial species. There is no warning of this variability to users of the 
ATP testing devices. The methodological approach used in the 4th Whiteley paper is the only paper 
published which has demonstrated so clearly this level of unreliability.  
 
 
Risk Analysis using FMEA (Whiteley paper 3) 
The results from the first laboratory phase provided a more robust approach to the interpretation of 
the data arising from ATP testing. The uncontrolled variability in ATP test data requires careful 
consideration when preparing a sampling plan for cleanliness monitoring using ATP testing. The 
strong benefits of ATP testing such as the timeliness of a quantitative data reading has meant that 
research on using ATP testing within healthcare settings has continued to be widely published. The 
goal of using ATP to provide a quantitative basis for cleanliness monitoring and even the use other 
monitoring systems with an integrated approach to cleaning monitoring had been attempted.9-11  
The early PhD work on risk with the posters etc., opened a pathway to reconsider the cleaning 
monitoring methods with the data that had been generated on the ATP testing and FM spot 
experiments. Clearly the risks around failure were more significant than the benefits alone, and so 
consideration was given to the appropriate risk assessment tool with which to consider the 
integration of ATP testing into a cleanliness monitoring process in conformity with the Australian 
requirements.  
The Australian Commission on Safety and Quality in Healthcare produced a new framework in 2012 
of ‘National Safety and Quality Health Service Standards’ (NSQHSS).12 This introduced into Australian 
healthcare the requirement for a uniform approach to quality standards setting, quality 
improvement goals, and risk based management of hazards for patients and all stakeholders.  
There are ten broadly focused “national safety and quality health service standards” within the 
NSQHSS. The third standard focuses on “preventing and controlling healthcare associated 
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infections”. Under standard three, criteria 3.15 states that healthcare facilities should comply with 
the intention of a clean and hygienic environment by “Using risk management principles to 
implement systems that maintain a clean and hygienic environment for patients and healthcare 
workers”.   
The introduction of NQHSS standardised approach to quality assurance and risk assessment in 
principle provided an ideal backdrop for the application of a risk assessment based approach to 
examining each of the four cleaning monitoring methods.  
A review of various methods of the risk assessment was undertaken with consideration of the 
significant reference document, which was ISO 31010 (IEC/FDIS) titled “Risk Management – Risk 
assessment techniques”.13 This comprehensive review document covers the 31 major techniques for 
risk assessment. The document also provides a ranking assessment for applicability. Two of the 
authors of the third Whiteley paper had experience with FMEA, but the process was also well rated 
for reliability and applicability for the intended task.  
After reviewing the literature on risk assessment methods and tools, the decision was confirmed to 
use Failure Mode and Effects Analysis (FMEA) to examine all of the four major cleaning monitoring 
methods. FMEA is a prospective method that through an FMEA committee uses the known, 
described, documented or identified failure risks, and compares their individual impacts on the 
intended outcome. The FMEA method also then considers and recommends possible strategies to 
mitigate these impacts in practical settings. The FMEA process within industry settings frequently 
uses a 10 point rating scale, but so as to fit into the Australian quality framework which uses a three 
tier rating approach the method was adjusted to conform to the Australian NSQHSS approach to risk 
assessment.  
The committee of three (authors) individually considered what would be the failure modes for each 
of the cleaning monitoring methods, and subsequently what would be the rating against the three 
scoring criteria used with FMEA including frequency, severity and detectability. The American 
Journal of Infection Control has a limit of 4000 words and a limit of just three graphs or tables, and 
so only the 15 high and medium failure modes could be included in the paper.  
This paper is the first ever comprehensive assessment of the failure modes of each of the cleaning 
and cleanliness monitoring assessment methods. The application of this method allowed for the 
consideration of the combination of the four methods which took account of the failures but which 
also allowed the benefits to be respected.    
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The critically important recommendation arising from the study was the outline by Figure 1 in the 
FMEA paper (the 3rd Whiteley paper) which proposed a new way to combine all of the cleaning 
monitoring methods into a single integrated approach to cleanliness and cleaning monitoring. The 
recommendation on integration demonstrates that the strengths of each of the respective methods 
can be combined to overcome the weaknesses of the other methods. The use of FMEA as a method 
of assessment for cleanliness monitoring is novel and contextualises the work within the PhD on 
building a proposal to constructively resolve a new scientifically valid and integrated approach to 
cleanliness monitoring within healthcare settings. 
The paper was submitted using this approach and has been viewed or down-loaded on more than 
300 occasions with one citation so far.  
 
 
Pilot Study Methods (Whiteley paper 5)    
The fifth paper within the PhD study was a pilot study that applied the learning from the early ATP 
papers, and applied the recommended integrated method for cleanliness monitoring within a busy 
and fully operational Intensive Care Unit (ICU). In this case the cleanliness monitoring integrated 
three of the four methods into a singular approach.  
The particular ICU was concerned about the potential for transmissions of healthcare associated 
infections (HAI). The project team for this study (co-authors) included staff from the School of 
Medicine, the Ingham Institute and Macquarie University. The project was approved by the ICU 
(Medical Director) and the project didn’t require ethics approval (a survey of the environmental 
cleanliness not involving patients or staff is not included by the Western Sydney University ethics 
guidelines).  
The three cleanliness monitoring methods used were visual inspection, rapid ATP testing and 
microbiological sampling of surfaces including growth on selected media. The methods used in the 
study are well described in the paper and the discussion here is intended to amplify the reasoning 
behind the approach taken in the study. 
The comparison and first method used in the study was a sampling run using pre-determined lists of 
high touch objects (HTO). These HTO were identified from the literature. This first sampling run used 
a lone researcher and applied a novel sampling approach and re-growth based on selective media 
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using biofilm recovery principles.14, 15 The sampling on this basis yielded a very low recovery rate for 
MRO of just 1/23.  
The role of visual inspection is core to the Australian approach to the monitoring of both cleaning 
and cleanliness.16, 17 Whilst the auditing approach taken in the reference documents rates various 
items on a checklist, the approach in this study was more observational and took account of items 
and surfaces that were seen to be frequently touched by staff in the ICU.  
Notes were also taken on terminal cleaning efficiency following patient removal and methods of 
decontamination during terminal cleaning. Staff handwashing practices were observed but not 
audited. No feedback was provided to staff on either cleanliness or handwashing or touching items 
with gloved hands outside the immediate patient zones. 
There are five separate findings arising from the study that are well discussed in the paper. The 
methodological approach on the second sampling day in particular had recognised flaws, but even 
despite this the application of the learning on ATP sampling proved a decisive benefit when 
combined with the visual component in providing almost immediate and immediacy of feedback on 
relative cleanliness of different surfaces. This mixed method approach allowed more targeted 
microbiological sampling which significantly enhanced the results in locating the presence of multi-
drug-resistant-organisms (MRO).    
The method of duplicate sampling using two different ATP testing devices was also highly novel and 
illustrated the risks of uncontrolled variability and a lack of a uniform scaling approach. The almost 
complete non-correlation of the two devices was another previously unpublished and highly novel 
outcome which is well discussed in the paper with reference to past literature. This was a 
particularly interesting finding given the overall results which demonstrated the benefit of using 
rapid ATP testing.  
The statistical analysis used followed conventional methods. The use of chi-square adjusted for low 
sample numbers (with incorporation of the ‘Yates’ correction) and Fishers exact test indicated the 
significance of the core findings using this new integrated methodological approach to cleanliness 
monitoring. The low sample numbers did limit the potential for a realistic finding using a Receiver 
Operating Curve (ROC) to establish appropriate cleanliness thresholds for each of the devices and 
these were distinctly different numbers, albeit without comparative statistical significance.18, 19 
The basic approach to finding biofilms in an ICU remains under development and only recently has 
the presence of dry surface biofilms been demonstrated within an ICU.15, 20 The methods for 
reproducing biofilm growth in laboratory conditions are also in the early stages of development.21 
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The presence in ICU of dry surface biofilms which harbour MRO poses a profoundly increased hazard 
and elevated risk for the cross infection of already vulnerable patients.  
The integrated method demonstrated in this paper showed improvements over all previous 
attempts for the identification of the locations of MRO which may be residential on hospital 
surfaces. This method also had a very significant outcome in indicating that the HTO that are of high 
risk for harbouring MRO are not just clustered on the near patient surfaces around the ICU patient 
bed.22-24 By using the visual component of assessment to identify HTO, and then applying the rapid 
ATP testing to those surfaces, the real time effect directed the microbiological sampling to clinical 
workspace well out of the anticipated sampling locations around the near patient surrounds.  
This new integrated method for cleanliness monitoring demonstrated that there was a 7 fold greater 
likelihood of quickly finding the less clean locations than using a simple HTO list approach which has 
been the dominant method in Australia and elsewhere. This exciting development has only been 
enabled by the new methods developed and trialled during this PhD.  
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Chapter 3 
A thematic & critical review of each of the papers 
included for PhD 
 
Précis  
This chapter provides a thorough review of each of the papers included in this PhD submission. The 
chapter outlines how the five papers together establish a cohesive thematic study which comprises 
this single body of original research. Each paper will be contextualised for contemporary relevance, 
methodology, results and contents, and the contribution of each of the papers into the single theme 
for this PhD thesis. The learning attained and the contribution of the principle author and 
contributions of the various co-authors in each of the five papers will also be outlined in this chapter. 
The papers are presented in chronological order.  
Introduction 
In the consideration of this PhD by a series of publications, there are five fully peer reviewed papers 
which have been published in scholarly journals. The five papers outline the validation of ATP testing 
devices and their application for cleanliness monitoring within healthcare settings. These five papers 
interlock as a continuous theme on the validation and use of rapid ATP testing. The study 
commences with laboratory work focussed on ATP device performance in a limited range of 
controlled experiments, and then moves onto statistical work focused on the reliability of the ATP 
testing devices. From here the theme of the study contextualises the use of rapid ATP testing as a 
cleanliness monitoring tool within healthcare settings, before coming back to the laboratory to more 
fully document the performance of the ATP devices using bacterial cultures replicative of healthcare 
applications. The final paper is a field based pilot study that uses two ATP testing devices that 
demonstrates a practical application of these devices within healthcare settings by building on both 
the risks of use and the validation process.  
The first paper is the initial validation study published to reveal both useful and concerning findings 
on ATP measurement comparing three commercial brands of ATP devices.  
The second paper develops the work of first paper, but applies the coefficient of variation (Cv) as a 
statistical measure of variance in the ATP readings obtained during the controlled experiments.  
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The third paper steps back from the benchtop work to consider the overlapping flaws of rapid ATP 
testing and the other accepted cleanliness monitoring methods used within healthcare settings. The 
study looked into the flaws of each cleaning monitoring method, and also useful synergies from the 
use of ATP testing with the other three major cleanliness monitoring tools. This third paper 
introduces to infection prevention professionals a new novel risk assessment approach using Failure 
Mode Effects Analysis (FMEA). A new and novel approach to cleaning/cleanliness monitoring is 
outlined in the paper.  
The fourth paper extends the work of the first and second papers and investigates the statistical 
problems of uncontrolled variability using the commercially available ATP devices using both pure 
ATP and two representative bacteria which are commonly found within healthcare settings. The 
fourth paper applies Cv to establish the case for careful interpretation of data arising from field 
based use of ATP testing devices based on the validation studies. 
The fifth paper takes two of the ATP testing devices out of the laboratory and uses the strengths of 
rapid ATP testing to overcome the weaknesses of environmental microbiology. This fifth paper 
demonstrates that rapid ATP testing, once validated, and despite imprecision and other flaws, can 
contribute practical usefulness in cleanliness monitoring and infection prevention within healthcare 
settings. This paper applies the teaching of papers 1, 2 and 4 (instrument dynamic range and 
limitations, variability and imprecision) and paper 3 (FMEA revised risk based approach) in a field 
based study within an active Intensive Care Unit.  
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First paper review 
Authors:  Whiteley GS, Derry C, Glasbey T. 
Title:  The comparative performance of three brands of portable ATP-bioluminometer 
intended for use in hospital infection control 
Publication:  Healthcare Infection: 2012:17:91-97 
Impact Factor: Not available: CSIRO as Publisher indicates IF <1 
Citations: 11 (Scopus search 4th February 2016) 
 
The seminal paper by Griffiths et al., for rapid ATP testing within healthcare was published in 2000.1 
Griffiths applies his personal experience in using rapid ATP testing within the context of food 
manufacturing and plant hygiene and through this small field based study indicated that ATP testing 
would be highly suitable for a similar application in cleanliness monitoring within healthcare settings.  
The findings demonstrated that ATP testing was superior to both visual inspection and 
environmental microbiology as a cleanliness monitoring tool within a healthcare setting. What was 
surprising in the papers which followed was that the studies were undertaken without having 
conducted any validation process for the ATP testing devices used in the studies.  
In 2011 a single ‘concise communication’ paper was published that attempted to provide a 
validation process for ATP testing against quantitated bacterial suspensions using Staphylococcus 
aureus.3 The findings were that of the five commercial ATP devices tested, all of the ATP devices 
lacked robustness in quantitation, particularly at low bacterial concentrations.  
Against that backdrop, in this first study, we set out to validate three commercially available ATP 
devices using a validation process in accordance with Pharmaceutical Industry guidelines.4  This 
meant firstly looking for linearity of response and comparing the results to a ‘gold standard’ and fully 
validated reference test. For this purpose, an HPLC method was used as a comparison.  
It was also recognised that testing against live bacterial cultures was also subject to the risks of 
variability in cellular lysis and ATP content. A new method was required, so in this first paper a pure 
(known source) of ATP was used and a standard volume (20µL) was applied directly to the ATP 
swabs using a validated micro-titre pipette. The advantage of this approach is that the experiments 
focused on only one measurement variable, which was the ATP reading (in RLU) from each device. 
This was a novel and previously unpublished method for validating these ATP devices.  
The findings of the paper were also novel. This remains the first published study in the medical 
literature that has focused on validating the dynamic range and reading scale of commercial ATP 
46 
 
devices based on pure ATP, directly applied to the swabs, and thus free from other confounding 
variables (cellular lysis, swab absorption, ATP cellular density and others).    
The results outlined in this first paper demonstrated that ATP devices could be relied upon when 
testing serial dilutions where concentrations were 10 fold differentiated as shown in Figure 1 within 
the published paper. The dynamic range of ATP readings (from lower limit of detection [LLD] to 
upper limit of detection [ULD]), was also shown to be different for different devices. The work also 
clearly demonstrated that at any quantitated application of ATP, each of the ATP devices showed a 
different scale on RLU.  
This first paper also clearly demonstrated that the reading scale of the different branded ATP devices 
lacked any overlap and therefore had nil interoperability. This has dramatic implications on the prior 
published cleaning threshold values in RLU from studies with only one branded ATP device, which 
could not meaningfully be applied to any other ATP device. The recommended ATP cleanliness 
threshold of 100 RLU was clearly marked on Figure 1 in the paper to illustrate this problem.  
However, the study also demonstrated that where the concentrations of serial dilutions were less 
well differentiated (we used 20%) then the ATP devices would reliably differentiate between the 
dilutions as the data irregularly overlapped as shown in figures 2-4 within the published paper. For 
each of these figures the 100 RLU cleanliness threshold was also marked illustrating how 
inappropriate this single level measurement was for the different branded ATP devices. 
The single level cleanliness threshold was a major problem not previously identified in the literature. 
In fact several studies had accepted the suggested RLU cleanliness threshold from 500 RLU using a 
3M branded device and this level of 500 RLU was reconfirmed in another study (2009) which also 
noted a lack of correlation between ATP/RLU results and microbiological results (cfu/mL)1,5. In 
another study the threshold value was recommended to be reduced from 500 RLU down to 250 RLU 
in an effect to improve the comparability with comparative results using environmental 
microbiology, and this was done using a 3M branded ATP device.6  
A study published in 2009 by a separate group compared two different devices (3M and Hygiena) 
without doing any comparative validation and simply noted the difference in results.7 Finally, 
another published study preferred the Hygiena branded ATP device and in the study seamlessly 
moved to recommend that the cleanliness threshold using ATP be reduced from 250 RLU (3M) down 
to 100 RLU (Hygiena), without any comment over the difference in scaling (interoperability) between 
the different branded ATP devices, thus assuming uniformity of scaling.8     
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In the same time period, a number of papers were published, or accepted for publication which 
posed questions over the validation of ATP for applications in healthcare cleanliness monitoring.9-10. 
Whilst the methods and commentary used were not based on the first paper method of direct 
application of ATP, a common issue identified was the lack of uniformity in scaling, the risks posed 
by uncontrolled confounders, and the lack of correlation with ATP data and contamination, 
particularly at the lower levels which was critical for healthcare applications.  
Another notable finding was the identification of the differing abilities of the ATP testing devices to 
quantitate the ATP concentrations at both ends of the dynamic range (Figure 1 from the paper). 
Within healthcare settings the instrument performance at the upper limits of the dynamic range is of 
a lesser concern than performance towards the lower end of the dynamic range. At the lower end of 
the dynamic range, two of the ATP testing devices (3M and Kikkoman) demonstrated poor 
quantitation below 100 RLU and could not reliably demonstrate any reading below 30-50 RLU. The 
introduction of the concept of a Practical Zero was important for field usage of these ATP devices.11  
In this first paper, the study results both supported and extended the findings of Aiken et al.3 
However, the paper also outlined through a controlled validation processes using only pure ATP, that 
the dynamic range of different brands of ATP testing devices was an unrecognised variable for 
studies using ATP testing. The problems of scaling, variability and imprecision required careful 
validation and consideration and particularly where measurements were attempting to distinguish 
between similarly soiled surfaces. The findings of the first paper were the foundation for the 
following work as part of the PhD study.  
There were some limitations to this paper. Firstly, the data set was based solely on exposure to pure 
ATP and not to any bacterial species. Secondly, it was published in a local Australian journal which 
somewhat limited its global reach and limited the possible influence of the findings. Thirdly, only a 
single ATP device from each brand source was used, and consumables, whilst stored as per 
manufacturers’ instructions, were not tested linearly across the time-line of recommended shelf life 
(to determine if the shelf life of the consumables is another variable). 
In the peer review of this paper both of the peer reviewers commented that this research would 
enhance the discussion on environmental hygiene.1 The first reviewer said that research when 
published “…will add to the discussion around evaluation of environmental hygiene in healthcare and 
also provide direction for further research into this subject”. The second reviewer similarly 
                                                          
1 email: official response from the editor dated 9th July 2012 
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commented “This study may generate and lead to further discussion…” and also that the research 
raised “Valid concerns regarding the concept of a cleaning benchmark…” which is precisely the 
outcome expected from the findings.   There have been 9 citations so far of this paper.  
The learning outcomes from this paper were substantial. Firstly, this was the first major authored 
paper and required substantial changes to my writing style. Secondly, the work itself reset my 
practices around experimental design, management of the resources (including time and co-authors) 
and also the recording and presentation of the results into a format suitable for publication.  
The co-authors contributed through various of the practical aspects of the study, including Dr 
Glasbey in setting up, validating and working with the HPLC, and ensuring that the pure ATP 
remained stable for the period of the experiments. Dr Derry contributed in editorial assistance and 
also in the preparation of the statistical analysis including tests of association and reframing Figure 1 
of the paper as used for the published version. The principle author was responsible for all re-writing 
and re-drafting following consultation with the co-authors, the recording, preparation and 
presentation of results including graphs, statistical analysis in consultation with Dr Derry, and 
primary responsibility for the submission and peer review of the paper.   
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Second paper review 
Authors:  Whiteley GS, Derry C, Glasbey T 
Title:   Reliability testing for portable adenosine triphosphate bioluminometers 
Publication:  Infection Control and Hospital Epidemiology: 2013:34:5:338-540 
Impact Factor: 2015 IF: 4.15 5 Yr IF: 4.50 (Source: Research Gate: 4th February 2016) 
Citations: 6 (Scopus search: 4th February 2016) 
In this second study, the results from the first study, using only pure source ATP and testing against 
the three branded ATP devices, were examined using a variance measure. The paper was accepted 
for publication into a ‘Special Topic’ edition to coincide with a “SHEA Spring Conference” with the 
theme “The role of the environment in infection prevention”. One of the peer reviewers 
commented2 on the paper “Overall, clearly written… I think that it [the paper] highlights a significant 
issue related to interpretation of results due to variability among different manufacturer products”, 
which was precisely the point of the findings. 
The results from the first study showed an unexpected level of variance. This was particularly so 
given the carefully quantitated volumes of pure ATP applied to the different ATP device swabs, from 
the same ATP solution container, on the same day, in the same experimental round with 
quantitation confirmed using a validated HPLC which had demonstrated almost no variability. Whilst 
the first paper had demonstrated the dynamic range of the ATP devices, and their poor precision 
when using closely separated dilutions series (20%), the level of variance was considered in this 
second paper using a variance measure of Coefficient of Variation (Cv).  
The Cv is a calculation of the standard deviation for an individual data set over the mean for the 
same data set. Cv is a simple expression of the variance and is the inverse of the signal to noise ratio. 
The paper set out the results from the calculations in graphical form in figure 1 as a scatter plot. In 
this paper all three of the ATP devices demonstrated a Cv as high as 0.4, i.e. the standard deviation 
for a data set was as high as 40% of the data mean. This level of imprecision is very poor and 
normally would be considered unacceptable for a scientific measurement device.  
This was the first study to use Cv as a measure for variance with ATP testing devices. All of the 
brands performed equally poorly and none of the brands gave any indication to users as to the level 
of variability. This paper presented a new confounding factor for studies where ATP testing was used 
as a measure of cleanliness. Whilst a standardised level of ATP (RLU) may be set with any particular 
                                                          
2 email: official response from the editor dated 28th October 2012 
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ATP device brand, the high and uncontrolled level of variance that is obtained in actual use of the 
ATP device, limits the meaningfulness of any RLU threshold due to device reading imprecision.   
This paper added to the debate over the usefulness of ATP/RLU cut-offs/thresholds for setting 
cleanliness standards for infection prevention in environmental surfaces and has received a number 
of independent citations. The implications of this work in combination with the first paper have been 
to undermine any suggestions that a universal ATP/RLU cut-off or threshold could be used for 
cleanliness monitoring in the context of hospital infection control. There remains the need to 
develop better science around cleanliness monitoring but at the point of publication of this paper, 
more work was required to thoroughly validate the ATP testing systems.12    
The limitations of this study were similar to that of the first study. Firstly, the work focused on 
application of pure ATP to the swabs rather than bacterial suspension or cultures. The second 
limitation was that although published in one of the key global journals in this infection prevention 
field, the paper was a “Research Brief” (word limit of 900 word plus one figure or table, and < 10 
references), and this so was not a full-length research paper. Finally, this second paper did not 
attempt to assess whether ageing or storage of the consumables had any impact on the variability of 
ATP/RLU readings.   
The learning experiences from the paper were highly productive. Firstly, the application of the Cv as 
a measure of variance provided a new platform from which to assess instrument reliability. It had 
been quite a confronting experience to find the unexpected variability and so separate statistical 
advice was sought from Mr Paul Fahey, who is acknowledged at the end of the paper. The 
authorship lessons from this paper were also that the strict limitation on word count required focus 
and acuity to ensure that the paper adequately described the work and expressed the implications 
for the findings. That the peer reviewers recognised this aspect was most pleasing.  
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Third paper review 
Authors:  Whiteley GS, Derry C, Glasbey T 
Title:  Failure analysis in the identification of synergies between cleaning monitoring 
methods 
Publication: American Journal of Infection Control: 2015:43:147-153 
Impact Factor: 2015 IF: 2.21 5 Yr IF: 2.50 (Source: Research Gate: 4th February 2016) 
Citations:  There have been 300+ downloads of the paper since publication but citations have 
not yet appeared in the literature. 
  
Following the publication of the first two papers in 2012 and 2013, and a range of other critical 
publications on the appropriateness of ATP testing in cleanliness monitoring, a re-evaluation of the 
project was required. The clear advantages of rapid ATP testing were still present, but were now 
offset by the findings of the first two papers and several other relevant publications. One significant 
paper, which went on-line in 2012 (Sciortino et al.), proposed to have achieved validation of three 
commercial ATP devices.13 However, even the singing endorsement of ATP testing by Sciortino et al., 
was subjected to pointed criticism over the poor response of the ATP devices at the LLD and a 
number of other confounders.14  
The need for a suitable audit tool for cleanliness monitoring and cleaning validation had already 
been established and the practicality of rapid ATP testing recognised.15,16  A second important 
cleaning verification tool that had become available from 2006 was the Fluorescent Marker (FM) 
invented by Dr Phillip Carling. This innovation used a small dab of polysaccharide based glue, laden 
with fluorescing material that dried to a clear film (still clearly visible under small low power UV 
light) but which could be wiped off easily through normal cleaning processes.17 Because the film is 
thin and clear the removal of the FM became an easy way to assess if a surface or object had been 
subjected to the intended cleaning (wiping) process.  A broad array of participating hospitals took 
part in a large validation trial and the results indicated that this tool not only improved the rate of 
cleaning but also appeared contributed to a diminishment to overall recovery rates of microbes 
responsible for HAI.18 
Some laboratory work was conducted on two forms of the FM which were supplied directly by Dr 
Carling. The first was the original “dab-on” solution. The second was the licenced/commercialised 
version under the tradename “DAZO” from Ecolab (Minneapolis-St Paul, MN). Laboratory studies as 
part of the PhD project considered drying characteristics and visibility. The results from those studies 
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were contained in several posters but as these findings only reconfirmed the literature the work was 
not submitted for publication.  
Several pertinent studies verified the usefulness of FM including one in Australia and another study 
where the technology was used in tandem with ATP testing.19,20 FM was also found to be an ideal 
tool for cleaning staff feedback and education, but it could also be misleading when cleaning staff 
could themselves identify the FM spot locations and then selectively clean and remove just the FM 
spots.21-23 Even by itself the results of FM still can lag the Hawthorne effect of personal 
observation.24 
The substantial observation on FM was that its use within healthcare settings was a constructive way 
of monitoring surface wiping and therefore reducing bioburden. Whilst FM does not provide any 
quantitative assessment of surface cleanliness per se, it does reflect that surface cleaning has been 
attempted and thus is a qualitative measure of cleaning (staff) efficiency.  Studies using FM, ATP and 
studies using both FM and ATP have all demonstrated the usefulness of timely feedback to cleaning 
staff through these new cleaning monitoring methods.25-27  
However, there was still no credible alternative cleanliness monitoring method that provided all of 
the requisite information to provide an adequate level of quality assurance over environmental 
surface cleanliness within healthcare settings. There remain only four practical options for 
cleanliness monitoring and cleaning validation which are all reviewed in the paper. The four cleaning 
monitoring methods are visual inspection, microbial recovery, ATP testing and FM technologies. 
Each of the methods has advantages, but equally all of the methods have shortcomings that limit 
their practical usefulness for cleaning auditing as an aid in infection prevention.  
This third paper is a study that steps back from the overlapping and sometimes conflicting array of 
advantages and disadvantages of the different cleaning and cleanliness monitoring methods. The 
goal of the study was to conduct a structured risk assessment on the proposition for using ATP 
testing within the broadest context of cleaning monitoring and compare the risks associated with 
ATP testing with the three risks associated with the three other cleaning monitoring methods.  
A structured risk based approach using Failure Mode and Effects Analysis (FMEA) was used by our 
small team to reflect on the data from the earlier studies, and from the broader and developing 
infection control literature. The FMEA team then assessed the failure risks of each of the 
cleaning/cleanliness monitoring methods. FMEA allows for the interrogation of potential or 
recognised failures for use each of the methods of cleaning/cleanliness monitoring and to both 
grade and attempt to mitigate each failure mode.  
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Only one other reference using FMEA in this field could be located, and it was for a poster 
presentation only and no paper was published.41 Therefore, this third paper is the first of its kind 
published in the infection control literature.  
The study in this third paper, was an important breakthrough in novel thinking on how to integrate 
the cleaning/cleanliness monitoring methods and unlock potential synergies between the various 
methods. Figure 1 in the published paper proposes a new pathway forward using all of the available 
cleaning/cleanliness monitoring methods with a scientifically based, integrated assessment of 
cleaning and cleanliness on hospital surfaces. In all prior publications authors have tended to 
recommend their pet/partisan method over and above the other methods. Whereas using FMEA to 
structure the risk assessment, this study arrived at a recommendation for process improvement that 
contextualised the use of ATP testing, as well as recognising the advantages of visual inspection 
without the need to denigrate visual inspection as an inferior monitoring method. 
The Australian requirements for a three-tiered risk classification were followed in the paper to 
provide a simple and locally flavoured outcome.28 FMEA also assesses and grades each failure mode 
for its likely frequency and the severity of the failure, and combines these two criteria with an 
assessment of the detectability of the failure mode to arrive at an overall risk quotient. The scoring 
approach reflected the Australian requirement for a three tier scoring scheme (graded 1 to 3) which 
once the risk quotient was obtained allowed each failure mode to be then grouped into risk 
classifications. The risk classification approach used in the paper separates the failure risk for each of 
the failure modes for each of the cleaning monitoring methods. In the paper, only the worst case 
failure modes are shown in Table 2 of the published paper.  
This novel approach to risk assessment for the cleaning and/or cleanliness monitoring methods had 
several limitations. Firstly, it was a small team used for the study and only two of the authors had 
previous experience with the FMEA methodology. As a small team care had to be taken to ensure 
the findings were anchored in objective literature and not just a circular and biased selection of 
failure modes. Secondly, as a novel approach it was initially difficult to secure peer review 
acceptance with reviewers who were unfamiliar with risk assessment strategies and methods, which 
tend to be predictive and qualitative. Finally, the small team did not use any practising healthcare 
professionals nor anyone currently engaged in an infection prevention role. 
This was a challenging paper to write. One of the peer reviewers commented “…the use of one 
monitoring technique to supplement another monitoring technique is new. Also, the use of FMEA for 
the purposes of evaluation is new and provides food for thought for the infection preventionists and 
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for environmental services.”3 This was an encouraging outcome after the effort applied in taking 
FMEA as a medical devices standard risk method and applying it in the assessment of methods with 
products, but for the common purpose of cleaning/cleanliness monitoring.   
In the process of this study and the writing of this paper a large number of lessons were learned. 
Whilst the outcome of the findings was pleasing, the process taught the importance of perseverance 
and the value of finishing the task. The management of the team process with the risk of selection 
bias in findings required additional rigour and reflection. The peer review process for this paper 
required major reconstruction of the paper and the key findings shown in Table 2, so as to bring the 
paper back to an acceptable size and format for the journal. The entire co-author/team group 
participated in the FMEA process, but I was the principle author in every aspect. Dr Derry also 
assisted greatly in the framing of Figure 1.  
This paper has been downloaded on more than 300 separate occasions since publication in February 
of 2015, and citations are expected. The full influence of this paper will be on-going and an abstract 
for an oral presentation is being submitted for the next meeting of the American Practitioners of 
Infection Control conference in 2016. The American Journal of Infection Control is recognised 
globally as the number one ranked Nursing journal on Infection Control and has an enormous 
readership.  
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Fourth paper review 
Authors:  Whiteley GS, Derry C, Glasbey T, Fahey P 
Title:  The perennial problem of variability in adenosine triphosphate (ATP) tests for 
hygiene monitoring within healthcare settings 
Publication: Infection Control and Hospital Epidemiology: 2015:36:6:658-663 
Impact Factor: 2015 IF: 4.15 5 Yr IF: 4.50 (Source: Research Gate: 4th February 2016) 
Citations: Publication was June 2015. No citations at this time.   
 
The fourth paper extended the work of the first and second paper, attempting to overcome some of 
the shortcomings of the earlier papers by broadening the work validating the ATP devices beyond 
pure ATP into bacterial responses. The methods used followed the teaching of the first paper in that 
the materials were applied directly onto the ATP swabs in order to remove variability arising from 
swab materials or swabbing technique. The use of different bacterial species opened up the issue of 
cellular lysis as a variable but the use of multiple units and quadruplicate applications minimised the 
impact of this source of variability. 
The work in the study consisted of a range of dilution series, both 10-fold and 20% dilution series. 
The freshly prepared bacteria suspensions were provided but all dilution series, including 
preparation of materials, confirmation of validation for pipettes, dilution series, application of the 
diluted suspension, enumeration and confirmation of enumeration, recording and interpretation of 
results, and work area clean up were all conducted by the principle author under both direct and 
delegated supervision within a PC2 Microbiology Laboratory. 
The purpose of the series experiments was in the first instance to investigate and reconfirm the 
dynamic range of each of the ATP devices using both two bacterial species and a pure ATP solution. 
Quantitation of the ATP was again confirmed using a validated HPLC method.  Learning from the 
earlier work, nearly every individual dilution sample was tested in quadruplicate with each of the 
ATP devices. The benefit of this was that the Cv could again be calculated for the entire sample 
group and thus express clearly the difficulty of this uncontrolled variability in the use of ATP devices. 
This paper has the benefit of further time to reflect more appropriately the breadth of literature that 
has been published in relation to ATP testing. Even during the preparation of this fourth paper, a 
separate study was published (manufacturer funded), using just one branded ATP device and that 
study not only failed to reflect on the critical literature in the field, but used a single point sampling 
methodological approach.29 A letter to the editor (principle author GS Whiteley) was written and 
submitted to Infection Control and Hospital Epidemiology criticising the sampling method, and this 
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letter was published by the journal.30 What was interesting in the reply was the concession by 
Visrodia et al., that the work would have benefited from a better sampling method, but they were 
concerned over the “cost” implications for field work applications.31 
This was the perfect introduction to the importance of the extension of the earlier work and the new 
paper submitted. One of the peer reviewers appropriately commented as follows: “This important 
report represents an in-depth extension of prior studies by the authors which increases both the 
depth and breadth of analysis of practical aspects of the use of ATP bioluminometers which had been 
widely marked for use in evaluating the cleanliness of near-patient surfaces in healthcare settings.  
Although concerns regarding the accuracy and sensitivity of ATP testing in clinical settings have been 
repeatedly raised during the past five years, this report represents the first in vitro analysis to 
objectively and independently (not manufacturer sponsored) assess the accuracy of the ATP systems 
currently being used…The methods of evaluation were innovative and appropriate.  The use of co-
efficient variation (Cv) was particularly appropriate.”4 
The work itself both extended the findings of the earlier work, but also introduced a fourth and 
again distinctly differentiated ATP device (Charm). As this paper was a full research submission the 
expression of the data could also be amended to better reflect the data sets covering the variability 
found with testing against pure ATP and the two bacteria (Pseudomonas aeruginosa and 
Staphylococcus epidermidis). The analysis of the data was conducted using Cv and as part of the 
statistical analysis the decision was taken to express the spread of the Cv data using box and whisker 
plots rather than the dot plot format. The box and whisker format allowed a more simplified 
presentation on the spread of the data and also showed outliers.  
Each of the ATP devices demonstrated similar patterns of variability which are shown as box and 
whisker plots as shown in Figures 1 to 3 in the published paper. An important observation was that 
outliers were present in the data as outliers, both above and below the whiskers which were placed 
at the 10th and 90th percentile calculations for each device and against each test solution.  This has 
major implications for sampling methods and perfectly illustrated the point which was made in the 
earlier letter to the editor.30 Figure 4 presented another aspect to the data which simply expressed 
the range and median points for the range of Cv for each device in each test platform. Whilst it looks 
like the ATP devices could be ranked for performance, in fact the key finding is that every one of the 
branded ATP devices showed a Cv range above 0.4 which means that for any reading obtained in the 
field, there is a 20% possibility that the reading could be wrong by a factor of 2.  
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This is a highly important finding and suggests an explanation for the poor precision of the ATP 
device when tested using a 20% dilution series (first paper). This finding also underscores the 
importance of getting the sampling methods correct. A quadruplicate sampling approach with 
calculation of the arithmetic median will provide the most reliable pathway to flattening out the 
uncontrolled variability in ATP data obtained through sampling in the field. This is not always 
possible in field work, but there are other ways being considered in fresh research that could 
provide an alternative approach that would be equally suitable.  
This fourth article had some limitations. Firstly, the work on dynamic range which compares the 
response to ATP and to two bacterial species could not be included in a single paper. Secondly, only 
one ATP device per brand was available for use in the experiments. Thirdly, the data set again could 
not accommodate measures that assessed variability across the entire shelf life period of the 
consumables.  
A major benefit of the journal chosen (Infection Control and Hospital Epidemiology) is that the 
primary readership are clinicians who are the members of the Society of Healthcare Epidemiology of 
America (SHEA). Predominantly the membership is comprised of practising infectious diseases 
physicians. The journal also has a broad global readership amongst infectious diseases clinicians and 
other infection prevention professionals.  
The full impact of this paper will continue for some time. But in response to this paper, one of the 
manufacturers of ATP devices has already responded with a letter to the editor.32 This letter is from 
a marketing manager and strongly puts a case in favour of the use of ATP devices for cleanliness 
monitoring within healthcare settings, citing much of the literature already published in support of 
that view. The response from Whiteley et al., author group will agree with the basic proposition that 
ATP has an important place in healthcare settings, as indicated in paper 3, but that the issue of 
uncontrolled variability does require an active response from manufacturers. This variability issue is 
a different problem from attempting to correlate ATP readings with just bacterial contamination. 33  
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Fifth paper review 
Authors:  Whiteley GS, Knight JL, Derry CW, Jensen SO, Vickery K, Gosbell IB 
Title:   A pilot study into locating the bad bugs in a busy intensive care unit 
Publication: American Journal Infection Control: 2015:43:1270-1275 
Impact Factor: 2015 IF: 2.21 5 Yr IF: 2.50 (Source: Research Gate: 4th February 2016) 
Citations:  Publication was June 2015. No citations at this time.   
 
This pilot study took key learnings from the first four papers and applied them within the challenging 
environment of an active Intensive Care Unit (ICU) in a primary care hospital. The context for the 
study was the attempt to locate dry surface biofilms.34, 35 The second author on this paper (Jessica 
Knight) had been tasked with the application of a new and more aggressive environmental recovery 
approach in an attempt to locate the presence of MRO and the possible locations of dry surface 
biofilms.36 The first run of sampling was applied to high touch object (HTO) locations that the prior 
literature had indicated were potential reservoirs. Only a single sample from 23 swabs demonstrated 
growth of an MRO. 
After discussions amongst the co-authors, it was agreed to trial the use of ATP testing as a rapid, 
real-time and relative indicator of surface cleanliness levels. It was hoped the ATP testing would 
discriminate between what was considered a clean surface and what may be indicated as a soiled 
surface and potentially contaminated. The sampling was somewhat ad hoc, and the methodology at 
risk of selection bias as was clearly indicated in the paper. The use of ATP testing did assist in 
directing the sampling locations towards the more contaminated surfaces in and around the clinical 
work area as shown in Figure 1 in the published paper. A significantly greater amount of samples 
demonstrated the presence of MRO once ATP testing was included in the field sampling and 
particularly on HTO and surfaces within the clinical work station as indicated in Table 2 in the 
published paper. Unfortunately as a Pilot study the number of samples was limited, and access into 
the working ICU was even more tenuous, thus preventing the extension of the work to extend the 
sampling and expand the number of surfaces to be examined.    
The importance of this paper is demonstrated by the five separate important findings revealed in the 
results of the study. Firstly, the field testing reconfirmed that the two ATP devices used provided 
readings in RLU on a different scale which practically demonstrated the lack of instrument 
interoperability. Secondly and surprisingly these two sets of readings in a real life application had 
almost no correlation (R2=0.0144), thus any comparison between the two sets of RLU readings could 
not be accomplished. Both of these findings are shown in Figure 2 of the paper.  
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Thirdly, the ATP testing gave the expected rapid outcomes which did aid in assessing the relative 
cleanliness of the different areas. As the results were quick and several “trial” readings were taken in 
the clinical work station, the actual readings were higher than for the other surfaces in the 
immediate patient zone (using the Hygiena ATP device), thus indicating a relatively more unclean set 
of surfaces. The readings were separated in some cases by an order of magnitude on the RLU scale 
which satisfied the concerns on where readings were differentiated by less than a factor of two (4th 
paper) and as per the dynamic range findings (1st paper). The real time response of the ATP testing 
demonstrated that the strength of the ATP testing (instantaneous results) helped to overcome the 
weakness of the microbial recovery i.e. real-time delay between testing and results.  
Fourthly, the statistically significant finding of the paper was that the use of ATP testing did assist in 
finding more MRO through environmental microbial recovery alone by providing the immediacy of 
feedback on surfaces sampled. Broadly the results were 1/23 on sampling without the assistance of 
ATP testing, and 12/36 with the assistance of ATP testing (using a matched sampling approach). As 
discussed in the paper, it was the very low recovery number (just 1 MRO positive sample) on the first 
sampling round that grounded the statistical findings. Another part of the reason for this may have 
been bias with the introduction of a second more experienced operator (the principle author), and 
this was also noted as a limitation on the paper.  
The fifth and final finding was the significantly large number of MRO recovered from surfaces within 
the clinical work area (13 separate MRO locations). We are not aware of any similar findings, using 
any methods, of as many MRO recovered from an ICU in a single study in such a short period of time, 
although recent evidence supports a more aggressive approach to investigation.37 This aspect of the 
work is continuing to be actively researched under a separate and on-going series of linked studies 
by several of the co-authors.    
The peer review comments on the paper were emphatically positive.5 Said the first reviewer: “This 
was an exceptionally well written study with a tremendous amount of promise for MRO in the ICU.   
The study had a strong structure, analysis of results, and appropriate identification of strengths/ 
weaknesses.”  
The second reviewer said “This was a very well planned and executed study, pertinent and timely. 
The novel approach to detecting MRO outside of patient care areas can provide infection control 
practitioners with another tool to identify and correct otherwise undetected sources of nosocomial 
infection. The statistical tools used were clearly described and appropriate to the study.” 
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This was the strongest set of peer reviewer comments of any of the five papers and sets a ringing 
endorsement to the work. The other pleasing thing about this feedback is that it included the lead 
up work of the earlier publications and provides a positive platform on which to use ATP testing. 
One of the challenges arising from this focused series of studies on validation of ATP testing devices 
has been remaining positive when there were so many findings that indicate difficulties in working 
with ATP testing devices. This fifth paper was another deeply rewarding experience as it allowed the 
ATP devices to be used in a valid and significant way. This study took advantage of the advantages of 
ATP testing, and allowed to the problems in interpretation and disadvantages of the RLU relative 
reading scale to be cast in context and not overstated.  
As the primary author my role in the research field work used skills acquired over my working 
lifetime, including extending my (long-ago) undergraduate training as an environmental health 
officer in observing the real aspects of field work in the ICU. Whilst my first co-author (Jessica Knight) 
did the microbial sampling I was able to conduct all of the matched ATP testing. As the principle 
author I also did all of the statistical analysis, although due thanks to Dr Chris Derry for his assistance 
in setting up the chi-square framework and revision based on the Yates correction due to the low 
sample numbers. The level of analysis in this ‘pilot study’ was more detailed and varied than any of 
the earlier papers and has greatly extended my analytical and statistical skill. Thanks also to 
Associate Professor Karen Vickery on the suggestions to run Fishers Exact test as a second tier and 
confirmatory method in addition to the chi-square.  
The study limitations were very well covered in the paper, but it is appropriate to add some 
commentary on the implications of the findings as part of the PhD theme.  
Firstly, a number of other studies have used predicative models including receiver operating curves 
(ROC) in justification of suggested hygiene thresholds that could be applied to ATP testing.8,38,39 Each 
of these attempts at a single standardised RLU hygiene threshold have been based on a single 
branded ATP device with the assumption on the uniformity of scaling using RLU. This fifth paper is 
the first since Anderson et al., (2009) that used two differently branded/ scaled devices in a field 
study, and which appropriately expressed the quite distinct scaling in both the application and 
findings.6 In this fifth paper the use of an ROC method suggested two distinctly different RLU 
thresholds (20 RLU: Hygiena and 350 RLU: Kikkoman), although neither threshold was correlated 
with MRO recovery.   
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Secondly, the findings whilst statistically significant in assisting with the locations of appropriate 
sampling locations within the ICU favoured no particular brand of ATP testing device. This too was an 
important outcome for the study. 
Thirdly, this fifth paper provided an appropriate thematic close to the PhD as a single unit of study. 
This paper used the findings of all of the earlier papers and demonstrated the findings and learning 
gained through the study to finalise this single piece of work. Rather than using the ATP testing 
devices as a regular monitoring tool where the data indicates poor performance, this paper used the 
ATP tests as a one off method of determining the relative cleanliness of different surfaces for the 
purpose of environmental microbial recovery. The relative difference in cleanliness in the study was 
indicated by more than ten-fold differences in the RLU readings which our earlier data clearly 
validated as a strength. 
The risks of single point sampling were overcome through the method of use, and through using a 
second ATP testing device as an alternative reading value. Whilst this had its own limitations, such as 
no discernible correlation between the two devices, the devices themselves both were able to 
indicate higher values for the more highly soiled surfaces.  
The fifth paper was published in the December 2015 edition of the American Journal of Infection 
Control and was given the prominence of the lead article for that edition of the journal. A separate 
press release on the study and its implications for cleanliness monitoring and infection prevention 
more generally was authorised and circulated by the American Practitioners of Infection Control for 
general media. An accompanying Australian press release was also prepared by Western Sydney 
University to coincide with the publication.   
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The PhD Theme summarised 
The project title for the PhD study is “A study into the validation of ATP testing devices for integrated 
cleanliness monitoring within healthcare settings”. The work commenced with a range of 
experiments focused broadly on the validation of three commercial brands of rapid ATP testing 
devices. At the time of commencement of the laboratory work, there were a number of published 
studies suggesting that ATP testing could be used as an alternative to microbial recovery as a 
benchmark for cleanliness and hygiene standards within healthcare settings. Prior to this body of 
work, no independent study had been published validating the ATP devices using a method based on 
standardised industry technical validation guidelines.  
The first paper demonstrated problems with the devices that required additional studies and 
illustrated the need for a full validation process prior to any broad acceptance of ATP testing. The 
second paper focused on the difficulties with data precision, which were demonstrated statistically 
using Cv, albeit on a study platform using only a known source pure ATP. The third paper continued 
the validation theme by examining the place that ATP testing had amongst the range of cleaning 
monitoring methods. This third paper contextualised both the place of ATP testing in cleaning 
monitoring and mitigated the weaknesses identified through the laboratory studies.  
The fourth paper extended the work on the first and second papers with a greater array of validation 
directed experiments and accentuated the expression of the imprecision of the commercial ATP 
devices through the use of Cv as an already accepted and appropriate statistical platform. This work 
using bacterial suspension as well as ATP, and building on the earlier work with ATP alone, clearly 
outlined for the healthcare sector the difficulty of measurements using the current generation of 
ATP testing devices. The problems with ATP testing have been broadly recognised.40   
The fifth and final paper concluded the thematic approach of the study and demonstrated that with 
a constructed approach to field use of ATP testing, and to interpretation of the data, the ATP devices 
can play an important role in monitoring of cleanliness and cleaning within healthcare settings. This 
was the goal of the study. The PhD thesis has demonstrated that the validation of the ATP testing 
devices is possible even with the limitations of the ATP testing devices revealed through these 
studies. The thesis and series of published findings has also shown that using ATP testing within an 
integrated cleanliness monitoring method provides a substantially improved approach versus the 
conventional methods. This has tremendous benefits for infection prevention across the entire 
global healthcare system.    
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Chapter 4 
Conclusions and Recommendations 
 
Précis  
This PhD set out to validate the use of rapid ATP testing for use in healthcare settings, and to 
integrate the use of ATP testing into an improved approach to cleanliness monitoring. This chapter 
draws the conclusions from the study arising from the findings of the five published papers. This 
chapter also comments on the apparent and remaining gaps in the knowledge and recommends the 
pathway for further research into this topical subject.  
 
Conclusions arising from the study 
The initial goal was to validate the use of rapid ATP testing for applications in cleanliness monitoring 
within healthcare settings. The study and publications of this PhD are the most comprehensive set of 
independent studies to date in the field of ATP testing, and have the advantage of comparing across 
a number of branded ATP testing devices. The studies incorporate a number of novel methods whilst 
following a standard industry process of instrument validation.  
The major conclusions arising from this PhD are summarised below. 
Findings from the laboratory validation phase of the research 
1. The reading scale for rapid ATP testing uses relative light units (RLU). Unfortunately the scale 
is relative in every sense and no two meters tested use the same algorithm to arrive at a 
common reading or RLU level. This leads to a number of subset problems including: 
 
a. The absence of a standardised scale means that none of the branded devices 
provide a data set which is in common with any other branded ATP testing device;  
b. The lack of a common scale removes the capacity to calibrate the ATP testing 
devices on a uniform basis, thus it is not possible to achieve accuracy in the 
measurements in the normal scientific manner; 
c. The lack of a common RLU scaling leads to interoperability between differently 
branded ATP testing devices; 
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d. The readings from different units appear so totally dissimilar that no comparison is 
possible from individual readings between differently branded ATP testing devices; 
e. The scaling is relative and so product innovation includes in one case additional 
reactivity (Kikkoman reacts to AMP as well as ATP) and in another the scaling 
algorithm includes a first step of at least three logs for a baseline (Charm). The 
impact of this is to further disassociate the commonality of RLU scaling; 
f. The different ATP testing devices have different dynamic ranges when tested against 
quantitated and pure ATP (Figure 1, from the first of the published papers); 
g. The limits of quantitation (lower and upper) for each of the ATP testing devices are 
reached without any indication given to instrument users; 
h. The poor reading precision at the lowest part of the dynamic range for both the 3M 
and Kikkoman branded ATP testing devices leads to a practical zero point around 
100 RLU. Readings below this level are relatively meaningless as the readings are 
below the lower limit of quantitation. The Hygiena ATP testing device demonstrated 
better reliability at the lower end of the dynamic range and showed a lower limit of 
quantitation at the indicated “0” (zero) point on the instrument. The Charm ATP 
testing device results are not shown in the included papers but that branded device 
appeared to have a lower limit of quantitation above 1000 RLU on its reading scale;  
i. All four of the ATP testing devices have poor precision in RLU readings across their 
full dynamic ranges;  
j. And, none of these problems is clear to any user without having done their own 
comprehensive validation.   
 
2. Rapid ATP testing devices are capable of distinguishing between cleanliness levels that are 
differentiated by a ten-fold difference in underlying ATP levels. Figure 1 of the first paper 
demonstrates that each of the ATP devices was reliable in this measurement criterion when 
using a median reading approach. This has important and practical implications for reliability 
in the interpretation of field based readings from surfaces to distinguish between strongly 
differentiated levels of organic soiling on various surfaces. 
 
3. The ATP testing devices have a poor capacity to distinguish between relatively similar levels 
of organic soiling is poor due to imprecision (Figures 2 -4 from the first paper). The poor 
precision with apparently uncontrolled variability in RLU readings suggests that the 
commercially available rapid ATP testing devices are generally not suitable for routine 
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testing against any specific cleanliness threshold expressed in RLU, and particularly where 
the surfaces have similar before and after levels of underlying ATP (cellular soils) 
contamination. 
 
4. The cleanliness thresholds that have been suggested in publications as suitable for ATP 
testing, imply that there is a single and consolidated scale which is universally applied to all 
branded ATP testing devices, which is incorrect. A single RLU cleanliness threshold is not 
possible as each branded device has its own unique scale without interoperability. The first 
cleanliness threshold readings on the RLU scale were 500 RLU and 250 RLU, based on work 
using the 3M device.1,2 The more recent 100 RLU was based on the Hygiena device.3  
 
5. The uncontrolled variability in readings is not recognisable by normal users who are not 
trained in the interpretation of data arising from ATP testing devices. This variability is the 
same whether testing pure ATP or bacterial cultures. The variability is inherent within the 
rapid ATP testing systems (see Figures 1-4, fourth published paper). Thus, significant care is 
required prior to any sampling planning, and further care is required for the interpretation 
of any RLU data from field usage of ATP testing devices. 
 
6. The high variability can be demonstrated using the statistical method of the coefficient of 
variance (Cv) as demonstrated in the fourth published paper. This statistical approach has 
allowed all of the discreet test points and samples at those points to be normalised for 
comparison purposes.   
 
7. The Cv for each of the branded ATP devices tested, regularly reached above 0.4 meaning the 
standard deviation was frequently above 40% of the sample mean (see Figure 4, fourth 
Whiteley paper). At this level, there is a 20% chance that any reading will be inaccurate by a 
factor of 2. In practical terms, this implies that any individual reading should be regarded as 
subject to an error level of from 50% to 200% of the original reading. 
 
8. The frequency of outlier results, both above and below the 10th and 90th percentile, both in 
sample values and Cv, strongly suggests that any sampling methodology should be based 
around the use of medians and not means due the likelihood of asymmetrical distribution 
within any data set.  
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Findings from the FMEA study 
 
9. ATP testing rapidly indicates surface cleanliness whereas FM spot removal indicates the 
performance of a cleaning task and the overall achievement level in surface wiping by a 
cleaning process. Thus ATP is an efficacy measurement and FM is an efficiency 
measurement.  
 
10. FM has the advantage of very rapid feedback to cleaning staff on cleaning efficiency. None 
of the other three cleaning monitoring methods (ATP testing, visual inspection or 
microbiological sampling) indicated cleaning efficiency as reliably as FM usage.  
 
11. ATP testing provides a rapid digital readout from measurement of the residual biological 
soiling levels (cleanliness) of a surface. The speed of feedback on relative cleanliness by ATP 
testing provides advantages over the alternative cleaning and cleanliness monitoring 
methods (FM, visual inspection and surface microbiology). 
 
12. ATP testing can be integrated into a cleanliness and cleaning monitoring with each of the 
other three cleaning and cleanliness monitoring methods to provide a better quality 
assurance outcome (see Figure 1, third published paper). This integrated approach uses the 
relative strengths of the different monitoring methods, to overcome the inherent 
weaknesses in each of the same monitoring methods. An example is that ATP testing can be 
used to guide microbial sampling by providing rapid feedback on relative surface cleanliness. 
 
Findings from the field application of ATP testing within an integrated 
cleanliness monitoring process 
 
13. The use of ATP testing to guide microbial sampling is significantly more likely to result in 
confirmation of contaminated areas as opposed to a list based approach or visual inspection 
alone.  
 
14. The integrated methodology as per Figure 1 in the third published paper, was shown to be 
superior to using visual inspection or a list based approach in isolation when looking to 
identify less clean surfaces on which MRO may be coincidentally present on HTO or surfaces.  
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15. This active and integrated approach to cleanliness monitoring provides an improved 
understanding of the spread of soils and level or risk of transmission of infective organisms 
across both patient and non-patient/clinical zones within hospital ICUs. Elimination of sites 
where MRO are present is an evidenced based application of cleanliness standards that 
should contribute to reducing the risks of HAI. 
 
16. The use of ATP testing was validated in accordance with the goals for the study. Despite the 
findings on precision and reliability, the use of an integrated monitoring methodology using 
the advantages of ATP testing resulted in findings which suggest that ATP testing can be 
used within healthcare settings for the purpose of integrated cleanliness monitoring. 
 
Additional notes on practical ATP Testing for use within a Healthcare setting 
 
17. A well planned study within a healthcare setting using ATP testing should be based on the 
following elements to enable the most representative results: 
a.  The ATP testing device and consumables should be well understood and 
consumables to be used should be within the sue by dates; 
b. The High Touch Objects or surfaces (HTO)to be sampled using ATP testing should be 
selected and a sampling plan arranged that takes account of cleaning schedules and 
cleaning materials being used. Not every HTO needs to be tested in a sampling plan, 
but a selection of HTO should be tested on each sampling run, and if possible the 
HTOs tested should be randomised or varied between each sampling run; 
c. Each site to be subjected to ATP testing should be initially tested, cleaned 
thoroughly, and then re-tested to ensure that the expected “best outcome” is 
established prior to any application of ATP testing within healthcare settings; 
d. The sampling plan and frequency should take account of the budget for the cleaning 
monitoring processes using ATP testing, including the labour time; 
e. Each surface should be sampled in duplicate (at least) and the sampling area should 
be the same amount of area for each duplicate sample. As note in this thesis, 
outliers can occur both above and below the median for any single reading and the 
possibility exists for a Cv >0.4 resulting in a 20% chance that any individual reading 
could be wrong by a factor of two. Consequently, if the duplicate samples are found 
to be very dissimilar (say separated by a 10-fold difference in RLU), then a third or 
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even fourth sample might be required. The median should always be preferred to an 
average result; 
f. The sampling plan for any study should commence with an initial period that defines 
the ‘normal’ or ‘expected’ cleanliness level across the HTO sampled; 
g. A second stage might involve an intervention which could include a new method of 
cleaning, or cleaning frequency, and/or staff feedback on the findings from the initial 
and subsequent sampling runs; 
h. A final stage might involve a follow up sampling run to determine the success or 
sustainability of the intervention and may confirm the need for continued random 
monitoring to sustain any improvements in cleanliness; 
i. Statistical models should follow standard pathways, although duplicate samples 
should use the median approach as the true reading.  
 
Recommendations on future testing and investigation 
This PhD study has opened a pathway for further investigation on a number of aspects of rapid ATP 
testing. These are not limited to the following suggestions but these proposals may form the basis of 
additional and subsequent research projects. 
There several identified key project areas, which are summarised in the following paragraphs. 
 
Researching a new scale for ATP testing devices 
 
18. This project into a new and universal scale for ATP testing devices would include the 
following issues: 
 
a. The RLU scaling approach is not standardised against a quantitative mass of ATP. 
This problem could be rectified, but there has been no suggestions from any of the 
commercial organisations to replace the subjective RLU scale with considerations of 
a suitable scientific approach to a new standardised scale for the expression of ATP 
reactivity;  
b. The various manufacturers of ATP testing devices are in commercial competition 
with each other. Therefore, care will be required to avoid any suggestions of 
anticompetitive conduct or collusion between competitors, even for the desirable 
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scientific goal of a commonly agreed scale for ATP testing to replace the current RLU 
scales.  
c. An independent and non-commercial organisation may be best suited to facilitate 
this outcome through a collaborative research program and dialogue with the ATP 
device manufacturers;  
d. The testing conducted within this PhD demonstrated that a common reaction drives 
the response across the dynamic range (Figure 1, first published paper). This rate of 
response is seen to be on a common basis for three of the branded ATP testing 
devices. This common response to ATP across the dynamic range should be also 
investigated with respect to bacterial suspension cultures so as to confirm the dose-
response curve for each branded ATP testing device.  
e. The investigation of the new scale could be initiated by plotting the dose-response 
to ATP on a ten-fold dilution scale for each device. The slope of the line could be 
calculated and the data for each device mathematically converted onto a normalised 
scale to provide a new and quantitative scale for measurement of ATP.  
f. The range of the ATP scaling could be reduced by recalculating the readings into the 
log10 for each number. Thus the variability that is so apparent on the existing scale is 
also flattened out when reduced to its log10 base value.  
g. The new scale would need to reduce this variability and provide a sufficiently 
discreet distance between each value in the scale that overlap of readings is reduced 
thus improving the precision of each discreet reading point on the new scale. The 
scaling will also therefore likely reduce the range of the numerical scale between the 
lower and upper ends of the dynamic range.  
h. It has been noted that the lower limit of detection for ATP testing devices when 
testing against a suspension culture of bacteria is between 10 up to 100 cfu/mL.4 
However, this will vary by organism possibly due to differences in lysis capacity.5 The 
most preferential approach would be to conduct a validation process for a new scale 
using a pure and validated source of ATP, and then to cross check the device 
sensitivity with a panel of suitable bacteria.  
i. The most important issue for any new ATP reading scale will be the need for 
improved precision at the lower end of the dynamic range. For all of the ATP testing 
devices, the lower limit of quantitation will also require improved reliability towards 
and at the indicated “0” (zero) level. The most important cleanliness related 
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applications are for data produced at the lower end of the dynamic range and so this 
is the most important part of any rescaling consideration.  
j. A common scale would provide the ATP testing devices with a quantitative basis on 
which standardised and uniform calibration could be achieved.  
k. The ability to calibrate ATP testing devices would introduce the capacity to indicate 
accuracy of ATP measurements against a common scale to improve reliability. This 
common scaling would be the best platform on which to provide a competitive 
advantage between the commercial organisations, through improvements in both 
accuracy and precision in readings of ATP.   
l. Once the accuracy of response to a calibrated range is established, variability would 
then be subject to competitive amongst manufacturers. The most competitive ATP 
testing devices would then have both measureable accuracy and calibration, with 
the added advantage of lower variability (better precision), whether due to 
improved reagent stability, light detection, or with better pricing.   
m. The attainment of the goals outlined above can only be achieved through a properly 
constructed and validated measurement scale for ATP which is calibrated against a 
known quantity of ATP.  
 
Researching a new method for cleaning product validation 
 
The results shown in this PhD demonstrate that ATP testing devices reliably distinguish between ATP 
based data sets when tested on the basis of a ten-fold difference in underlying ATP. It is accepted 
that sanitising and cleaning compounds are intended to clean and remove up to 3 logs of bacterial 
soils.6 The difficulty of using live bacterial suspensions for this testing includes both the cost and the 
time taken to achieve feedback (it is very time inefficient). A testing system that can provide 
measurements that indicate results in a quick and efficient manner would be a major benefit to both 
industry and healthcare settings where these cleaning products are used in this global market.  
 
19. Researching a new test method cleaning product validation using ATP testing would include 
the following considerations:  
 
a. There are additional methodological issues to be considered with any cleaning 
process such as wiping technique, wiping pressure, and wiping material 
characteristics.7 However, the significant advantage of using a standardised ATP 
74 
 
testing approach would be the improved efficiency through reduced response time 
which would allow each of the variable to be controlled and independently 
measured, and have almost immediate feedback from the testing;  
b. The faster feedback from ATP testing as opposed to standard microbiological 
techniques would provide the opportunity to increase the number of test replicates 
thus improving the reliability of any results; 
c. The issue of relative scaling with RLU is not a problem as it has already been 
established that for each of the brands tested, the three log change in ATP is 
measured at the same response rate. Therefore, this work could be conducted 
irrespective of the brand and scaling approach used by the ATP testing devices;  
d. The key qualifying feature of a three log diminishment in soiling could easily be 
validated against any of the ATP testing devices once the methodological approach 
to cleaning processes are considered.  
e. The use of a “scrub testing” device similar to those used for paint and other surface 
coating testing systems would standardise many of the concerns such as wipe 
direction, wipe pressure and overall wipe repeatability.  
f. The ATP enriched soiling systems would also then be validated using both ATP 
testing devices and compared with results using live bacterial suspensions in a 
controlled laboratory environment. In this way both the soils and the methods could 
be validated to be applied as a single test methodology; 
g. The possibility of cleaning products affecting the ATP reaction and thereby causing 
interference in the RLU readings will also need to be broadly addressed. This would 
involve a number of fairly simple controlled experiments which as yet the literature 
has not reported. The findings using actual products would have immediate 
relevance to field usage of ATP testing devices and would be ideally published 
quickly as a short report or similar. 
 
Researching a new sampling algorithm for ATP testing devices 
 
20. The researching of a new algorithm approach, to guide the sampling methodology in the 
normal use of ATP testing could be used to define cleanliness thresholds based on a 
statistical model that could be applied to any brand of ATP testing device. This might be 
achieved even with the current and inadequate RLU scale.  
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Within healthcare settings there is a public health need to both characterise and standardise 
surface or environmental cleanliness. Without a common scale on which to measure ATP 
standardisation is probably not possible without a more complex and mathematically driven 
approach to both sampling and data interpretation. 
 
So then, applying the principle established in the fourth published paper, i.e. that anyone 
reading has a 20% chance of being wrong by a factor of two, a bandwidth approach to data 
interpretation might be workable. This would allow any individual reading, or set of replicate 
readings, to be interpreted within a surrounding zone. This could also allow a cleanliness 
threshold to be determined that accounted for the current level of imprecision. 
 
Further work on investigating this approach would be a useful and very practical application 
of the findings that could produce a useful platform for benchmarking studies within any 
healthcare settings. This approach might also be validated for cleanliness studies 
investigating cleanliness outcomes from medical device cleaning processes.  
 
Applications in other fields such as environmental health could also be considered. One 
advantage of the environmental health applications is the criteria used for cleanliness 
monitoring. Cleaning in food preparation areas is measured on a clean versus unclean 
approach where a numerical cut-off or cleaning threshold is less important and undefined.    
 
Extending ATP testing into Applied Epidemiology with Cleanliness and 
Cleaning Monitoring 
 
21.  The ultimate goal of cleanliness monitoring and cleaning monitoring is to improve the 
standards of hygiene within healthcare settings and to thus reduce the risks associated with 
MRO on uncleaned or insufficiently clean surfaces. There are an enormous range of 
potential confounding factors for a study of this type. In fact, there may need to be a layered 
approach of several studies, each of which isolates a limited number of factors, but each one 
builds on the results of the earlier findings. 
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The range of confounding factors includes all of the ATP testing issues identified in this 
thesis, and also factors such as cleaning materials, cleaning methods, cleaning frequencies, 
cleaning supervision, cleaning and cleanliness monitoring methods, management systems, 
quality assurance factors, hand hygiene compliance monitoring (ideally validated), patient 
monitoring and even cohorting, interlocutory microbiological testing of patients and 
environmental surfaces, microbial identification technologies including genetics (whole 
genome sequencing) to confirm identification of MRO and transmission associated events, 
initial epidemiology and follow up, properly designed and randomised trials and of course a 
cost versus benefit aspect on the processes. 
 
Cost versus benefit is a critical feature of the infection prevention paradigm. Clearly the 
hazards presented by an insufficiently clean healthcare environment involve patient 
morbidity and potential mortality. However, the budgets within healthcare are not unlimited 
and the value of a life concept is to be compared against hard costs such as effective and 
efficient cleaning services, materials, and the management overheads required to ensure 
cleaning and cleanliness standards are set and achieved. These costs are also to be 
compared with the costs associated with a patient who sustains an HAI and then has 
extended treatments, length of hospital stay, and potentially diminished quality of life 
following the HAI. 
 
These critically important matters will need to be addressed, but at this time the nature of 
the cost benefit study, and the epidemiology are beyond the boundaries for this thesis.  
   
Continuing to promote and publish results from this PhD study 
 
22. Publishing the results of this PhD more widely would also be useful in combating the “weight 
of numbers” approaches taken by ATP testing device promotors and manufacturers.8 There 
has been a number of abstract submissions for conferences in 2016 that are being submitted 
in the normal manner.  
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Chapter 5 
The comparative performance of three brands of 
portable ATP-bioluminometer intended for use in 
hospital infection control 
 
The comparative performance of three brands of portable
ATP-bioluminometer intended for use in hospital
infection control
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Abstract. Background: Portable adenosine triphosphate (ATP)-bioluminometers have been used in the food
industry to monitor the effectiveness of surface cleaning but their intended use in hospital infection control suggests a
need for instrument validation to confirm effective technology transfer.
Methods:The performance of three readily available brands of portable bioluminometer was compared in terms of
their ability to generate relative light units (RLU) from a range of standardATP solutions. Quality control of standards
was carried out using high pressure liquid chromatography (HPLC).
Results: There was no significant difference (P = 0.05) in the ability of different meters to effectively measure
hygiene change on a log scale in a central measurement range of 0.001 to 1.0mgL–1 ATP. Outside this range meter
performance deteriorated, with the possibility of individual and comparative measurement error. No out-of-range
warning system existed for any of the meters. While different brands generated widely different log10RLU values for
fixed quantities ofATP in this range, curve similarities suggested standardisation possibilities to enable comparison of
results. Testing at a higher level of resolution in the 0.0001 to 0.002mgL–1 ATP range proximate to a proposed 100
RLU cleaning benchmark also revealed poor repeatability as a potential for measurement error.
Conclusions: Portable ATP-bioluminometers, when used to indicate surface cleaning effectiveness, demonstrate
reliable performance when measuring over a very wide range of ATP concentrations. Monitoring hygiene in terms of
an absolute threshold value such as a cleaning benchmark may, however, be invalid as a concept when using existing
portable ATP-bioluminometer technology.
Received 12 July 2012, accepted 19 July 2012, published online 28 August 2012
Introduction
Assessment of the effectiveness of hospital surface cleaning in
Australia relies primarily on direct visual examination, a
practice enshrined in National infection control guidelines.1
Although unreliable, visual assessment persists because of
simplicity of approach and immediacy of feedback to guide
the cleaning process.2,3 The alternative of microbiological
monitoring offers the advantage of quantitative results for
changes in surface loads of indicator organisms and
pathogens, but demands time and technical expertise which
are not always available. To address these issues several
innovative methods of cleaning assessment combining
accuracy, quantification and immediacy of results are under
consideration internationally.4
One possibility is the use of fluorescent ‘soiling spots’
marked on high touch objects (HTOs) or near-patient surfaces
before cleaning, with subsequent examination under
ultraviolet light to detect cleaning efficacy through either full
or partial removal.5,6While the chemiluminescent technology
is simple and immediate, results do not measure soiling but
rather cleaning efficiency and readings are qualitative only.
Another approach relies on portable bioluminometry to
measure adenosine triphosphate (ATP) residues on relevant
surfaces, potentially yielding quantitative results.7 While this
has been successfully used in the food industry for at least
15 years to monitor contact-surface hygiene, validation for
use in the hospital setting still requires attention, and this
served as motivation for the research described in this paper.
ATP is the energy currency of living cells and is, therefore,
capable of acting as proxy for a broad range of contamination
types in the hospital setting, including microorganisms,
human cells, food waste, vomitus and faeces.8,9 ATP-
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bioluminometry is not, however, specific for these substances
or for any microbial indicator or pathogenic species.10 ATP
detection alone cannot indicate factors such as infectivity,
virulence or infectious dose that are related to disease
transmission risk, which cannot be assessed without
identification of specific microorganisms.11 ATP monitoring
can, however, act as a proxy for surface hygiene change
associated with adequacy of cleaning practice.12
The ability of commercially available portable
bioluminometers to achieve accurate ATP measurement
depends on several factors, the most basic of which is the
technical performance of the instrument itself.13 It is,
therefore, surprising that minimal research attention has been
given towards instrument validation before the conducting of
intervention research studies in the hospital setting.
In validating any instrumentation the intended operational
environment must be taken into account. Important
differences may exist between the hospital sector, where the
use is intended, and the food industry where the meters have
been successfully used in the past. Preliminary investigation
showed that in the food industry the instruments are primarily
used in hazard analysis critical control point (HACCP)
assessment, aimed atmonitoringwell defined control points in
relatively linear food production processes, with risk
parameters lying within circumscribed ranges.14–16
Hospital monitoring presents fundamental differences,
including the verywide range of environments and surfaces to
be monitored, the ad hoc nature of the cleaning process
required at any time, and the unpredictability of contaminant
level and type to which a surface may be exposed.17 In
addition, an interest in comparing results for different
hospitals and units, where different brands of meters with
different performance characteristics may be in use, has been
identified.18
In terms of the different operating principles employed by
different instrument manufacturers, it is important not only to
validate ATP-bioluminometry in general for hospital use, but
to include different brands of instrument in such validation.19
The authors see the ultimate establishment of validation
criteria for portable bioluminometers as a complex process
requiring clear definition of healthcare sector objectives and
determination of the capacity of the main types of unit to meet
these objectives. The paper discusses findings on the
reproducibility of ATP readings relating to individual and
comparative metering performance of three existing brands
with the aim of encouraging dialogue on the validation issues
identified.
The fundamental principle of all ATP-bioluminometry
is the measurement of light from the two-stage luciferin
reaction, which give fireflies and glow-worms their ‘glow’:
(i) luciferin (in reagent) +ATP (from surface) ! luciferyl
adenylate + inorganic pyrophosphate
(ii) luciferyl adenylate +O2! oxyluciferin +AMP+ visible
light (read by bioluminometer)
While this biochemical reaction is highly efficient in terms
of chemical to light energy transfer, it presents challenges to
those wishing to capture the reaction chain in vitro, with
manufacturers using a variety of reagents and metering
arrangements to achieve their aims.20 In anticipation of
variations in results during different monitoring events,
bioluminometer read-out is given in relative light units
(RLU), based on ordinal rather than interval scaling. Ordinal
scales allow results in a specific series of observations to be
ranked against one another, although numerical differences
between successive values may not be constant, in contrast
to those in interval scales such as the Celsius temperature
scale. Unfortunately there is no benchmark to determine
what constitutes a ‘specific series of observations’ in
bioluminometry so that monitoring at different times, in
different settings, and with different brands or designs of
meter might produce unwanted variability in the results.
While attempts have been made in the past to test meter
performance in terms of microbiological standards relating to
pathogens and indicator counts, several complications have
intervened, includingvariation inATP level basedondifferent
species and phase of growth.21–23 This potential confounder
was avoided in the current project by assessingRLUgenerated
against standard ATP solutions monitored for stability at
regular intervals using calibrated HPLC.
Materials and methods
Three commercially available portable ATP-bioluminometer
kits and fresh manufacturers’ reagent tubes including swabs
were obtained from laboratory suppliers in the Sydney region.
Two of the brands were from large multinational
manufacturers and had been referred to by name in healthcare
publications in the United Kingdom and United States of
America, whereas the third was a relatively new brand. Other
brands are believed to exist. In this paper the brands are
described as Brands A, B and C for purposes of anonymity.
Manufacturers’ packaging claims suggested suitability of
the bioluminometers for use in both food and healthcare
settings.
ATPwas obtained from SigmaAldrich (Castle Hill, NSW,
Australia) and a nine-step, 10-fold dilution series in the
0.00001mgL–1 to 1000mgL–1 range was made up using a
phosphate buffer diluent immediately before validation
testing. An additional five-step, linear dilution sub-series was
made up in the 0.0001 to 0.002mgL–1 ATP range to assess
Implications
* Portable ATP bioluminometers reliably indicate
largely different ATP levels.
* Monitoring of hygiene using an absolute threshold
such as a cleaning benchmark may be invalid using
existing technology.
* The paper suggests that equipment design and ATP
measurement scaling be revised before the equipment
is accepted for use within healthcare settings.
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meter resolution within a critical ATP band relating to a
recently proposed 100 RLU hospital cleaning benchmark.24
ATP solutions were stored in sterile equipment, on ice during
each bioluminometer assessment run.
The bioluminometerswere set up as per themanufacturers’
instructions and the reagent tubes checked for freshness in
terms of expiry date. In using the bioluminometers the
manufacturers’ instructions were adhered to, which typically
involved placing the manufacturers’ swabs with collected
ATP in the tubes provided, releasing the reagent, mixing
for a controlled period, and positioning the tube in the
bioluminometer for reading. To remove potential errors
relating to surface swabbing, however, the recommended
swabbing procedure was modified by directly applying a
20mL aliquot of each solution in the standard ATP series onto
each swab using a 10–100mL calibrated micropipette, with
new micropipette tips for each standard. The amount of
20mLwas selected by empirically determining the absorptive
capacity of each manufacturer’s swab type, and using the
lowest capacity which could safely be absorbed without risk
of over-saturation. Assessment was repeated six times for
each bioluminometer at each ATP concentration, and where
more than two swabs exceeded the interquartile range for
measured ATP, five additional swabs were tested at that
concentration. This yielded a total of 95, 93 and 90 readings
for bioluminometers A, B and C, respectively.
Quality control for ATP solutions was carried out using
high pressure liquid chromatography (HPLC) before and after
each test series. The standard curve for the stock solution was
derived from a certified ATP standard (Sigma Aldrich),
calibration samples being run in triplicate, with results
showing strong positive linear correlation (r2 = 0.9998).
Raw RLU data generated at each ATP concentration was
saved in Excel spreadsheets (Microsoft, Seattle, WA, USA)
and median, interquartile and total ranges estimated. Non-
parametry of data was confirmed using a Normal Probability
Plot and a relevant test of statistical significance
(Kruskal–Wallis) applied using Minitab (Minitab Inc., State
College, PA, USA) to identify association between related
datasets at the assumed level of significance (P = 0.05).
Graphs of overall performance, and performance at the
hypothesised cleaning benchmark were prepared using
PASW (IBM, New York, NY, USA).
Results
Curves were generated for the bioluminometers using
logarithmic scales for bothRLUandATP to accommodate the
very wide metering range and to assist visual interpretation of
results (Fig. 1). Median values for RLU at each ATP
concentration were used as a summary index in preference to
means, in terms of the relatively small datasets with high
interquartile and total ranges.25
A test of association indicated no significant difference
between performance of the three bioluminometers in the
middle of themeasurement range, from0.001 to1mgATPL–1
(P< 0.39), when logs of both RLUs and ATP median values
were analysed. The Chi-square test, however, assesses ratio
relationships and marked differences in absolute values of
RLU at specific ATP concentrations existed (curves are
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Fig. 1. Performance curves for three brands of portable ATP-bioluminometer.
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parallel but not coterminous). For example, at the 0.01mg
ATP L–1 standard there is an 11-fold difference in RLU
between the most and least optimistic instruments.
In terms of the upper end of the range (1 to 1000mg ATP
L–1), a significant difference in performancewas found to exist
between the bioluminometers (P < 0.03), as suggested by the
convergence of curves for two of the meters, with rapid
flattening and divergence of the curve for the thirdmeter. This
may relate to differences in light measuring technology
between the meters, including variations in the chemical
extinction point for the available luciferin reagent.
At the lower end of the range (0.00001 to 0.001mg ATP
L–1) there was also a fall-off in monitoring performance, with
significant differences between the three brands (P< 0.04).
None of the meters, however, had a warning system or
automatic shut down to alert the user to the fact that it was
operating outside its apparent effective (accurate) range.
Next the ability of meters to measure fine changes in ATP
level in the vicinity of an absolute cleaning benchmark, as
recently proposed in the literature, was assessed.23 This
cleaning benchmark is basically an action-threshold limit
value (TLV) which is intended to indicate when a sufficient
state of hygiene exists for the surface to be considered ‘safe’,
and does not require further cleaning.
Five linear sub-dilutions of standard ATP, lying within the
range 0.0001 to 0.002mgL–1, which relates to the potential
‘window’ in which the cleaning benchmark subsists, were
tested. The results are presented in Figs 2 to 4 as line graphs
with box and whisker plots indicating spread of data at
individual ATP concentrations. It should be noted that ATP
levels in these graphs are in mg L–1 and that end points of the
curves do not comply exactly with those shown in Fig. 1
because different median values are in use. Proximity of the
line graphs to the 100 RLU cleaning benchmark does not
indicate meter accuracy but is an artefact based on window
selection.
A test of association showed significant difference in
monitoring ability for median RLU generated by the three
brands at this level of resolution (P < 0.002).While the graphs
suggested that each meter was capable of generating a
relatively linear response based on median data from four to
five swabs for each ATP value, interquartile and total ranges
for RLU at specific concentrations of ATP was unacceptably
large, in many cases overlapping the range of adjacent
measurements.
While the preliminary validation described here essentially
involved the capacity of the instrumentation to accurately
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measure ATP concentration, it was noted that differences
which might impact on ultimate monitoring accuracy existed
in ancillary equipment. For example, different brands of
swabs had different absorptive capacities for fluid, which
might influence uptake and release of ATP.26,27 The impact of
these differences onmeter validation still needs tobe explored.
Discussion
Environmental hygienewithin hospitals has a direct impact on
rates of cross infectionwith keymicroorganisms and effective
cleaning has been shown to reduce rates of infection.28,29
To assess the effectiveness of cleaning it is important to
scientifically verify the cleaning processes to ensure that
improved hygiene has been achieved and that the surface is
sufficiently clean to reduce the risk of cross infection.30,31
It has been proposed that portable ATP bioluminometry can
be used as a reliablemethod of verifying cleanliness standards
on environmental surfaces and objects in place of routine
microbiology.Work in Australia using ATP as an indicator of
surface hygiene has examined applications including medical
device cleaning andmore broad applications in environmental
surface cleanliness.32–34
The results of our study suggest that portable ATP-
bioluminometers have capacity to generate data over a wide
effective measurement range, which augurs well for cleaning
assessment in the hospital setting where surface soiling can
vary from the invisible to the excessive. Performance
characteristics, however, vary with brand and this needs to be
addressed if error is to be avoided during comparative
assessments with different meters.21
The threemeters produced very similar response to surface
hygiene change in terms of log10RLU within an effective
measurement range, as shown by the close similarity of
parallel traces in the central portion of the graph in Fig. 1.
While the traces are currently displaced in relationship to one
another, synchronisation could be achieved by simple
manipulation of the y-axis intercept value, c, in the straight line
formula y =mx + c.This suggests potential for standardisation
of log10RLU results for the different brands, facilitating
comparative assessments.
In practice, this could be achieved using one of two
approaches. The first would involve the determination of an
industry standard for log10RLU generated by ATP standards
within an accepted effective metering range. Meters would
then need to be adjustable (or have an internal data adjustment
capacity) to standardise theATP values currently generated to
this range. Alternately, manufacturers could produce
log10RLU curves for existing meters, similar to the ones
shown in Fig. 1, enabling the user to carry out standardisation,
or inter-meter comparisons, themselves. Given that the
hospital industry is frequently time poor, metered adjustment
might be preferred.
Having established that hygiene change can easily be
interpretedwhenvalues are available as log10RLU, it is logical
to suggest that portable bioluminometers should display
results in log units as well as the current numerical units. This
would also facilitate their meaningful use over a very wide
range of surface contamination levels. Logarithmic
interpretation of data has long been applied in bacteriology
where a sliding scale of measurement sensitivity has been
needed to cope with exponential growth of microorganisms.
Ready availability of log10RLUdata in bioluminometrymight
well lead to synergies between bioluminometric and
microbiological monitoring in hospitals.
An important validation criterion for any meter should be
its ability to warn the user or shut down when it is operating
outside its effective measurement range. Figure 1 shows that
at the upper end of the effective measurement range for each
meter there is a point at which results cease to be comparable,
with a rapid flattening of response in all meters. Individual
measurements taken within this range run the risk of
generating lowered results, which may potentially reduce
cleaning imperative. At the lower end of the range there is also
a levelling out in meter response, with potential to produce
misleading results in the vicinity of the proposed cleaning
benchmark. Earlier work using quantitated live microbes
indicated that reliability of the ATP bioluminometers is
questionable at the lower end of readings.19
A broad discussion on the concept of a ‘cleaning
benchmark’ is needed. Certain researchers have proposed this
type of action-threshold limit value (TLV) for RLU as a point
below which contamination is so low that the surface can be
assumed clean and unlikely to act as a source of infection. To
determine this point, measured ATP values may have to be
related to microorganism presence, and critics have pointed
out that there is a highly inconsistent relationship between
ATP and number of microorganisms present based on
interspecies variations, growth phase and a range of other
variables.10,11
Originally proponents of an absolute TLV proposed 500
RLU,7,3 which was subsequently reduced to 250 RLU,23 and
finally 100 RLU.24 The results from this validation study
indicate that the currently proposed 100 RLU level is
disturbingly close to the lowest range of effective
measurement capacity of all three meters (Fig. 1).
Inorder to assess the ability of the three brands to accurately
measureATP at a high level of resolution proximate to the 100
RLU cleaning benchmark, the study within the 0.0001 to
0.002mgL–1 ATP range was carried out (Figs 2, 3 and 4). A
potentially unacceptable level of variance for each of the
meterswas found to exist, with values in interquartile and total
range for RLU tending to overlap for adjacent values in the
linear series. It would seem, therefore, that fundamental
problems with the concept of a cleaning benchmark and the
apparent inability of the existing technology to accurately
measure at this point give rise to validation problems relating
to this intended use.
While the study is based on limited data for three
instrument brands, it is hoped that it will encourage discussion
between the healthcare sector and the bioluminometer
industry, in order that the prerequisite of developing detailed
Portable ATP-bioluminometer reliability Healthcare Infection E
validation criteria and manufacturer specifications can be
attended to as precursory to investigative studies based on
ward monitoring. To achieve this, further research is required
into the extent and intended use of the instruments, their
measuring characteristics and capacity, the format and quality
of data required for integration into ward-focussed
assessment, and the nature of the integrative risk monitoring
framework to be informed in the future by hospital
bioluminometry.
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r e s e a r c h b r i e f
Reliability Testing for Portable Adenosine
Triphosphate Bioluminometers
Measurement of adenosine triphosphate (ATP) using portable
bioluminometers has been adapted from the food manufac-
turing sector, and it has been suggested that it could be used
as an indicator of surface soiling or cleanliness in hospital
settings.1 Some healthcare authorities are considering the use
of portable ATP bioluminometers as a tool for standard set-
ting for surface cleanliness to improve cleaning standards.2
Central to this approach is the use of a commonly accepted
level of detected ATP—expressed as relative light units
(RLUs)—that may be used as a surrogate for underlying soil-
ing, including the presence of pathogenic microorganisms.3
It has been demonstrated that improvements can be made
to cleaning processes with fluorescent markers through a sim-
pler approach that provides a qualitative efficiency measure-
ment of the cleaning process.4 Measurement of surface hy-
giene using ATP bioluminometers is thought to provide a
more quantitative surrogate of surface cleanliness.5
A proposed ATP/RLU standard for acceptable cleanliness
has been revised from 500 RLUs, originally suggested by Grif-
fith et al,1 to 250 RLUs by Lewis et al6 and most recently to
100 RLUs by Mulvey et al.7 However, a close examination of
the references reveals that different brands of ATP biolumi-
nometers were used to establish the data in each reference—
a substantial problem given that each unit reads on a different
relative scale.8 Even with a single branded unit variable results
are observed without a clear explanation.9 There also is debate
over the validity of using ATP measurement as an analogue
for surface soils and the presence of pathogenic microorgan-
isms.10
Our aim was to validate the reliability of measurement of
3 commonly available brands of portable ATP bioluminome-
ters. Two of the brands selected (Hygiena and 3M) feature
prominently in the published literature, and the third brand
(Kikkoman) provided a different approach to luciferase pre-
sentation (a powder rather than a preprepared liquid).
Our method was selected to minimize confounding vari-
ables, such as brand-to-brand differences in RLU scaling,
swab absorption, cell lysis mechanism and efficiency, liber-
ation of cellular ATP, and variations in cellular ATP during
bacterial cycles. To achieve this, the method used an ATP
source of known purity (Sigma-Aldrich). The ATP was diluted
across multiple dilution series, which enabled testing of the
3 devices across the full dynamic range of detection for each
device, from the lower limit of detection to response tapering.
We included multiple 10-fold dilution series as well as mul-
tiple narrower-range dilution series. A calibrated micropipette
(Thermo Scientific) was used to apply the diluted ATP directly
onto the swabs for each of the portable ATP bioluminometers,
following an earlier method.11
At each dilution point, each brand was tested in triplicate
or more frequently. The swabs for each brand were from mul-
tiple batches, stored in accordance with the manufacturers’
recommendations, and used within the use-by dates. High-
performance liquid chromatography (HPLC; Shimadzu) was
used to validate accuracy, precision, specificity, and linearity
and as a quantitative control for ATP.
Materials used in our experiments included 667 ATP swabs
in 153 separately measured dilution series (3M: 246 swabs in
57 runs; Kikkoman: 222 swabs in 49 runs; Hygiena: 199 swabs
in 47 runs). HPLC data were generated over 22 runs against
72 dilutions. ATP concentrations ranged from 105 mg/L to
1,000 mg/L.
Similar to many other studies, our results indicated con-
siderable variability; data are shown in Figure 1. The raw data
were subjected to test of association, which found no signif-
icant difference. The nonstandardized RLU scaling, which was
different for each brand, required a single common calcu-
lation for comparison. The coefficient of variance was de-
termined to be the best method of expression of the variability
in RLU readings. The experimental method of multiple runs
(153 test runs plotted in Figure 1) over the full dynamic range
of detection did not allow for an overall standard deviation
or mean to be determined for each device. HPLC demon-
strated a lack of variability with excellent precision and re-
peatability of ATP analysis, provided that the limits of de-
tection were observed.
The variability of the coefficient of variance shown in the
ATP data for the 3 brands strongly suggests that these ana-
lytical systems were rarely able to produce a reliable response
no matter the dilution or quantity of ATP. These findings
have implications for interpretation of data obtained using a
portable ATP bioluminometer when monitoring surface hy-
giene as part of infection control practice. Use of these devices
in the food sector is based on a validation pathway quite
distinct from the way in which usage has been trialed in the
healthcare setting.1,3
Portable ATP bioluminometer units are reliable for distin-
guishing between very different levels of ATP where the con-
centration is varied by at least an order of magnitude, thus
reducing the relative impact of the variance.8 The usefulness
of these units in healthcare settings is not ruled out by our
findings provided that usage allows for wide disparity in nar-
rowly focused measurements of similarly clean or soiled sur-
faces. We caution against use of a finite measure of cleanliness
based on RLUs until standard measures are improved and
the units are able to read reliably on a common RLU scale,
with a clear association with quantitated ATP levels.
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figure 1. Coefficient of variance (CoV) for 3 portable adenosine triphosphate bioluminometers. n values indicate the number of separate
dilutions tested per brand. HPLC, high-performance liquid chromatography.
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http://dx.doi.org/10.1016/j.ajic.2014.10.026Background: The 4 monitoring methods used to manage the quality assurance of cleaning outcomes
within health care settings are visual inspection, microbial recovery, fluorescent marker assessment, and
rapid ATP bioluminometry. These methods each generate different types of information, presenting a
challenge to the successful integration of monitoring results. A systematic approach to safety and quality
control can be used to interrogate the known qualities of cleaning monitoring methods and provide a
prospective management tool for infection control professionals. We investigated the use of failure mode
and effects analysis (FMEA) for measuring failure risk arising through each cleaning monitoring method.
Methods: FMEA uses existing data in a structured risk assessment tool that identifies weaknesses in
products or processes. Our FMEA approach used the literature and a small experienced team to construct
a series of analyses to investigate the cleaning monitoring methods in a way that minimized identified
failure risks.
Results: FMEA applied to each of the cleaning monitoring methods revealed failure modes for each. The
combined use of cleaning monitoring methods in sequence is preferable to their use in isolation.
Conclusions: When these 4 cleaning monitoring methods are used in combination in a logical sequence,
the failure modes noted for any 1 can be complemented by the strengths of the alternatives, thereby
circumventing the risk of failure of any individual cleaning monitoring method.
Copyright  2015 by the Association for Professionals in Infection Control and Epidemiology, Inc.
Published by Elsevier Inc. All rights reserved.Cleaning in health care settings is a manageable activity that can
be audited for consistency and quality.1 The processes of cleaning
environment surfaces within hospitals can be monitored by 4
distinct methods: visual inspection, microbial recovery, rapid ATP
bioluminometry detection, and use of fluorescent marker (FM)
technologies.2 Each of these monitoring methods generates a
distinct type of information that is difficult to integrate into a single
monitoring result.3,4
Although cleaning has the goal of removing soils and pathogens,
the monitoring methods used for management and supervision of
cleaning have a distinct quality assurance role.5 The goal of any
monitoring method is to provide feedback on cleaning failure to
assist in the management and improvement of environment
cleaning within health care settings.6-9
The sampling approach taken for the monitoring of environ-
ment surfaces within health care settings is a constant problem.10,11afetySci, PO Box 1076, North
teley).
tion for Professionals in Infection CThe apparently random distribution of soils, including dry surface
biofilms and pathogens, presents a challenge for any sampling plan
investigating the nature of environment contamination, and is
complicated by the presence high-touch objects.12-14 Health care
environment cleaning protocols are management tools that set out
the practical steps to achieving the goal of removing soils and
improving the quality of environment surface hygiene.15,16
Health care cleaning processes are designed on a risk-based
format with the highest risk areas requiring the most frequent or
highest-intensity cleaning.17 The secondary process of cleaning
monitoring is intended to ensure that soil removal goals are met
with optimal efficiency and efficacy.18
If the cleaning monitoring method is flawed due to uncontrolled
orunrecognized failure, then thedataoncleaningoutcomeswill also
beflawedandunreliable. This compromises themanagementgoal of
ensuring that the primary process of cleaning has been achieved.
We focused on the failure of cleaning monitoring methods and
not on the actual processes of cleaning. Failure mode and effects
analysis (FMEA) is a reliable safety and quality management risk-
assessment tool that identifies potential failure conditions or er-
rors that may cause failure for products or processes.19 The FMEAontrol and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
Table 1
Ordinal conversion table for assigning values to identified failure risk cofactors
Failure risk cofactor and criteria Descriptor Value
Frequency
The failure mode is unlikely to occur, or cannot
occur, during normal monitoring operations
Low risk 1
The failure mode is fairly likely to occur during
normal monitoring operations
Medium risk 2
The failure mode is highly lightly to occur, or
always occurs, during normal monitoring
operations
High risk 3
Severity
Occurrence of the failure mode will have minimal
or no effect on the monitoring results, or on
the associated cleaning outcome
Low risk 1
Occurrence of the failure mode will have some
effect on the monitoring results, or on the
associated cleaning outcome
Medium risk 2
Occurrence of the failure mode will have
considerable or extreme effect on the
monitoring results, or on the associated
cleaning outcome
High risk 3
Detectability
Occurrence of the failure mode is easy to detect.
Feedback is likely to inform immediate
monitoring-failure mitigation
Low risk 1
Occurrence of the failure has a possibility of being
detected. Feedback may inform early
monitoring-failure mitigation
Medium risk 2
Occurrence of the failure mode is difficult or
impossible to detect. Feedback is unlikely to
inform monitoring-failure mitigation
High risk 3
G.S. Whiteley et al. / American Journal of Infection Control 43 (2015) 147-53148applied here investigated if current cleaning monitoring methods
could be optimized to reduce cleaning failures as a type of medical
error.20,21
Within this management context, FMEA as a risk tool can add
value by systematically examining failures to mitigate or minimize
their influence on the cleaning process being undertaken.22 An
ultimate aim is the identification of failure modes within cleaning
monitoring systems as a quality improvement process in health
service provision.23
FMEA is typically conducted on products or processes, through
the application of existing information on identified failures or
failure modes to anticipate failure events. A failure mode is defined
as a “loss of intended function” under normal operating conditions.
FMEA was selected as a suitable method for prospective risk
assessment of the 4monitoringmethods due to its applicability as a
forecast model and as a risk-assessment tool that is frequently used
in the context of medical devices.24
A risk-assessment team of 3 individuals with collective skills in
FMEA and cleaning monitoring using each of the 4 methods was
formed, with the following aims:
 To identify a modified approach for the application of FMEA in
failure analysis relating to the 4 commonly used cleaning
monitoring methods,
 To test the feasibility of the approach by carrying out a pre-
liminary assessment of the 4 monitoring methods using the
modified FMEA approach and to identify areas of commonality
and work toward a monitoring model that could include the 4
methods in an integrated monitoring approach, and
 To identify strategies for the development of potential syn-
ergies during an integrated application of the 4 cleaning
monitoring methods.
For each of the identified failure modes, literature support was
required as part of the process of identification and consideration of
mitigation for each major failure mode.
METHODS
The initial step in the FMEA process was for the FMEA team
members to identify all possible causes of failure (loss of intended
function) for each of the 4 cleaning monitoring methods.24 Each
identified failure mode was substantiated by relevant material in
the literature. Where similar, multiple, or overlapping causes of
failure were identified, these were gathered under a common
failure mode. A comprehensive list of failure modes was noted for
each cleaning monitoring method.
The risk associated with each of the failure modes was then
assessed individually by each of the FMEA team members. Each of
the failure modes was graded against 3 distinct categories with
associated risk criteria. These categories were first graded for the
likely frequency of occurrence of that failure mode during normal
use, second for the severity of the effect of this failure mode on the
validity of the information produced, and finally the assessment
was also graded for whether the failure mode had any detectability
in the normal course of its use. The grading system applied for this
study is shown in Table 1. It uses a 3-tiered scoring approach similar
to the 3-tiered risk criteria that are used in Australian Infection
Prevention.23 In the FMEAmethod used in our study, each category
was assigned a score of 1-3 (low to high).
After the grading of each failure mode against each of the 3
categories (frequency, severity, and detectability), the grades for
each failure mode were multiplied to produce a single score known
as the risk priority number (RPN). The RPN is an overall indicator as
to whether the failure mode requires further consideration ormitigation to minimize the identified failure risks. Whereas some
authors have suggested use of weighting to accentuate critical
failures, for the purposes of simplicity no weighting of the RPN was
used in our study.25 Using the 3-point grading system outlined in
Table 1, there are only 10 possible RPN scores, with a minimum
score of 1, a median of 7, and a maximum score of 27. The RPN for
each failure mode was noted and ranked from high risk to low risk
of the nominated failure occurrence.
Following the establishment of each RPN a structured dialogue
was conducted to arrive at a common view on the RPN score using a
modified Delphi approach.26 The FMEA team members then
reconfirmed each identified failure mode through the published
literature andwhere no published evidence in support of the failure
mode was available then that failure mode was discarded.
The RPN scores were finally ranked and divided into 3 classes
based on a low, medium or high risk classification.23 For ease of
interpretation, the failure modes with RPN scores less than the
median of 7 were accepted as low risk. Scores >7 and <13 were set
as medium risk. Scores >13 were accepted as high risk.
The combined FMEA results were then considered to investigate
whether combinations of the cleaning monitoring methods would
provide mitigation of the effects of failure modes. This allowed for
the FMEA team members to identify any novel approaches that
could provide an enhanced approach to cleaning monitoring. This
step allows for mitigation to be used as a form of redundancy
whereby a reduction of the overall risks arising from cleaning
failure is practically achieved by reducing the risks of failure of the
cleaningmonitoringmethods. Thus the risk assessment approach is
used as predictive tool to improve practice in advance of failure.
This will lead to further research opportunities.RESULTS
For the 4 cleaning monitoring methods 32 failure modes were
identified and risk-assessed. Table 2 shows the 15 failure modes
G.S. Whiteley et al. / American Journal of Infection Control 43 (2015) 147-53 149ultimately found to be associated with the highest RPNs and
associated failure risk.
The consideration of mitigation identified a novel combination
of the 4 cleaning monitoring methods. This was particularly crucial
for the high and medium risk failure modes. The new model for
cleaning monitoring is outlined in Figure 1.
Costs were considered on a desktop basis for the purposes of
cost consideration on both individual basis and as a combination of
all 4 methods.
The high and medium risk failure modes identified using FMEA
for each of the cleaning monitoring methods is noted below for
each of the cleaning monitoring methods.
Visual inspection
The highest RPN was for visual inspection. Although a surface
may look clean, human vision cannot detect microscopic-level
contamination.11 This method is the current standard approach for
normal cleaningmonitoring within Australian and American health
care settings.27,28
Similarly, visual inspection cannot detect nonpathogenic soils
that can be left in situ due to a flawed cleaning method, or a lack of
cleaning.6,7,12
Visual triggers for cleanliness have a major behavioral effect and
cannot be discounted as important.29 The usefulness of visual in-
spection is that it is the only cleaning monitoring method that as-
sesses the visual appearance of the hospital, which is also seen by
patients, their families, and the other noncleaning staff members.
Visual inspection is the only cleaning monitoring method that
matches the appreciation of hospital cleanliness with all of the
stakeholders and that provides a representative outcome of the
hospital aesthetics. It is also noted that visual inspection carries
only an existing cost overhead in terms of staff time used.
Mitigations noted for visual inspection included each of the
other cleaning monitoring methods.
Microbial recovery (environmental Swabs)
A high RPN and high risk classification was also associated with
the delay between microbial sampling and reading results, which
frequently takes longer than 48 hours.27,28 This delay renders
cleaning monitoring results to low relevance because the patient,
the cleaning processes, and the environment may have changed
several times in the interim.10
Medium and high risk was associated with technical swabbing
issues and poor sampling planning.11 Sampling planning is parti-
cularly vulnerable to statistical error in terms of representative
sampling due to the low level of sampling and the high surface area
for potential contamination, even with high-touch objects or sur-
faces. Using a validated sampling and recoverymethod canmitigate
many of these failures. Sampling plans should also take into ac-
count the risks of pathogenic viruses where appropriate because
bacterial recovery methods will not work.30 The presence of
biofilm-mediated pathogens presents yet another challenge that
was assessed as a medium risk failure mode.13 Interference due to
disinfecting solutions use can also be overcome through the use of
validated protocols with appropriate robustness.10
As noted in Table 2, the use of the other cleaning monitoring
methods (ATP bioluminometry and FM) can mitigate the time
failuremode and assist in targeting the environmental surfaces that
require samples collection for microbial recovery.
Rapid ATP detection
Since use of rapid ATP testing was first suggested, many tech-
nical problems have been described with regard to its use withinhealth care settings.6,31-33 The failure modes identified from our
FMEA, which are categorized as medium risk, are noted in Table 2.
The 3 highest RPN and medium risk scores came from unrep-
resentatively low ATP readings due to a failure of ATP detection.32
The correlation between high ATP bioluminometry readings and
microbes has been established, but there does not appear to be any
ATP level (in relative light units) that correlates with nosocomial
pathogens at low levels, nor with viruses present on surfaces.34-37
The lack of correlation with specific pathogens is not recognized
as a failure insofar as the setting of an appropriate alert level noting
that none of the brands of ATP bioluminometers claim direct cor-
relation with known pathogenic microbes, particularly at low
concentrations on surfaces.8,36,37
Difficulties interpreting the results of ATP are a medium risk
failure mode that underscores the importance of validation and
training.16,31,33
Mitigations noted against ATP testing are the adjunct use of
microbial recovery methods and FM to indicate the frequency of
cleaning on relevant environment surfaces, a validated sampling
plan, and appropriate levels of training in the use an interpretation
of ATP readings.32
FM technologies
The data for FM technologies are impressive with excellent
correlationwith cleaning outcomes.38 Failuremodes noted for were
only for unintended or detectable visibility (and preferential
removal of FM marker) and for the lack of quantitative information
provided through the removal of an FMmarker. FM technologies in
themselves only measure whether a surface has been attempted to
be cleaned, and do not provide an indication of the quantitative
hygienic status of a surface. If the FM spot is removed then the data
generated are nominal (pass or fail) and are therefore qualitative,
although the authors note the highly impressive value of the data
and the evidence in favor of this cleaning monitoring method.4,8,39
In Table 2, the 2 medium risk failure modes can both be miti-
gated through the use of alternative cleaning monitoring methods.
The visibility of the FM spots is a noted problem, and the additional
problem of well-prepared cleaning staff (with their own fluores-
cent lights to identify the location FM spots) can be mitigated
through the sequential or parallel use of rapid ATP detection.40
Mitigation
The FMEA assessors considered the failure modes in combina-
tion with all 4 cleaning monitoring methods. The failure modes
identified for visual inspection were given the classification of high
and medium risk, but in each case the use of an alternative rapid
method such as ATP bioluminometry could mitigate the risk rating.
For microbial recovery, the use of a rapid method of testing, again
such as ATP, could work well to mitigate the delay issues, given that
correlation has been established with at least high levels of mi-
crobial contamination. The classification of medium risk for failure
modes of ATP testing can in each case be mitigated through the
concurrent use of FM or microbial recovery (during any outbreak of
disease). The lack of quantitative information as a failure mode for
FM can be mitigated easily through adjunct use of ATP.
Figure 1 outlines a new theoretical approach that attempts to
overcome the identified failure modes of the cleaning monitoring
methods by using the strengths of 1 method to cover the weak-
nesses of another method. Figure 1 demonstrates the potential
synergy provided by using the cleaning monitoring methods
concurrently and in sequence, rather than in isolation or in a par-
allel trial. When considered together as a bundle of solutions for
cleaningmonitoring, the 4methodswork best in combination, with
Table 2
Fifteen failure modes ultimately found to be associated with the highest risk priority numbers (RPN) and associated failure risk
Cleaning Monitoring
method Failure mode Frequency* Severity* Detectability* RPNy
Risk
classificationz Mitigation suggestions
Visual Inspection Surface looks clean but is contaminated with pathogenic
microbes11
3 3 3 27 High Testing of surfaces with a quantitative method for
determining surface hygienemay indicate contamination
(eg, ATP testing)
Surface looks clean but is contaminated with non-visible
soils6
3 2 3 18 High Testing of surfaces with a quantitative method for
determining surface hygienemay indicate contamination
(eg, ATP testing)
Surface looks clean but has not been subject to routine
cleaning processes12
2 2 3 12 Medium Use of an FM technology will indicate surface cleaning
frequency rate. ATP testing alone will not be sufficient to
indicate cleaning frequency
Microbial recovery Result from sampling is delayed by 48 h or more27 3 3 2 18 High Testing of surfaces with a rapidmethod (eg, ATP testing) can
rapidly inform the sampling processes by indicating any
loci of contamination
Pathogenic bacteria are not detected on swab but are
present on high-touch obejects10
2 2 3 12 Medium Validation of sampling methods with examination of
different methods results can improve microbial
recovery
Viruses (pathogenic) are not detected by sampling
methods30
2 3 2 12 Medium Selection of a virus-sensitive sampling and recoverymethod
is required where cross-infection with viruses is a known
risk factor
Pathogenic bacteria are not detected due to poor
environmental sampling plan or methodology11
2 2 2 8 Medium Validation of sampling methods with examination of the
effect of different methods can improve microbial
recovery. Adjunct use of rapid ATP detection can assist in
identification of possibly contaminated environmental
locations
Pathogenic bacteria are present in biofilms that are not
recovered in normal sampling13
2 2 2 8 Medium Swabbing techniques should utilize different approaches to
dislodge resident organisms. Subsequent recovery
techniques may be required for cultures to adjust for
slower recovery dynamics
ATP bioluminometry Failure to detect the ATP present on contaminated surfaces
(possible lysis failure by ATP consumables-reagent)32
2 2 3 12 Medium Microbial recovery can be used for confirmatory quality
control where FM indicates inadequate cleaning but low
ATP readings do not reflect inadequate cleaning. A
validated sampling plan will ensure testing is
representative
ATP swab fails to pick up sufficient bacteria to indicate
surface contamination (falsely low ATP reading)32
2 2 3 12 Medium Microbial recovery can be used for confirmatory quality
control where FM indicates inadequate cleaning but ATP
readings are in the low range and biofilm is suspected
Failure to detect viruses due to absence of ATP32 3 2 2 12 Medium Use of an FM technology is low cost andwill indicate surface
cleaning frequency in addition to use of rapid ATP
detection. A suitable microbial recovery method for virus
detection could also be used
Similar before-and-after ATP readings that do not indicate
that cleaning has or has not occured31
2 2 2 8 Medium Rapid ATP detection requires a carefully considered
sampling plan to ensure that multiple readings are taken
for proper interpretation of the results. Adjunct use of FM
will indicate if cleaning has occurred
Incorrect interpretation of the ATP readings from the
hospital surfaces33
2 2 2 8 Medium ATP readings are subject to both variability and sampling
error. Careful validation of the sampling plan and use of
ATP will reduce both types of error. Adjunct use of FM
will indicate cleaning. Training in reading ATP results is
essential
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carefully considered and adjunct use of each of the available
methods.
The costs attached to cleaning monitoring method are a sub-
stantial concern, but these do vary by geographic region, com-
mercial availability, and local practices. The individual cost
components on any 1 cleaning monitoring method are outside of
the range of this study and will require further investigation and
quantitation. The opportunity for cost-efficiency in the mixed
monitoring approach outlined in Figure 1 should be further
investigated to find the balance between cost and efficiency in the
supervision of cleaning services.
In an integrated study using the 4 monitoring systems in par-
allel, costs could be managed in a very different manner to suit the
location of the monitoring and the specific infection control
circumstance.
DISCUSSION
The worst of all failure modes observed from the 4 cleaning
monitoring methods was for visual inspection.6 The use of micro-
bial recovery through environmental sampling has a major failure
mode due to the delay in receiving results.10 Clearly FM is a simple
tool that provides excellent quality data on the frequency of non-
cleaning; that is, the qualitative question of how often the cleaning
is not conducted as intended.38 There is also a need for a moni-
toring process that has the role of quantitation of cleaning perfor-
mance in terms of surface cleanliness, and rapid ATP testing could
be developed to fill this void, subject to interpretation and valida-
tion issues.8,31-36
Not 1 of the current cleaning monitoring methods could over-
come all of the potential failure modes that were identified for that
monitoring method when considered in isolation.
When the cleaning monitoring was considered in a single
flowchart (Fig 1), it became clear that use of the monitoring
methods in combination offered the opportunity to mitigate the
effect of failure modes through the synergistic value of the cleaning
monitoring methods were used both in parallel and in sequence.
The strength of visual inspection was maximized, whereas the
high-risk failure modes are mitigated through use of both FM and
ATP bioluminometry. A highly targeted (adjunct) use of microbial
recovery, particularly during an outbreak, can be used to provide
quantitative information against any specific pathogens of concern
where timely feedback is less of a concern.27,28,37
When using both FM and ATP testing for cleaning monitoring,
health care providers must set a suitable acceptable level of pass or
fail using the data generated.8 For example, FM will indicate the
frequency of cleaning for surfaces and infection control pro-
fessionals (ICPs) should consider the acceptable level of success
before any intervention on the quality of the cleaning service
provided.4 Similarly for rapid ATP, the appropriate level of pass or
fail for the brand of ATP device should be carefully considered
before implementation of use of rapid ATP detection, so that
intervention on the quality of cleaning service provided is
appropriate.36
The issue of cost of monitoring is the subject of ongoing studies,
and costs will vary by location and commercial issues. The outline
considered in Figure 1 demonstrates that by using an integrated
approach, costs of monitoring can be managed to achieve the
lowest potential cost to yield the greatest likelihood of successful
cleaning performance.
This work is intended as an exemplar on the use of FMEA, and is
by no means fully comprehensive. The failure modes identified by
our FMEA assessors are subjective and may not fully reflect all of
the potential failures in cleaning monitoring methods. However,
Fig 1. Model for cleaning monitoring.
G.S. Whiteley et al. / American Journal of Infection Control 43 (2015) 147-53152the work in reconstructing the approach of cleaning monitoring
using all 4 available methods does offer ICPs a new approach to
drive quality improvements in environmental cleaning processes
through more reliable data collection in ongoing studies. Further
studies are underway to investigate and confirm the findings of this
FMEA-based risk assessment study.References
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objective. To investigate the reliability of commercial ATP bioluminometers and to document precision and variability measurements
using known and quantitated standard materials.
methods. Four commercially branded ATP bioluminometers and their consumables were subjected to a series of controlled studies with
quantitated materials in multiple repetitions of dilution series. The individual dilutions were applied directly to ATP swabs. To assess precision
and reproducibility, each dilution step was tested in triplicate or quadruplicate and the RLU reading from each test point was recorded. Results
across the multiple dilution series were normalized using the coefficient of variation.
results. The results for pure ATP and bacterial ATP from suspensions of Staphylococcus epidermidis and Pseudomonas aeruginosa are
presented graphically. The data indicate that precision and reproducibility are poor across all brands tested. Standard deviation was as high as
50% of the mean for all brands, and in the field users are not provided any indication of this level of imprecision.
conclusions. The variability of commercial ATP bioluminometers and their consumables is unacceptably high with the current technical
configuration. The advantage of speed of response is undermined by instrument imprecision expressed in the numerical scale of relative light
units (RLU).
Infect Control Hosp Epidemiol 2015;36(6) :658–663
The original suggestion to use rapid adenosine triphosphate
(ATP) bioluminometers to monitor surface hygiene has yet to
see practical fulfilment among healthcare infection control and
prevention practitioners.1 Rapid ATP bioluminometry has
been shown to reliably distinguish between 10-fold serial
dilutions of various common bacterial species.2,3 ATP devices
also produce a nearly instantaneous measurement of surface
cleanliness, which has been suggested to provide useful feed-
back for quality improvement of cleaning services.4
Currently, authoritative sources have declined to endorse ATP
testing on a stand-alone basis for monitoring surface hygiene in
healthcare settings.5–7 While the detection of ATP on different
surfaces has been validated with multidrug-resistant organisms
(MDROs) where a large amount of contamination is present,
little correlation has been made using ATP measurements when
small amounts of infectious contaminants are present.8,9
Variability has been identified as a concern in the use of
handheld ATP bioluminometers,10,11 and 3 particular aspects
are troublesome. First, the ATP reading scale known as relative
light units (RLUs) lacks quantitation against a known standard
and therefore cannot be calibrated, coincidentally diminishing
interbrand comparability.12
Second, as we have shown previously, this high variability
leads to poor precision (repeatability) at a magnitude that
prevents ATP devices from adequately distinguishing between
similar ATP concentrations or similar levels of contamina-
tion.12 In this earlier study, the presence of raw data ‘outlier’
readings was unpredictable and nominally undetectable to
those using an ATP device, and these outliers can occur both
above and below the interquartile range.12 This variability can
cause unexpected and unusual results, such as ATP readings
that are higher following cleaning than prior to cleaning.13
Third, the impact of this variability is greatest at the mea-
surement level that defines the boundary between acceptable
and unacceptable cleanliness. This criterion has been suggested
through various studies at the lower end of the RLU reading
range, between 500 RLU and 100 RLU, and is dependent upon
the brand of ATP bioluminometer.14,15 Attempts to correlate
proposed cleaning standards with benchmarks expressed in
RLUs, at the low RLU levels required for hospital hygiene, have
been manifestly unsuccessful.16–19 Even the applications of a
method utilizing a receiver operating curve have not resulted
in a widely accepted definitional boundary for an ATP-based
cleaning benchmark.15,20
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Uncontrolled variability leading to poor precision is a
major problem for statistical methods comparing differing
treatment or control groups.21 The risk of type I and type II
errors in environmental monitoring is increased if the
devices are subject to substantial variability.22 These type I
and II errors using handheld ATP bioluminometers can pre-
sent as false-positive or false-negative results, generating
additional costs either way. Variability in results from ATP
bioluminometers is the most recurrent technical concern
regarding their use in cleaning monitoring studies using quasi-
experimental frameworks.
Another particular concern with portable ATP devices is the
risk of random error, which is undetectable in single mon-
itoring samples.23 Most studies have been focused on the risks
of systemic error through reading inaccuracy over a wide range
of dilutions; however, the magnitude of random error and
accompanying dispersion of the data set (ie, RLU readings) has
confused many studies.2,3 The issues of systematic error with
ATP devices are not considered in this paper.
In this study, a continuation of our work, 4 commercial brands
of rapid ATP bioluminometers were tested to validate their
performance in a series of controlled experiments. The aim of
this study was to assess the precision of and reproducibility of
results from the ATP devices to qualify their role in cleanliness
monitoring. The critical aspects of this study were the evaluation
of the precision of the ATP measurements as expressed in RLUs
and the assessment of the magnitude of random error using both
pure-source ATP and bacterial ATP.
This paper outlines our findings regarding variability for all
of the ATP devices we tested under controlled conditions.
methods
The 4 commercial brands of ATP bioluminometers and their
consumables were considered in this work: 3M (Cleantrace),
Kikkoman (Lucipac-pen), Hygiena (Ultrasnap), and Charm
(Pocket Swab Plus). This series of experiments investigated
the response of each brand of ATP device across dilution
series to known ATP quantities and to various bacteria in
suspension cultures through direct application to swabs.12 This
method of application removed swab technique as a variable,
thus exposing more clearly the underlying variability of the ATP
devices. The use of multiple repetitions of dilution series
established a practical dynamic range of concentrations for each
of the ATP bioluminometers, both for a known source of
ATP and for the ATP of bacterial species included in the studies.
Each ATP device and its consumables were used in accordance
with the respective manufacturer’s instructions, including
refrigerated storage, use at room temperature, and consumables
used prior to the expiration date.
Testing Using Quantitated ATP
Our study used a known source of ATP (Sigma Aldrich, Castle
Hill, Australia) to assess ATP device response; while the
quantitative aspects of the concentration of the ATP were
confirmed using high-performance liquid chromatography
(HPLC; Shimadzu, Japan) in a validated method. The use of a
fully validated, laboratory HPLC allowed a defined quantity
of ATP to be used on each sample, thus anchoring the
experimental results and qualifying the confusing RLU scaling
to minimize the risks of random and/or systematic errors in
measurement. The method of application used 10 µL of each
concentration of ATP solution applied directly to each swab
using a calibrated pipette.12
At each dilution point, replicated testing with a minimum of
3 swabs was used for each ATP bioluminometer, and wherever
possible, test points were sampled in quadruplicate. For each
dilution series, the experiment was repeated at least twice,
using multiple batches of consumables from each of the ATP
device suppliers.
The ATP solutions were tested in both a 10-fold dilution
series and in a number of 20% dilution series at various
concentrations of ATP. In total, >840 swabs were used to
sample >200 concentrations. The Charm device and con-
sumables were obtained toward the end of the study, so the
number of sample concentrations and total number of swabs
used to test that brand were smaller than for the other three
brands.
Microbiological Testing
The experiments using bacterial-suspension cultures were
each repeated on multiple occasions. At each concentration in
the dilution series, testing was conducted in quadruplicate, and
medians have been used to present typical responses.
The bacteria used in the experiments were Staphylococcus
epidermidis (ATCC 12228) and Pseudomonas aeruginosa
(ATCC 15692). All were tested as suspension cultures. While
the strains tested are not regarded as intrinsically invasive,
both S. epidermidis and P. aeruginosa have been associated
with implanted device failure (S. epidermidis), multi-drug-
resistant organisms (P. aeruginosa), and healthcare-associated
infections.24,25
Staphylococcus epidermidis and P. aeruginosa were enumer-
ated by dilution series onto nutrient agar–spread plates
(Oxoid, Thermo Scientific, Waltham, MA) incubated at 37°C
for 48 hours. The P. aeruginosa plates were read at both
24 hours and 48 hours. The quantitative enumeration of the
suspension cultures allowed for quantitation of the results and
also minimized the risks of systematic error from RLU
measurements.
Phosphate-buffered saline solution (PBS; Univar, Sydney,
Australia) was used for the dilution series at 10 mMol/L
and buffered to pH 7.0 The solution was freshly made and
sterilized with each experimental round. During an early
experimental round, dilutions prepared with tryptone soy
broth (TSB) were found to interfere with one of the ATP
bioluminometers (Kikkoman), and the use of TSB was
discontinued thereafter. This TSB interference observation was
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confirmed subsequently with separate laboratory operators in
an independent test run.
Tests were conducted in 10-fold dilution series and a
number of 20% dilution series at various concentrations of
suspension culture. All test concentrations were tested in
quadruplicate; however, in some instances samples were
measured in triplicate. Testing against bacterial cultures was
conducted by direct application in the same way ATP was
tested, with 10 µL applied per swab. In this study, we used
>1200 ATP swabs and ~ 300 individual concentrations of
bacterial suspensions.
Statistical Approach
Because the ATP bioluminometer readings in RLU were not
comparable between brands, absolute measures of random
error, such as standard deviation, were not directly comparable
between brands. The standard deviation increased with
increases in the underlying value of tested dilutions, so another
statistical measure was required.26 To assess the relative size of
the random error, measurements were normalized using the
coefficient of variation (CV), which is the ratio of standard
deviation to the mean.27 This method is particularly helpful
with non-symmetrical data.28
This normalized measurement allowed the comparison of
instrument precision among brands at varying concentrations.
A CV of 0.4 implies the average distance between observations
at a single concentration for that ATP device; the mean of
those observations is 40% (0.4) of that mean. Alternatively, if
the mean was equal to the absolute truth of the measurement
for that ATP device, the expected error (or precision in this
case) would be ~0.4 times the mean, but according to Reed
et al,27 a 1 in 5 chance remains that the reading will be incor-
rect (imprecise) by a factor of 2 or more.27 The higher the CV,
the lower the precision of the equipment.
The replicated data from the experiments were used to obtain
the individual CV for each set of readings for each device at each
concentration point, which captured the precision in a highly
variable data set with these rapid ATP bioluminometers.10,29 The
use of CV as statistical approach can also capture both the ran-
dom error and some of the systematic errors, which directly
affects the precision of ATP measurements.
The distribution of CVs is summarized in Figures 1–3 using
boxplots. In the plots, the central line in each box represents
the median value, with a box drawn around the second and
third interquartile ranges. The whiskers (the lines extending
both below and above the box) represent the tenth and nine-
tieth percentiles of the range; the dots above and below
represent values that are outside the expected spread of results
(ie, outliers).
The regularity of outliers both above and below the inter-
quartile ranges of samples was noted as a problem early in
these studies. Arithmetic median was used rather than averages
to remove the distortion caused by outliers in raw data sets.
When considering dynamic range, however, this sampling
approach is not always available for use in field-based mea-
surements. The CV method was preferred to signal-to-noise
ratio (x/σ) due to the large volume of random error.
All calculations were conducted and graphs were produced
in Microsoft Excel 2010 (Microsoft, Seattle, WA), and where
required, these calculations were confirmed using Sigma Plot
(Systat, San Jose, CA) or SPSS (IBM, NY).
results
Variability measures for all 4 bioluminometers were standar-
dized using the coefficient of variance (CV). The 3 testing
platforms for the ATP bioluminometers and their consum-
ables first quantitated pure-source ATP (Figure 1) then the
ATP of the 2 bacterial species S. epidermidis (Figure 2) and
P. aeruginosa (Figure 3). The variability expressed as CV was
present across the full dynamic range for all ATP biolumin-
ometer brands tested and was not concentration dependent.
Figure 1 indicates the CV present in all 4 ATP biolumin-
ometers and displays the contrast of very low CV calculated
for the HPLC. HPLC measurements, taken in triplicate,
demonstrated a correlation of r= .998, indicating the high
precision and low variance expected of a fully calibrated
precision laboratory instrument. When compared with the
HPLC values, all 4 of the ATP devices indicated higher
levels of variance, and 2 of the devices (Kikkoman and
Hygiena) produced CV> 0.4. In a prior study, also using
known-source and quantitated ATP, the 3M device also
produced CV= 0.4.10
Figure 2 shows the CV for all 4 ATP bioluminometers when
measured against quantitated dilution series using the Gram-
positive bacterium S. epidermidis. Figure 2 indicates that all 4
ATP bioluminometers scored a CV> 0.4 and 2 of the devices
(Kikkoman and Charm) showed CV> 1.0 (σ> x).
figure 1. Coefficient of variation for 4 ATP bioluminometers
using ATP testing.
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Figure 3 indicates the CV for all 4 ATP biolumino-
meters when measured against quantitated dilution series’
using the Gram-negative bacterium P. aeruginosa. Figure 3
clearly indicates the same pattern of CV shown in Figures 1
and 2.
The experimental series used>500 sample concentrations and
>2,000 swabs with robustly defensible and repeated outcomes.
Figure 4 shows the overall spread for the 4 devices with
the range (high–low) and median indicated for each ATP
bioluminometer brand and each material tested. The median
readings of all 4 ATP devices against the 3 validated soiling
materials (pure-source ATP and 2 bacteria) yielded CVs
clustered between 0.0995 and 0.39. As shown in Figure 4, all
4 brands produced at least 1 high-range value (CV> 0.5),
which undermines confidence in instrument precision for field
use, particularly where surface sampling uses only a single
swab.
discussion
The use of rapid ATP testing in the monitoring of environ-
mental cleanliness in healthcare settings has the advantages of
quick response, semi-quantitative evaluation, ease of use,
and immediate feedback regarding cleaning performance
outcomes for surface cleaniness.4,6 Rapid ATP monitoring also
has identified flaws that require careful consideration when
designing a sampling regimen.9,11,29
A high level of variability using rapid ATP bioluminometers
was observed across all of the brands tested with CV results;
similar results were acquired between brands for both quan-
titated ATP and bacterial suspension cultures. The lack of
precision and lack of reproducibility when using commercial
rapid ATP bioluminometers undermines both the validity of
the results and the confidence with which the devices can be
used, particularly in busy healthcare environments with
cost constraints on sampling. Furthermore, variability in RLU
readings increases the likelihood of both false-positive and
false-negative outcomes from studies in which metering
variation is not considered prior to interpretation of results.
In healthcare, complexity in the management of cleaning is
compounded by the irregular distribution of microorganisms
despite recognition of some location patterns.30,31 The presence
of dry-surface bacterial biofilms containing multidrug-resistant
organisms adds another level of uncertainty in the monitoring of
cleanliness.32 The accurate measurement of cleanliness failure
is essential for infection prevention, and if measurement is
accurate and precise, the sampling method can be minimized as
a confounder in underestimating the presence of pathogenic
contaminants.33
In cleaning monitoring, the use of an environmental
sampling method can lead to both type I and type II statistical
errors. The dangers of a false-positive RLU reading (type I error)
may be the cost of additional cleaning. This cost could be sig-
nificant if the cleaning benchmark is set unreasonably low or if
the ATP bioluminometer overstates the level of contamination
due to random error. Importantly, false-negative test results
with inaccurately low RLU readings (type II error) compound
the potential infection risks from insufficiently cleaned surfaces.
Quality assurance is compromised when a device such as an
ATP bioluminometer lacks the precision required to reliably
articulate cleanliness as intended by its use. Reliability in the
precision of RLU readings is particularly important at the low
end of the dynamic range where the correlation between ATP
detection and the presence or absence of pathogenic microbes
is most difficult to determine.8
One way to reduce variability is to address the RLU scaling,
which is highly relative and is different for each brand of ATP
device.12 An interim way to manage the impact of variability
figure 2. Coefficient of variation for 4 ATP bioluminometers
using Staphylococcus epidermidis.
figure 3. Coefficient of variation for 4 ATP bioluminometers
using Pseudomonas aeruginosa.
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with ATP devices is to manage the sampling plan through the
sequential and parallel use of different methods of cleaning
monitoring.34
The results presented here were obtained with the advantages
of controlled conditions, multiple repetitions, large numbers of
swabs used in a wide array of concentrations across the entire
reading range of the devices. Unfortunately, this strictly con-
trolled approach probably underestimates the level of variation
that occurs in uncontrolled field-based studies; for example, swab
technique adds additional variability. A shortfall of this study was
that just 1 ATP device per brand was used in the experiments.
Purchased consumables (albeit used according to manufacturer
recommendations) lack consistency that may not be reflected in
manufacturer-supported studies with fresh consumables and
strict batch controls. However, this work does represent the
normal experience of field use, suggesting that all brands of ATP
devices exhibit similar variability and lack of precision.
Furthermore, in this study, more repetitions may have
decreased the range of CV results, thus bringing the mean
and median into closer alignment. However, the range data
(Figure 4) would be unaffected.
Rapid ATP measurement using handheld devices is quick
and relatively inexpensive, but caution is required in the
interpretation of results. As ATP devices are currently config-
ured, the inherent variability and lack of precision in the
results obtained may lead to erroneous conclusions; thus, data
collected using these devices and the conclusions stemming
from them warrant careful consideration.
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http://dx.doi.org/10.1016/j.ajic.2015.07.013Background: The persistence of multidrug-resistant organisms (MDROs) within an intensive care unit
(ICU) possibly contained within dry surface biofilms, remains a perplexing confounder and is a threat to
patient safety. Identification of residential locations of MDRO within the ICU is an intervention for which
new scientific approaches may assist in finding potential MDRO reservoirs.
Method: This study investigated a new approach to sampling using a more aggressive environmental
swabbing technique of high-touch objects (HTOs) and surfaces, aided by 2 commercially available
adenosine triphosphate (ATP) bioluminometers.
Results: A total of 13 individual MDRO locations identified in this pilot study. The use of ATP bio-
luminometers was significantly associated with the identification of 12 of the 13 individual MDRO lo-
cations. The MDRO recovery and readings from the 2 ATP bioluminometers were not significantly
correlated with distinct cutoffs for each ATP device, and there was no correlation between the 2 ATP
devices.
Conclusion: The specific MDRO locations were not limited to the immediate patient surroundings or to
any specific HTO or type of surface. The use of ATP testing helped rapidly identify the soiled locations for
MDRO sampling. The greatest density of positive MDRO locations was around and within the clinical staff
work station.
Copyright  2015 by the Association for Professionals in Infection Control and Epidemiology, Inc.
Published by Elsevier Inc. All rights reserved.5,6Pathogenic microorganisms are a persistent risk to patient
safety in modern health care settings, particularly within active
intensive care units (ICUs).1 The presence of multidrug-resistant
organisms (MDROs) embedded within dry surface biofilms adds
further complexity to the cleaning process.2 A validated scientific
approach to evidence-based cleaning requires a multidisciplinary
understanding of all intersecting parts of the hygiene puzzle.3
The location of MDROs within an ICUmay be subject to patterns
of localization and dispersion.4 There is an expected “hot zone” of
bacterial surface contamination normally focused around the bedpSc, MSafetySc, Dip AICD, PO
ley).
tion for Professionals in Infectionof an infected patient. The transfer of these MDROs away from
the patient area and throughout the ICU is thought to occur largely
via unwashed hands and gloved hands.7,8 High-touch objects
(HTOs) are located throughout clinical areas and can provide a
likely transit point for microbes owing to the frequency of hand
touches.9
A lack of cleaning in the clinical workspace, which is distant
from the direct patient surroundings, may allow biofilm develop-
ment without mitigation.10 This opens the potential for MDRO to
move seamlessly between residential biofilm locations either close
to or away from the patient, and then back and forth via hands onto
surfaces and objects that are frequently touched within the ICU.11
The identification of residential biofilm locations thus becomes a
critical requirement in the validation of any cleaning process within
health care settings and particularly in ICUs.12Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
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cleaning has been shown to be superior to visual inspection of
cleaning performance.13 Various studies have indicated that ATP
devices can detect and reliably indicate high readings in relative
light units (RLU) when high numbers of bacteria or ATP sources are
present.14-16 Recent studies have further indicated that despite the
lack of species identification, commercial ATP devices may aid the
detection of MDRO species on surfaces.17 The use of commercial
ATP devices in ICU settings has been shown to add limited
improvement to cleaning validation within ICUs.18,19
The poor level of precision with the current generation of ATP
meters requires careful consideration in the methodology of any
sampling plan.20 Field trials using different brands have not shown
any definitive correlation either with cleaning or between
brands.21-23 The use of overlapping monitoring approaches has
been suggested as a method to overcome individual weaknesses in
monitoring systems.24
In the present study, conducted within an active ICU, a series of
environmental cleanliness assessments were conducted to identify
locations of MDROs. Microbial sampling was also conducted to
confirm the presence and location of MDROs and likely hotspots for
the presence of dry surface biofilms. Two commercially available
ATP devices were evaluated to determine whether they could be
reliably used to indicate soiled versus relatively clean surfaces as a
rapid indicator for prospective sampling locations.
METHODS
In this pilot study, 3 separate sampling runs were conducted. All
sampling sites were identified as HTOs that have been previously
reported in the literature.2,9,10,25 The first sampling run was per-
formed by a single operator only obtaining microbial swabs using
the method described below. On the second and third sampling
runs, 2 operators sampled various HTO locations, performing
microbiology and ATP sampling. The full set of sample locations is
listed in Table 1.
Environmental swabs were taken using a sterile gauze cloth
soaked in a 0.9% sodium chloride solution, swabbed onto the sur-
face using sterile tweezers, and then immediately immersed in
sterile tryptic soy broth (TSB).26 The gauze swabs were then incu-
bated at 37C for 24 hours and tested for the presence of
methicillin-resistant Staphylococcus aureus, vancomycin-resistant
enterococci, and multidrug-resistant gram-negative bacteria by
spread plating onto methicillin-resistant S aureus and vancomycin-
resistant enterococci chromogenic media (bioMérieux, Marcy-
l’Étoile, France), extended-spectrum beta-lactamase chromogenic
media, and horse blood agar (Edwards, Sydney, Australia). Potential
MDRO growth was identified and tested for antibiotic susceptibility
viamatrix assisted laser desorption ionization time-of-flight (VITEK
automated microbial identification system; bioMérieux).
The 2 commercially available ATP bioluminometers and their
consumables selected for the study were the Kikkoman ATP device
with Lucipak-Pen swabs (Foodcare Systems, Leeton, Australia), and
the Hygiena ATP device with Ultrasnap swabs (Key Diagnostics,
Lane Cove, Australia). All consumables were stored in accordance
with themanufacturers’ instructions. ATP swabs were taken at each
identified location first with the Hygiena device and then with the
Kikkoman device. The final swab taken at each location was for the
microbial recovery of MDROs as described above.
The first sampling run used only environmental swabs on likely
HTOs. Sampling sites for the second and third runs were selected
after the first run. The second run used both nonpaired and a paired
combination of the 2 ATP devices with microbial sampling. The
selection process for the second sampling run was neither well
matched nor randomized. The third run used a matched-pairedapproach with both ATP devices and microbial sampling at each
sample location.
Statistical analyses were performed using both Excel 8.0
(Microsoft, Redmond, WA) and Sigma Plot 12.0 (Systat, San Jose,
CA). Tables and Figures were drawn using Microsoft Excel 8.0. The
c2 calculations were manually rechecked and corrected using the
Yates correction (for low sample numbers). The Yates correction
used 1 degree of freedom (df) in the calculation df ¼ (r  1) (c  1),
where r represents rows and c represents columns.27 Fisher’s exact
test was calculated using Sigma Plot.
RESULTS
A total of 62 environmental swabs were obtained from the 3
sampling runs (23 from the first run,16 from the second run, and 23
from the third run). The first sampling run collected microbial
swabs from 23 separate HTO locations. The second sampling run
examined 29 separate HTO locations, using a combination of 16
environmental swabs and 43 ATP swabs (28 Hygiena and 15 Kik-
koman). During the second sampling run, only 13 of the 29 loca-
tions had the environmental swabs matched with the use of both
brands of ATP swabs. The third sampling run used a fully matched
approach, in which all 23 sites examined were subject to 23 envi-
ronmental swabs and 23 of each of the branded ATP swabs
(46 swabs). Table 1 lists the sampling locations and methods.
The first sampling run collected 23 microbiology swabs using a
single operator, without ATP testing. From this first sampling run, a
single MDRO-positive sample was confirmed from a patient folder
within the immediate patient zone (MDRO recovery rate of 4.3%;
n ¼ 23). The time interval from sampling to MDRO confirmation
was longer than 72 hours.
The second sampling run introduced the use of ATP testing. The
results of ATP tests are expressed in RLU. The nearly immediate RLU
readings were accepted to indicate the general level of soiling in
each sample location.14-16 Many of the sampling locations with
relatively low RLU were not sampled for either MDRO or for the 2
branded ATP tests. This sampling approach limited the power of
findings from this pilot study and introduced the potential for
sampling error, particularly with insufficient replicates from each
sample location.28 The rise in ATP levels in this second sampling
run, as sampling locations moved from the immediate patient zone
toward the clinical workstation, is illustrated in Fig 1.
This second sampling run examined a total of 29 individual HTO
locations. Environmental swabs were taken on all surfaces with
relatively higher RLU readings. Sixteen locationswere swabbed using
environmental swabs; 3 of the 16 swabs were taken using only a
single branded ATP reading (all Hygiena). All of these 13 locations
were examined with environmental swabs and using a paired
approach using both brands of ATP tests. From the 13 swabs with
matching pairs, 5 of the environmental sampleswere later confirmed
(>72 hours) as positive for anMDRO. From this second sampling run,
only the 13 matched pairs were included in the statistical analysis.
The third sampling run sampled 23 locations focused around the
clinical workstation, with all samples paired (both ATP devices and
microbial swabs). Seven of the 23 locations were confirmed as
positive for a known MDRO. Several of the MDRO-positive items
were later removed for further examination for microscopic
investigation of dry surface biofilms.
The HTO sample locations that were positively identified with
MDROs during the 3 sampling runs are listed in Table 2. Terminal
cleaning was performed in the patient surroundings after evacua-
tion of any patient from the individual bed bay during each of the 3
sampling runs.
The combination of the paired testing in sampling runs 2 and 3,
where the data were matched with both environmental microbial
Table 1
Sampling locations and methods used for each sampling run
HTO First sampling run Second sampling run Third sampling run
Signage on patient chart table Micro only
Pathology folder on patient chart table Micro only
Cord holding MSDS in bedpan room Micro only
Isolation room (MRSA patient), supply table, top ATP (Hyg and KK), micro
Isolation room (MRSA patient), chair, top ATP (Hyg)
Isolation room (MRSA patient), chair, seat ATP (KK)
Isolation room (MRSA patient), bed railing ATP (Hyg and KK), micro
Isolation room (MRSA patient), IV pole ATP (Hyg)
Isolation room (MRSA patient), IV device top ATP (Hyg), micro
Isolation room (MRSA patient), IV pump face ATP (Hyg), micro
Bedside monitor ATP (Hyg)
Patient chart table top ATP (Hyg)
Patient chart table, bulldog clip ATP (Hyg and KK), micro
Patient supply table, top ATP (Hyg and KK), micro
IV pole ATP (Hyg and KK), micro
Bedside blood pump, face of device ATP (Hyg and KK)
Bedside oxygen pump, face of device ATP (Hyg)
Patient bathroom, soap dispenser button ATP (Hyg)
Patient bathroom, door handle ATP (Hyg)
Bedpan room, door handle ATP (Hyg)
Bedpan room, bedpan washer handle ATP (Hyg), micro
Bedpan room, boxes or crates (2 items) ATP (Hyg and KK), micro
Bedpan room, inside storage box ATP (Hyg)
Clinical work station, arterial blood gas machine ATP (Hyg and KK), micro
Clinical work station, telephone ATP (Hyg and KK), micro
Clinical work station, NUM clipboard ATP (Hyg and KK), micro
Clinical work station, storage room door handle ATP (Hyg)
Clinical work station, crash cart handle ATP (Hyg)
Clinical work station, keyboard and mouse ATP (Hyg and KK), micro 6 samples: ATP (Hyg and KK), micro
Clinical work station, crash cart clipboard ATP (Hyg and KK), micro 11 samples: ATP (Hyg and KK), micro
Clinical work station, chair ATP (Hyg and KK), micro 6 samples: ATP (Hyg and KK), micro
Hyg, Hygiena; KK, Kikkoman; micro, microbial sampling; NUM, nurse unit manager.
Fig 1. Second sampling run, all sample locations using Hygiena ATP testing.
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sampling locations (MDRO recovery rate of 33.3%; n ¼ 36).
Using this abridged approach, the first sampling run using only
microbiology swabs to locate MDROs (4.3%) was comparedwith the
combined matched dataset from the second and third sampling
runs (36%). The MDRO success rate with and without the use of ATPto guide sampling locations was tested and found to be significantly
associated using both the c2 test (with Yates correction; P < .025)
and Fisher’s exact test (P ¼ .01).
The data from the first sampling run and matched data from the
second and third sampling runs are summarized in Table 3. As
shown in Table 3, the Hygiena device has a lower reading range (in
Table 3
Data summary from the first sample run and matched data from the second and third sample runs
Samples MDRO identified MDRO negative
First run, n (%) 23 1 (4.3%) 22 (95.7%)
Second and third runs, n (%) 36 12 (33.3%) 24 (66.7%)
Hygiena range for MDRO 36 3-260 RLU (average, 87.3 RLU; median, 54.5 RLU) 5-297 (average, 69.6 RLU; median, 31.0 RLU)
Kikkoman range for MDRO 36 378-2,833 RLU (average, 1,206.8 RLU; median, 864 RLU) 106-36,452 RLU (average, 2,449.2 RLU; median, 845.5 RLU)
Table 2
Confirmed locations of MDRO
HTO Hygiena Kikkoman MDRO
Patient folder on patient notes bench No reading No reading MRSA
Isolation room, patient bed railing 118 639 MRSA
Bedpan room, clamp box lid 26 2,671 VRE
Bedpan room, gray crate on shelf 3 786 VRE
Clinical station, keyboard and mouse 260 2,436 VRE
Clinical station, crash cart clipboard 221 1,125 VRE and ESBL (Enterobacter cloacae)
Clinical station, computer keyboard, space bar 19 443 Enterococcus faecalis
Clinical station, crash cart clipboard, rear side bottom left corner 24 942 Acinetobacter baumannii
Clinical station, chair height adjustment handle, front 27 2,833 Pantoea agglomerans
Clinical station, crash cart clipboard, front side, top left corner 32 378 MRSA
Clinical station, chair, top of back rest, center front (fabric) 77 1,321 Acinetobacter pitti
Clinical station, chair, side of seat, center (fabric) 106 483 Acinetobacter pitti
Clinical station, chair, side of seat, center (fabric) 134 425 Enterococcus faecium
ESBL, extended-spectrum beta-lactamase; MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant enterococci.
Fig 2. Data plotted for MDRO and ATP readings.
G.S. Whiteley et al. / American Journal of Infection Control 43 (2015) 1270-5 1273RLU) than the Kikkoman device. In this study, the Hygiena device
recorded readings ranging from 3 to 260 RLU for MDRO-positive
locations and from 5 to 297 RLU for MDRO-negative locations.
Compared with the Kikkoman device, both datasets for the Hygiena
device showed lower average and median results. The average and
median results were quite well separated, with the average higher
than the median. The median results for the Hygiena device were
gigher for the MDRO-positive locations.
Application of the c2 test demonstrated that the Hygiena de-
vice was incapable of indicating MDRO locations when a cutoff of
15 RLU was applied (P > .15 with 1 df). The cutoff value of 15 RLU
was determined using a receiver operating curve sensitivity
analysis.
The results for the Kikkoman ATP device showed readings
ranging from 378 to 2,833 RLU for MDRO-positive locations and
from 106 to 36,452 RLU for MDRO-negative locations. The Kikko-
man data also showed a significant separation between the average
and median values.
Our c2 analysis failed to demonstrate that the Kikkoman ATP
device was capable of indicating MDRO locations at a cutoff of 350
RLU (P > .15 with 1 df). This 350 RLU cutoff was determined using a
receiver operating curve sensitivity analysis.Data for the Kikkoman and Hygiena devices are plotted together
in Fig 2. There was no correlation between the 2 sets of readings
(R2 ¼ 0.0144).
DISCUSSION
In this pilot study, it would be easy to overstate the significance
of the results, owing to a range of potential methodological flaws.
These concerns include the selection method used for sampling of
HTOs, the introduction of a more experienced operator with ATP
sampling in the second sampling run, the variability of readings
with the portable ATP devices as a potential confounder, the
aggressive swabbing technique used to locate MDROs and potential
biofilm-related organisms, and lack of assessment of total hetero-
trophs in the microbial sampling. The statistical analysis was
complicated, because a fully matched dataset could not be obtained
from the second sampling run.
Nonetheless, the ATP testing served as a relative indicator of
surface cleanliness, and the timely results guided the microbial
sampling, whichwas otherwiseweakened by the delay in obtaining
results of microbial sampling in isolation.24 As indicated in Fig 1, the
timeliness provided by the ATP testing contributed to the signifi-
cantly improved sampling outcomes when searching for MDROs on
surfaces within and around the ICU (P < .025, c2 test with 1 df,
and P ¼ .01, Fisher’s exact test). The results were significant even
with all microbial samples (including 3 nonpaired samples)
included (P < .05, c2 test with 1 df; P ¼ .021, Fisher’s exact text).
The purpose of cleaning is to remove soils including bacteria and
other biologicalmaterials; however, cleaning has been described as a
weak science, with poor reliability.29 Part of the challenge in
improving cleaning performance is to enable better science that
allows staff to monitor and identify where the microbes of concern
are located, and then whether or not the cleaning process has been
efficacious.30 The use of rapid ATP testing for the purpose of
assessing HTO cleanliness provides practical assistance for
improving the discovery rate for MDRO locations above that using
literature or visual inspection alone as a guide to sampling locations.
The initial sampling of HTO was focused around the immediate
patient zone and the clinical treatment area with reference to
G.S. Whiteley et al. / American Journal of Infection Control 43 (2015) 1270-51274recognized HTOs. When ATP testing was included, the higher RLU
readings from the 2 ATP devices suggested the need for intensive
investigation of the staff clinical area, inwhich all clinical staff were
frequently moving to and fro, with both ATP devices and environ-
mental swabbing (Fig 1). The majority of MDRO-positive locations
were identified in this area.
In this pilot study, insufficient data were available to test the
significance of the differences in RLU readings between HTOs in the
immediate patient zone and those in other areas within the ICU. In
the clinical workstation, the focus of sampling was on HTO sites
that were later found to be uncovered by any cleaning protocol or
cleaning responsibility. The list of contaminated HTOs and the
range of MDROs recovered is provided in Table 2.
Using the ATP devices significantly improved the sampling
approach. A cutoff of 350 RLU could reasonably be applied to the
Kikkoman readings, even though the threshold was not signifi-
cantly associated with the likelihood of finding an MDRO. A cutoff
of 15 RLU when using the Hygiena device might be possible for all
but 1 of the MDRO locations indicated with >15 RLU, which is a
recognized standard for school cleaning.31
Our results underscore the danger of applying a single 100 RLU
cutoff without first testing the appropriate cutoff for a particular
ATP device.32 With single point sampling results from ATP testing,
there is a 20% chance of reading imprecision by a factor of 2.28 This
variability is also noticeable in the noncorrelation between the 2
devices shown in Fig 2 (R2 ¼ 0.0144).
As indicated in Table 3, the RLU readings from the 2 ATP devices
were 1 order of magnitude different at the average levels and more
than 1 order of magnitude different at the median levels. This
finding also highlights the danger of using average readings be-
tween different brands of ATP devices.20 The reason for the differ-
ence in relative sensitivity between the 2 branded ATP tests was not
determined, but may be related to variability in swab material, lysis
systems, or light detection, or even in broad reactivity of the un-
derlying biochemistry of the enzymes used in the swabs.
In this pilot study, we found that many of the HTOs fromwhich
MDROs were recovered were not items included in cleaning pro-
tocols.10 Such items as telephones, computer keyboards, and chairs
were sampled in between use by clinical staff. Other items (eg, the
crash cart clipboard) were not used during the sampling runs, but
were observed to be handled on several occasions to access nearby
drawers, cupboards, and, on one occasion, a handwashing sink.
Hand hygiene compliance was not audited during this pilot
study, but is typically reported as adequate.33 Clinical staff were
observed to use items in the clinical area both with and without
gloved hands. Terminal cleaning by cleaning staff using disposable
chlorine wipes inside vacated patient zones was observed during
the sampling. No cleaning of the clinical workstation was observed
during any of the 3 sampling runs.
In conclusion, the findings of this study suggest the need to
review the hygiene standards adopted in the clinical workspace,
away from the immediate patient zones in busy ICUs, and indicate
that ATP testing may help identify HTOs with less than optimal
cleanliness. Better monitoring of cleaning may improve the surface
hygiene outcomes from effective cleaning protocols applied to all
HTOs within and around clinical work areas inside ICUs.24 This pilot
study was part of a wider project, and other studies of the various
components required for hygiene improvement within health care
settings are currently underway.
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The importance of stakeholder consultation
for infection control guidelines
Trevor Glasbey1,3 BSc (Hons), PhD
Greg S Whiteley2 BSc (Appl), M SafetyScience
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NSW 2322, Australia.
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We write regarding the Australian Infection Control Guidelines
(AICG), last published in 2004 andnow locatable on theAustralian
Government website at http://www.health.gov.au/internet/
main/publishing.nsf/Content/icg-guidelines-index.htm
When the AICG were first published the then process was that
there were several working drafts circulated to all of the
stakeholders for consultation.When one visits the website version
of the AICG, the face sheet is the same, the publication date is
indicated as 2004, and even the index is the same.
However, if one has a copy of the original printed version, once
you get into the body of the document you will find significant
differences. The website indicates that some amendments have
been made in December 2007, however, without a comparison
copy the extent and nature of these changes is not obvious. We
highlight three unacceptable changes in the internet version.
First, is the recommendation of the use of anionic detergents
in the chapter on prions and related diseases (Chapter 31). In the
original there were only two references to anionic detergents
for cleaning. However, an investigation of the revised chapter
on prions repeatedly and widely indicates the use of anionic
detergents for pre-cleaning of potentially contaminated
instruments. The recommendations are unreferenced and
contradict the literature, which is confused at best about anionic
detergents as a mandated step. We cannot determine where
the original reference arose.
Second, the revision of a single section has introduced somemajor
contradictions. For example, section 31.3.3 of the current (2007)
version states “instruments potentially contaminatedwith higher-
infectivity tissue should be immersed in a dedicated container in
sterile water until they are reprocessed”, which contradicts the
discussion point in an earlier section (16.3.4), which states
“Instruments potentially contaminatedwith CJD agents should be
kept immersed in a dedicated container in an anionic detergent
solution, at ambient temperature, until they are manually cleaned
and reprocessed using the methods shown in Table 31.9”.
Third, is the recommendation in the same chapter for the use
of ultrasonic cleaning machines for cleaning potentially
contaminated instruments. This represents an infection risk due to
the creation of aerosolised particles above the liquid phase.
No safety instructions are given and the recommendation is not
referenced (and is in fact in contradictionwith advice given earlier
in section 16.3.4).
In summary, the new amendments have not been subject to
widespread consultation. This is in contravention of official
government policy and the Council of Australian Government
(COAG) Principles. The errors contained in the document might
increase risks for health care workers. This is a good example of
why consultation among all of the stakeholders is always a good
plan for a guidelines document of this nature.
Conflicts of interest
Whiteley Corporation manufacturer a range of cleaning,
decontaminating and disinfecting products for reuseable medical
devices and hospital surfaces.
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Abstract
The Interim Infection Control Guidelines for Pandemic Influenza in Healthcare and Community Settings, published by the Australian
Commonwealth Government in 2006, have been reviewed and found to contain recommendations that, if they were made by a private
organisation, would be potentially illegal under the Therapeutic Goods Act 1989, and also raise some concern in relation to occupational
health and safety. The guidelines also fail to recommend the use of disinfecting productswith specific claims relating to influenza virus that
have been approved by the Therapeutic Goods Agency.
In 1996, the Australian Government through the gazetting of
Therapeutic Goods Order Number 54, 1996 (as amended),
introduced a range of controls over the disinfectant market in
Australia. During the following year, all states of the
Commonwealth formally ceded their powers in this area to the
Australian Government. The Therapeutic Goods Administration
(TGA) administers the regulatory scheme, which was augmented
in 2002 with the Medical Devices Regulations (2002) to cover not
just the higher risk products under a uniform international
scheme, but also to bring under control even the cleaning products
intended for use within healthcare. The TGA, through a range of
instruments, also controls the label claims of all products in this
category, and for any of the products intended for use exclusively
within healthcare, this is a pre-market scheme. In practice, this
means that any therapeutic claims (such as efficacy in disinfection
of, for example, influenza virus) are required to be approvedby the
TGA, and that in order to gain TGA approval, the manufacturer is
required to submit fully validated test data for review. It is
therefore particularly strange that the Australian Guidelines for
Infection Control within the context of an influenza pandemic1 do
not even mention the TGA as the regulator of therapeutic goods.
The recommendations contained within these guidelines for
surface disinfection focus generically on alcohol and chlorine as
active materials. There are four areas of concern over the
recommendations as they are currently framed. The affirmation of
these guidelines by distinguished authors2 lends weight to the
opinions expressed within the guidelines, but fails to address the
legal requirements of the Therapeutic Goods Act or allow for a
hierarchy of control so important in managing risk, and
particularly risk in occupational safety.3
First, there is the equity problem of unqualified recommendation
of products by brand name within the official interim guidelines
where the opportunity of consideration of legal alternatives is not
provided. The products named are chlorine-based disinfectants
without any specific approved claims (e.g. for killing of the
influenza virus on surfaces). The most galling situation is the
specific recommendations superimposed, wherein information is
provided by the guidelines which if repeated by the companies
involvedwould be strictly illegal under the Therapeutic Good Act
1989. These guidelines as they stand are very good for the
company named, but deny equity to all other companies, even
when some other companies have products registered and
accepted to kill influenza virus, information that the named
products do not have on their official labels.
Second, while the strengths recommended for disinfection
(1000ppm or 0.1%) would not be classifiable as hazardous under
the Australian Occupational Health and Safety regulations,4 such
solutions are not available off the shelf. In the case of liquid
chlorine, the actual disinfectant solution will be prepared by
dilution of a significantly higher concentration solution. Such
solutions are highly corrosive and classifiable as both a hazardous
substance and a dangerous good under Australian Occupational
Health and Safety regulations. Sodium hypochlorite solutions are
also notoriously unstable with respect to loss of active chlorine,
and therefore ameansof analysing for active chlorine is essential to
ensure a correct working dilution.
Solid chlorine (sodium dichloroisocyanurate), although more
stable than liquid chlorine, is also ahazardous substance (irritating
Healthcare Infection 2009; 14: 177–179
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to skin and eyes, and the respiratory system). It is also a powerful
oxidising agent (classified under theAustralian Dangerous Goods
Code as a class 5.1 oxidising agent). There is therefore aworkplace
requirement5 to segregate this material from certain other
dangerous goods (e.g. class 3 flammable liquids such as alcohol).
By contrast, many hospital grade disinfectants with TGA
approved claims relating to influenza are not classifiable as
hazardous substances or dangerous goods.
Third, the recommendation for use only of chlorine-based
disinfectant, at 1000-times the strength of what is used in
swimming pools, is completely impractical. During a pandemic,
the need for surface disinfection is not limited to clinical areas. For
example, a patientwaiting roomwill be amixed environmentwith
fabrics, carpet, magazines, chairs and other objects that may
become contaminated by droplets or fomites from a coughing and
sneezing viremic patient. The use of chlorine-based disinfectants
may also affect safety measures such as the fire resistance of
upholstery.6 Clearly, the inexpensive option of a chlorine-based
solution will be likely to lead to damage that far outweighs the
initial cost of purchase. This is so unnecessary when there are
products registered to kill influenza virus on surfaces, which are
not corrosive, are non-staining and are safe to use when used as
directed on the approved label.
Fourth, the unpleasantness and impracticality associated with use
of chlorine products at this strength will likely also lead to
incorrect, insufficient or inappropriate non-use. This elevates the
recommendations to the level of the absurd. It is humannature that
unpleasant tasks are avoided. The problems with hand washing
compliance are a case in point. Widespread non-compliance with
the recommendations will almost certainly lead to the
psychological phenomenon known as ‘normalised deviance’ and
in fact raise the risk of transmission via contaminated inanimate
surfaces.
Readers should be aware that this is not at all a fanciful problem, as
evidenced by the findings on the last two major pandemics that
affected Australians. (i) SARS, involving a coronavirus, was
spread and its virulence increased via inanimate surface spread.7,8
(ii) The 2007 outbreak of equine influenza occurred primarily due
to a breakdown in surface disinfection within the quarantine
process, which saw the virus escape quarantine via inanimate
objects taken out of quarantine by humans and then infect other
horses.9 The Honorable Ian Callinan, who led the Commission of
Inquiry into the Equine Influenza outbreak, said about the
outbreak:
‘I find that the most likely way that the virus entered the
general horse population is by its escape from infected
horses at EasternCreekQuarantine Station on contaminated
person or persons or equipment leaving the Quarantine
Station and coming into contact with a horse.’9
The current Interim Infection Control Guidelines for Pandemic
Influenza in Healthcare and Community Settings (2006) make the
point that the human influenza virus does remain viable on
surfaces for up to 48 h.
The problems that have arisen in the guidelines could have easily
been avoided through a consultation process in accordance
with the accepted Council of Australian Governments
recommendations. A consultation process with the stakeholders
involved in this sector would have pointed the authors back to
legislative process and included the correct references to the
regulator. The corrections are quite simple.
Recommendations
(1) Remove all reference to company brand names.
(2) Recommend use of only TGA approved hospital grade
disinfectants with label claims noted against influenza virus
on surfaces.
(3) Refer inquirers with questions on specific products to the
online portal for the Australian Register of Therapeutic Goods
for information regarding the general approval status of
products being recommended by category.
At the present time, the Australian Infection Control Guidelines
are undergoing amajor revision by theAustralian Commission on
Safety and Quality in Health Care, and this revision offers an
opportunity to bring the Australian Infection Control Guidelines
in line with not only global best practice, but with Australian
Therapeutic Goods legislation. In this respect, it is perhaps
advisable to include both regulators and industry representatives
alongside clinicians while drafting such guidelines. It is also
highly recommended that all guidelines shouldbe reviewedby the
relevant governmental agencies for compliance with existing and
upcoming legislation.
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Sampling Plans for Use of Rapid Adenosine
Triphosphate (ATP) Monitoring Must
Overcome Variability or Suffer Statistical
Invalidity
Reply to Visrodia
To the Editor—We write with respect to the article by Visrodia
et al.1 on using a commercial rapid adenosine triphosphate
(ATP) device for validation of cleaning of flexible gastro-
endoscopes. The importance of timeliness in quality assurance
testing in this device area is critical owing to the time pressures
on the use of the gastroendoscopes by clinical staff involved in
patient care. The work is a useful additional contribution to
this growing field of use for ATP devices.2
Nonetheless, we highlight concerns with 2 aspects of the
method adopted within the work by Visrodia et al.1 First, this
work, like earlier references, utilizes only a single brand of
rapid ATP device with acknowledged manufacturer support.
The recommendations on “validated” relative light units
(RLU) are entirely device specific and exclude other com-
mercial devices. And, whilst the ATP/RLU readings in Visrodia
et al.1 may seem dramatic (some > 100,000 RLU), the work
lacks evaluation of microbial presence that could anchor the
study against a quantitated standard.3
Second, the work does not address any of the major pub-
lished criticisms of the use of ATP systems as they are currently
configured. Several authors have commented on the dangers of
overstating the usefulness of these commercial ATP devices,
the risks of alternative sources of ATP, the lack of correlation
with specific pathogens of concern, the amount of ATP present
within any particular cells or bacterial species, and the mea-
surement variability that undermines statistical measures
applied to the research.4–7
In this regard, and of specific concern in terms of method
in Visrodia et al.,1 is the way that ATP measurements and
samples were obtained—for example, samples from the brush
and flush sampling were divided into only 2 parts, with one
part apparently used for a single ATP test and the other
part tested for protein residues. The entire sample set of
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figure 1. Box-and-whisker chart of mupirocin-susceptible,
methicillin-resistant S. aureus isolates. Left to right: combined
groups 1 and 2; group 1, tissue isolates; group 2, nares isolates.
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ATP testing appears to be without duplicates or preferably
triplicate testing. Reliance by Visrodia et al.1 upon the
sample means of groups of singular ATP readings is under-
mined by the knowledge of variability where the standard
deviation can be as high as 40% of the data mean for the indivi-
dual brand of device used.8 The authors themselves note the risk
of singular testing in the body of the discussion: “to sample more
than one… and to use more than 1 rapid indicator,” but we
wonder how the statistical assumptions hold valid without mul-
tiple (replicate) samples taken for the ATP testing.
We also note 2 problems with the scaling of all commercial
ATP devices. First, the scale of RLU is completely relative and
cannot be used interoperatively between differently branded
devices.2,3 Second, the variability for each of the brands is so high
that without a sampling approach that accounts for multiple
samples at any one point, the ability of the scientists involved to
meaningfully apply statistical methods renders the article subject
to first principle flaws.9 Reporting the RLU readings on a log
scale is not the same as taking multiple samples, identifying the
median value, and then log plotting the data. Perhaps this was
done, but it remains unclear within the text.
We feel obliged to inform those who may be reliant upon
the work to take care in not applying the work using one brand
of ATP device to another brand of ATP device, as noted in
the commentary by Petersen.10 Likewise, we caution against
relying on the statistical positioning in the field use of ATP
without an appropriately constructed sampling plan to
account for inherent variability. This overlay of concern will
continue to apply until all ATP device manufacturers can agree
to a commonly applicable scale that minimizes the impact
of variability, no matter what the assignation given to the
replacement reading scale.
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Reply to Whiteley et al
To the Editor—We appreciate the commentary byWhiteley et al1
on our study in which several rapid indicators were used to
detect residual contamination in gastrointestinal endoscopes
following manual cleaning.2 The authors raise several concerns
about an adenosine triphosphate (ATP) measuring device used
in our study, including our use of a single commercially available
ATP device, our reliance on only 1 ATP test per component
sampled, possible variability in ATP results, and the inability of
ATP monitors to identify specific microbes or quantify colony
counts.1 Indeed, rapid indicator testing in endoscope reproces-
sing is a relatively new arena, and more research is undoubtedly
needed to evaluate the utility of various devices and determine
the association between residual organic debris, viable microbes,
and patient outcomes.
Our study was a small pilot project designed to evaluate
materials and methods that could be used to assess endoscope
cleaning effectiveness. At that time, we sought to determine
whether the recommended practice of visual inspection was an
adequate standard for verifying whether manual cleaning had
letters to the editor 237
sufficiently removed residual contamination prior to exposing
endoscopes to high-level disinfection.3,4 In addition to inspecting
each component and the sampling materials for visually appar-
ent evidence of residual contamination, our team conducted
rapid indicator tests for blood, protein, and ATP. Multiple
types of rapid indicators were used in order to assess various
approaches for monitoring cleaning effectiveness and to com-
pare their results. In summary, we found2 that endoscopes
with and without visually apparent debris had levels of blood,
protein, and ATP exceeding previously validated benchmarks.5,6
Although high ATP levels may indicate the presence of viable
microbes,7,8 such results could also reflect the presence of blood
or other types of cells.9 Indeed, we found ATP levels were quite
high in every sample that also tested positive for blood.
As noted by Whiteley et al1 and acknowledged in the
limitations section of our article, we did not include the
performance of microbial cultures, because the goal was to
evaluate multiple rapid indicators and sample collection
methods. Furthermore, the value of conducting microbial
cultures prior to high-level disinfection seems limited. In a
subsequent study conducted by our team (as yet unpublished)
we used microbial cultures as one of the indicators of
endoscope reprocessing effectiveness.
The main goal of our study was to identify user-friendly
materials and methods that could be used to evaluate manual
cleaning effectiveness in the clinical setting. The chosen ATP
monitoring system provided a numerical result reflecting the
amount of ATP present. We found this to be superior to mon-
itoring systems that measure residual protein or blood, which
require users to interpret color changes on swabs or dipsticks.
Given the imperative for cost containment and to improve
efficiencies on the front lines, we believe it would not be
desirable to perform duplicate or triplicate testing as suggested
by Whiteley et al.1 Their concern about variability within and
between ATP measuring devices deserves additional study.
However, we found that post–manual cleaning ATP and pro-
tein levels far exceeded benchmarks for manually cleaned
endoscopes and perhaps are less likely to be affected by the
degree of variability cited.
Quality assurance in endoscope reprocessing is needed, and
rapid indicator testing is an area of growing interest and
understanding. ATP testing offers potential, but given its
relatively recent application to this field, additional research is
necessary to better define its role.
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l e t t e r s t o th e e d i t o r
The Role of ATP Luminometers in Infection
Control
To the Editor—I would like to caution readers on the interpreta-
tion of the article by Whitely et al1 in this issue. This study, like
many before, makes themistake of assessing ATP luminometers as
bacterial detection systems. Studies have demonstrated,2 and
responsible manufacturers will confirm, that there is not a 100%
direct correlation between ATP and plate counts, so evaluating
an ATP system’s performance based on bacterial detection is
an impractical assessment of the tool. For hospitals seeking to
monitor microbial cleanliness, the necessary testing method is
conventional microbiology plating. ATP testing is not a substitute
for microbiology testing, and responsible ATP manufacturers do
not make that claim. Furthermore, the author makes a hasty
judgment on the value of ATP systems: “The original suggestion to
use rapid adenosine triphosphate (ATP) bioluminometers to
monitor surface hygiene has yet to see practical fulfillment among
healthcare infection control and prevention practitioners.”
In reply, I direct readers to the abundant published evidence
to the contrary.3–8 ATP testing is designed to demonstrate
whether cleaning regiments are working correctly and whether
cleaning agents and techniques are working properly to remove
biological contaminants such as blood, protein tissues, skin cells,
etc., which can facilitate microbial growth. ATP testing plays a
key role in training, process improvement, and ongoing
monitoring of overall hospital cleanliness. There is undeniable
and plentiful evidence that monitoring cleaning with an objec-
tive tool like ATP testing improves cleaning thoroughness,
improves staff training, and optimizes cleaning regiments. In
fact, ATP testing has been proposed as an acceptable method by
the Centers for Disease Control and Prevention (CDC) in the
United States and accepted as a national standard by Danish
government. The benefits of ATP are also recognized in the UK
National Health Service Healthcare Cleaning Manual (2009).
ATP testing has proven effective as an intervention tool over and
over. In comparison to other proposed methods such as fluor-
escent gel black light or visual inspection, ATP testing is the best
available option to monitor cleanliness other than microorganism
testing, which is impractical for the determination of room
cleanliness.9–11 ATP testing systems are the best available option
for improving cleaning regiments, training employees, demon-
strating effectiveness of cleaning agents, and improving hygiene in
the environment with the end goal of reducing the spread of
infection. ATP systems play a very important and valuable role in
overall efforts to improve cleaning. Considering the purpose of the
ATP systems and additional studies cited, there is overwhelming
evidence that ATP testing is a very valuable aspect of cleaning
monitoring and improvement within healthcare industry.
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Reply to Roady
To the Editor—We welcome the engagement and comments of
Ms. Roady in response to our research article.1 We agree that
the use of rapid ATP testing has a growing body of published
support. However, the lack of common acceptance for rapid
ATP testing at this point in time is well expressed in the EPIC 3
Guidelines (2014) from an expert committee in the United
Kingdom.2
Unfortunately, Ms Roady somewhat misses the point
of our paper. In our study, we did not attempt to equate rapid
ATP testing with detection of bacterial contamination. We
showed that the variability that occurs when measuring
responses to controlled quantitated microbial cultures
is the same variability that occurs when controlled con-
centrations of pure ATP solutions are measured. The
issue is therefore not correlation with detection but data
variability.
This variability is undetectable to ATP device users and
applies to all sources of detected ATP. The ATP variability
problem (ie, imprecision in results) that we have outlined in
our most recent paper is common to each of the ATP device
brands we tested. This finding does have implications for
sampling methodology and analysis.3
We set out to validate several branded ATP devices
using a standardized approach and focusing on precision
and accuracy.4 The first issue we encountered was uncon-
trolled variability and the lack of precision at any testing
point. The issue of accuracy is problematic because the
scale of relative light units (RLU) is neither universally
standardized nor standardized among ATP device
suppliers.
We welcome the engagement with the industry. We would
like to see better quality of results for ATP testing devices,
including testing for precision and the development of a
common measurement scale. There remains a tremendous
upside for ATP use once these issues are resolved.
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Infection Control Implications of Protracted
Lengths of Stay With Noninfluenza Viral
Influenza-Like Illnesses in Hospitalized Adults
During the 2015 Influenza A (H3N2) Epidemic
To the Editor—Infection control (IC) precautions for hospi-
talized adults with influenza consist of standard, contact, and
droplet precautions with single rooms recommended or with
patients cohorted, but guidelines for viral influenza-like ill-
nesses (ILIs) are not standardized.1 During the January 2015
influenza A (H3N2) epidemic in our location, the high volume
of patients with ILIs became problematic, creating a major
strain on bed availability.
In January 2015, a total of 54 adults were admitted with
influenza A (H3N2) and 37 adults were admitted with viral ILIs
diagnosed by multiplex polymerase chain reaction (PCR) assay
of nasopharyngeal swab samples. Of the 54 influenza case
patients, 53 (98%) had influenza A (H3N2) and 1 (2%) had
influenza B. One patient had a dual-positive rapid influenza
diagnostic test for influenza A and influenza B, but PCR testing
was positive for influenza A (H3N2).
2–6
Of the 37 adults with viral ILIs, 16 (43%) had respiratory
syncytial virus (RSV), 10 (27%) had rhinovirus/enterovirus
(R/E), 5 (14%) had human parainfluenza virus type 3
(HPIV-3), 4 (11%) had human metapneumovirus (hMPV),
and 2 (5%) had coronavirus (Table 1). Elderly patients, more
commonly admitted for viral ILIs, had longer LOS for viral
ILIs than for influenza. RSV patients were older (mean age,
83 years), with LOS similar to that of influenza patients.
Importantly, HPIV-3 patients had the longest LOS of any viral
ILI (mean, 19 days) and were more seriously ill, with 1 death
due to HPIV-3 pneumonia. Two patients had co-colonization
1368 infection control & hospital epidemiology november 2015, vol. 36, no. 11
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Accurate assessment of cleaning effectiveness is critical to 
reducing the incidence of multiple drug resistant organisms 
(MDRO) in the healthcare setting (Dancer 2009). The 
Australian requirement (NHMRC 2010) for direct visual 
inspection (DVI) of surfaces as primary monitoring strategy is 
echoed in standards and guidelines elsewhere. This 
approach is subjective and inaccurate and liable yield an 
unacceptable number of false negative results for surface 
contamination (Griffith et al. 2000). New quantitative 
monitoring methods are emerging but these present new 
range of challenges, one of which relates to the imprecision 
of the point at which a surface can be considered “clean”. 
Microbiological tests can offer a definitive cut-off, such as the 
presence or absence of pathogens, but delay in receiving 
results remains a problem. While results of innovative tests 
such as ATP-bioluminescence monitoring are immediate, 
interpretation of results still requires research in terms of the 
relationship of results to actual risk in terms of safe exposure 
threshold to determine a “practical zero” to guide surface 
cleaning practitioners. This requires the development of a 
risk assessment methodology, towards which some basic 
ideas are presented in this poster. 
 
1. A literature review was carried out and a model developed 
to represent steps in the cleaning and monitoring process 
with risk-related outcomes. The “false negative” was then 
identified as the critical outcome in terms of human exposure 
risk to contaminated or inadequately cleaned surfaces. 
  
2. The Australian guidelines and standards relating to 
cleaning in the healthcare setting were reviewed and the 
common practice of relying on DVI determine practical zero 
identified (AG:DHA 2004; NHMRC 2010; NSW Health 2007; 
VG:DHHS 2011; SA/SNZ 2003).  
  
3. DAZO(o) and (e) (original and Ecolab) chemiluminescent 
marker was sourced. Each type was subjected to drying and 
naked-eye visibility measurements as well as definitional 
description under UV light, in terms of expected practice 
(Carling et al. 2006; Carling et al, 2008). Results were 
recorded and photographed. 
  
4. The performance of three commercial brands of hand-held 
luminometer (3M’s Biotrace, Kikkoman’s Lumiscan and 
Hygiena’s Ultrasnap) were assessed against LC-MS 
determined ATP curves in terms of recommended thresholds 
(Lewis et al. 2008; Andersen 2009; Boyce et al. 2009; Mulvey 
et al. 2011) and using recommended procedures (ISO 
13485:2008, VG:DHHS 2005).  
 
 
 
Cleaning indicator tools for validation purposes: 
Following preliminary validation work on traditional and new testing procedures, it was found that a model based on the detection of false negatives 
had capacity to accommodate all monitoring types as the starting point for more complex risk modeling relating to the determination of safe 
exposure thresholds for residual contamination on surfaces. To facilitate use of such a model, however, other risk factors need to be identified and 
accommodated if effective and early feedback is to be given to staff in the interests of risk mitigation. Such risk factors include level of MDRO 
present, presence of other material (protective residue or biofilm), frequency of exposure (high touch objects [HTOs] being particularly relevant), 
nature of surface (texture and composition) and patient immune status. To guide cleaning the concept of acceptable risk needs to be expressed as a 
definitive “practical zero” result which can guide the cleaning process. 
 
During validation it was found that DAZO chemiluminescent markers dried effectively although the DAZO(o) had greater mass, dried slower and 
showed some hydroscopicity in comparison to DAZO(e). DAZO(o) also had a smaller footprint per volume with better-defined boundaries (see above 
photographs). There was some visibility of deposited spots which is an undesirable quality in tests required to develop a practical zero relating to 
traditional cleaning practice which uses DVI as an integral part of the process.  
  
Validation testing of ATP-bioluminescence monitors is underway although early results have suggested some variability of individual meter 
performance against ATP standard curves, the generation of some false negatives when instruments are required to operate at a high level of 
resolution close to the critical measurement range, and drop-off in measurement accuracy as reagents approach the end of their shelf-life. The 
ability of such meters to measure to very low levels of ATP, however, offers possibilities for their role in identifying a practical zero. 
 
 
 
This poster suggests a risk assessment framework which 
might be used as a common vehicle for determining safe 
exposure thresholds in the derivation of practical zero in 
assessment of cleaning relating to a range of HTOs in 
different healthcare settings.  
 
While microbiological assessment can provide a benchmark 
for retrospective surface monitoring, proactive monitoring in 
terms of the restrictive time frame applicable to infection and 
cleaning cycles requires other methodologies.   
 
For many years, reliance has been placed on direct visual 
inspection which, although immediate, has shown to be 
inadequate in terms of accuracy. While other proactive 
alternatives to visual inspection are available, research is 
needed to contextualise the relative advantages and 
disadvantages of each within a broad risk management 
framework, and here concepts such as safe threshold and 
practical zero require further investigation. 
 
The cut off point for a realizable practical zero should be at or 
below the point at which the possibility of a false negative 
outcome occurs. 
Thanks to the staff of the Microbiology and Environmental 
Health divisions of the Hawkesbury Campus of the University 
of Western Sydney for advice and in particular to Carol 
Adkins for loan of equipment. 
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Corporation for analytical and other support 
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Technology including ATP measurement, Artificial Test Soils 
(ATS) and other methods are being trialed in order to provide a 
validated basis for cleaning and hygiene performance standards 
(Griffiths 2000, Boyce 2009). It is important that measure which 
provide a numerical reading are appropriately qualified and 
validated so as to provide a meaningful data set which indicate 
clearly, accurately and with good repeatability the actual hygiene 
status of the surface to be examined.
We took three commercially available hand held instruments 
used to measure ATP as an indicator of soiling presence on a 
surface. We also used two versions of a chemiluminescent 
Artificial Test Soil (Carling 2006). Each system was subjected to a 
qualification process for validation as per ISO 13485:2008 and 
the ICH Guidelines (ICH 2005).
Results demonstrated that whilst the ATP hand held units have 
reasonable performance across a log scale, variability across a 
narrow range of data is variable and repeatability may be difficult 
to achieve. 
These findings may undermine some publications where 
interpretation is based on data without linearity within the range 
of the tests being undertaken. The results highlight the need to 
thoroughly understand a device prior to purchase and to ensure 
that readings are interpreted with some care.  
ATP Hand Held Units Validation
Three commercial brands of ATP hand held measurement devices 
were selected from brands available in the Australian market. The 
three brands were Biotrace (3M); Lumiscan (Kikkoman), and 
Ultrasnap (Hygiena). Each of the brands were used with their own 
dedicated surface sampling consumables. All three brands of 
consumables were tested close to the end of the stated shelf life of 
the consumables to represent a worst case outcome as intended in 
a sampling system under ISO 13485:2008. ATP was sourced from 
SIGMA laboratories as an individual reagent and also within a 
Adenosine 5’-triphosphate (ATP) Bioluminescent Assay Kit. Storage 
of the ATP was as per recommendations (<20oC) until use. 
Standard solutions were made up as per instructions and buffered 
to pH 7.8. All stock solutions/reagents were stored in ice until 
immediately prior to use. Using a calibrated microtitre pipette 
precisely 10µL of the ATP solution was placed directly onto each 
swab. The swabs were aseptically re-capped and reactant solutions 
released as per instructions and mixed for 15 seconds and then 
placed into the ATP meter. Readings were recorded. All readings 
were taken in quadruplicate with some samples repeated on five 
separate occasions (outliers). Readings of individual swabs were 
regularly reconfirmed to ensure individual reading repeatability. All 
ATP readings were calibrated using LC-MS (HPLC mode). 
Artificial Test Soil  – ATS Chemiluminescent Validation
Original ATS Chemiluminescent marker was sourced from Dr 
Carling and recently released DAZO spots were sourced from 
Ecolab. Each type was subject to drying and naked eye visibility 
measurements as well as definitional description under UV light. 
Results were recorded and photographed. 
ATP Readings
Higher concentration (< 1mg/L)
Biotrace Kikkoman Hygiena 
Lower concentration (<0.1 to 40 µg/L) 
Biotrace Kikkoman Hygiena 
ATS Chemiluminescent Spot Markers
An essential component of any quality driven approach is accurate information. The standard approach to ensuring accurate information within 
industrial and healthcare settings is validation. Full and proper validation ensures that the information provided will be accurate and defensible on 
each and every occasion that information is required and measured. 
Our experiments sought to provide a basic validation of the two newest forms of cleaning monitoring systems, these being ATP measurement using 
commercially available hand held meters (and their requisite consumables), and the chemiluminescent spot marker systems (DAZO or equivalent).
The use of these measures is subject to separate consideration. This poster outlines the outcomes purely of the scientific measurements to achieve 
validation of the two approaches. 
ATP: as the normal use of the swab consumables involves a variable other than the machine (i.e. swab technique), it was decided to use the ATP 
directly onto each swab thus eliminating a variable, and thus to more accurately assess the reliability (repeatability) of the ATP measurement via the 
luciferase reaction (Boyce 2009). This approach demonstrated that each unit had considerable variability despite the accuracy of the application of 
the ATP standards. Other issues observed in the data were the exhaustion of the luciferase reaction with the Hygiena Unit at high concentrations of 
ATP (the reaction levels off). Generally the variability in the Kikkoman device was poor within the chosen dilution series. 
ATS: both versions of the DAZO chemiluminescent markers dried effectively although the DAZO(o) [original] had greater mass, took longer to dry 
and also exhibited some evidence of hydroscopicity. The DAZO(o) had a much smaller footprint, with well defined boundaries, whereas the DAZO(e) 
had a larger footprint and less well defined margins. 
ATP: Using a pure solution of ATP allowed the validation process to 
demonstrate the lack of linearity and repeatability for the three hand 
held ATP meters. Two brands performed more erratically under  
these test conditions. The Biotrace Unit uses a Photo-multiplier 
within the luminometer where as both the Hygiena and Kikkoman 
units make use of Photo-Diode Array technology (Griffiths 2008). 
It is essential that the units and scale of measure have separation 
between different known levels of ATP present. This allows the 
more contaminated areas to be clearly identified from the less 
contaminated areas. This is important as it saves time in 
unnecessary rectification work by cleaning staff. 
All three brands of ATP units demonstrated a lack of separation 
between known levels of ATP. This undermines the reliability of any 
individual reading. In our experiments readings were conducted in 
quadruplicate to allow for calculation of median values. Even so, 
the variability was particularly high for the Kikkoman unit. 
For any use of these units in the field, it is very hard to see much 
costs savings as readings will best be conducted in quadruplicate in 
order to minimise variability. 
DAZO: each of the two types of chemiluminescent marker 
performed reliably and repeatedly. The  slightly hydroscopic nature 
of the original DAZO(o) was not a diminishing feature. Both 
versions yellowed over time but neither were ostensibly visible. 
Both versions were validated as suitable for use with repeatability  
in application, appearance and removal. This system has been 
demonstrated well in the literature (Carling 2008). 
Thanks are due to laboratory staff at the University of Western 
Sydney (Hawkesbury Campus). 
Thanks are also due to staff at the Whiteley Corporation facility at 
Tomago in NSW.
Thanks also to Carol Adkins for the extended use of the 
luminometer from the Department of Microbiology at Hawkesbury.
Thanks also to the Higher Degree Research staff for the Poster 
format with UWS colours.   
Boyce JM, Havill NL, Dumigan DG, Golebiewski M, Balogun O & Rizvani R; “Monitoring the 
effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence 
assay”: Inf Control Hosp Epidemiol:30:678-684:2009
Carling PC, Briggs J, Perkins J, Highlander D; “Improved cleaning of patient rooms using a new 
target method”:Clin Infect Dis:42:385-388:2006
Carling PC, Parry MM, Rupp ME, Po JL, Dick B, Von Beheren S; “Improving cleaning of the 
environment surrounding patients in 36 acute care hospitals”: Infect Control Hosp 
Epidemiol:29:1035-1041:2008
Griffith CJ, Cooper RA, Gilmore J, Davies C & Lewis M; “An evaluation of hospital cleaning 
regimes and standards”; J Hosp Infect:45:19-28:2000
Griffith CJ; “Choosing a luminometer”: International Food Hyg: 19:23-25:2008
ICH Expert Working Group; “Validation of Analytical Procedures: Text and Methodolgy Q2(R1)”; 
International Conference on Harmonisation of Technical Requirements for Registration of 
Pharmaceuticals for Human Use: ICH Harmonised Tripartite Guidelines: 2005
0
50,000
100,000
150,000
200,000
0 0.2 0.4 0.6 0.8 1
R
e
la
ti
v
e
 L
ig
h
t 
U
n
it
s
 (
R
L
U
)
ATP in mg/L
Biotrace ATP meter
0
1000
2000
3000
4000
5000
6000
7000
8000
0 10 20 30 40
R
e
la
ti
v
e
 L
ig
h
t 
U
n
it
s
 (
R
L
U
)
ATP in µg/L
Biotrace ATP meter
0
500
1000
1500
2000
2500
3000
3500
0 10 20 30 40
R
e
la
ti
v
e
 L
ig
h
t 
U
n
it
s
 (
R
L
U
)
ATP in µg/L
Kikkoman ATP meter
0
100
200
300
400
500
600
700
800
900
1000
0 10 20 30 40
R
e
la
ti
v
e
 L
ig
h
t 
U
n
it
s
 (
R
L
U
)
ATP in µg/L
Hygiena ATP meter
0.000000
0.000050
0.000100
0.000150
0.000200
0.000250
0.000300
0.000350
0.000400
0.000450
0.000500
starting weight 12 mins 24 mins 40 mins 60 mins
W
e
ig
h
t 
 (
g
)
DAZO(o) weight - dried onto glass cover slips
A
B
C
D
E
control
0
2
4
6
8
10
12
14
16
18
20
Start 60 mins next day
W
e
ig
h
t 
(m
g
)
Drying time - room temperature
DAZO(e) drying time and weight
averages
[N = 20]
DAZO (o) DAZO (e)
POSTER TEMPLATE BY: 
www.PosterPresentation
s.com 
The problem of rapid ATP systems may be 
scaling using Relative Light Units (RLU) 
Greg S Whiteley*, M Safety Sc., PhD (Candidate)1,2 Chris Derry, MSc (Med), PhD (Candidate)1 Trevor Glasbey, PhD2   
 * Principle & Corresponding Author : email gsw@whiteley.com.au 
1University of Western Sydney; 2Whiteley Corporation 
Introduction 
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B 
Figure 1: Relative Light Unit (RLU) scaling shown as both  
linear and Log10: Co-efficient of Variance (CoV) 
Table 1: Quantitative background 
Figure 2: Existing Data on CoV 
Showing  the Coefficient of Variance (CoV) as a dot plot clearly demonstrate that portable ATP 
meters do have the same level of reproducible reliability and robustness as a fully validated HPLC. 
The current methodological approach for ATP measurement, using field based, hand held devices 
cannot be expected to possess accuracy at the level of a stabilised analytical system. The variance 
displayed by all brands is much higher than might otherwise be expected as seen in Figure 2 below. 
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The problem of variability with use of rapid ATP 
bioluminometers has been overlooked in 
published work and is invisible where single 
point sampling is undertaken without duplicate, 
triplicate, or preferably quadruplicate sample 
measurements. (Whiteley 2014) Thus variability 
in the use of rapid ATP bioluminometers is the 
most recurrent technical concern for cleaning 
monitoring studies within healthcare applications 
using quasi experimental frameworks. 
 
The risk of type I errors due to unrepresentative 
sampling in environmental monitoring worsens if 
the ATP devices used for monitoring have  
uncontrolled variability. (Martin 1994)  
 
In this work the variability which has plagued so 
many of the published studies using rapid ATP 
monitoring has been fully investigated and 
defined. The four brands used in the study have 
their own characteristics which form the basis of 
brand to brand differences, but it an up to 
individual preference when making a purchasing 
decision. (Griffiths 2008) What this study has 
clearly indicated is that variability in the readings 
obtained require careful consideration when 
developing sampling plans for use of ATP 
monitoring within healthcare settings. 
 
The findings on variability in the use of rapid ATP 
bioluminometers appear to be uniform across all 
of the brands tested with CoV results showing 
no difference between brands, either in the 
spread of variance or clustering of CoV 
outcomes. The implications of this work are 
directly relevant to how cleaning monitoring with 
ATP bioluminometers is conducted and the 
impact on any statistical measures to be applied 
to the findings. (Whiteley 2014) As we have 
noted above, the use of median results provide a 
more consistent platform on which statistical 
findings could be based, thus suggesting a 
discontinuance of averages as an approach to 
sampling standardisation with ATP. This is 
particularly important at the low end of the 
dynamic range where the issue of a practical 
zero is applied to ensure low end conformity of 
data. 
 
The alteration of the scaling from its normal 
linear scale into the log10 of the original data 
and then recalculating the CoV illustrate the 
problem with the current scaling approach. As 
seen in Figure 1, none of the ATP devices 
compare favourably with the HPLC, although 
when the data is in the Log phase, variability 
(CoV) is reduced to a manageable level. 
 
Conversion of the current scaling into a single 
and unified scale that is in the log phase, rather 
than the current disassociated and non-unified 
Linear RLU scale will be highly desirable to 
reduce variability and improve practicability in 
rapid ATP testing. Further studies are underway. 
The data on variance is plotted as range data with the median noted on each data set 
Linear Log 10 Linear Log 10 Linear Log 10 Linear Log 10 Linear Log 10
3M Kikkoman Hygiena Charm HPLC
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0.0000
0.1000
0.2000
0.3000
0.4000
0.5000
0.6000
0.7000
0.8000
0.9000
C
o
e
ff
ic
ie
n
t 
o
f 
V
a
ri
a
n
c
e
 (
C
o
V
) 
CoV Range and Median as Linear and Log 10 
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3M Kikkoman Hygiena  Charm HPLC 
30 runs 31 runs 29 runs 12 runs 22 runs 
94 data points 97 data points 91 data points 49 data points 72 data points 
Method 
ATP Testing 
In this series of experiments, a known source of ATP (Sigma 
Aldrich, Castle Hill, Australia) was used to assess ATP device 
response. The quantitative aspects of the concentration of the ATP 
were confirmed using HPLC (Shimadzu, Japan) in a validated 
method. The method of application followed the prior published 
method. (Whiteley 2012)  
 
Experimental work demonstrated that direct application by micro-
titre pipette of 10 – 20 µL of ATP , stored in ice during the 
experiment, provided a robust, repeatable and defensible method of 
application that removed other error from the work. At each dilution 
point a minimum of three swabs were used for each device and 
wherever possible test points were sampled in quadruplicate.  
The use of medians was preferred in range finding as the use of 
averages was found to be affected by the regularity of outliers in the 
sampling groups.  
 
The ATP work was repeated on multiple occasions, with multiple 
operators present. All swabs were used prior the recommended 
expiry period. All swabs were stored in below 5oC until prior to use 
when they were allowed to reach room temperature. Multiples of 
differing batch lots were tested.     
 
The Charm device and consumables were obtained for testing 
towards the end of the study, and so the number of sample points 
(runs) and total number of swabs used is somewhat less than the 
other three brands. 
  
Statistics and Graphs  
 
The ATP readings are made in Relative Light Units (RLU). Each 
branded device has its own unique numerical presentation and 
scaling for RLU. No two units share a common scaling.  
 
In these studies the RLU were noted for each data point and the 
mean, standard deviation and Coefficient of Variance (CoV) were 
calculated for each sampling run. The raw data was then converted 
to its log 10 and the statistics were re-calculated using MS Excel 
(Microsoft Corp, Seattle, USA). The graphs was also drawn using 
MS Excel.  
The use of rapid Adenosine Triphosphate (ATP) bioluminometers in 
the monitoring of surface hygiene as originally suggested by Griffiths 
has yet to see practical fulfilment amongst healthcare infection 
control and prevention practitioners. (Griffiths 2000) Reviewers have 
noted the potential for the use of ATP in providing near instantaneous 
results on quantitative measurements of surface hygiene. (Carling & 
Huang 2013; Mitchell et al 2013) Despite a large number of studies, 
authoritative sources have declined to declare ATP monitoring has 
sufficient evidentiary support for regular use in the monitoring of 
surface hygiene within healthcare settings. (Loveday et al., 2014)  
 
Rapid ATP bioluminometry has a reliable capacity to distinguish 
between ten-fold serial dilutions of ATP and various common 
bacterial species. (Aitken 2011, Whiteley 2012) Brand to brand 
benefits have been suggested in controlled studies in the endeavour 
to pick winners, despite clear problems with sensitivity within the 
scaling. (Andersen 2009, Sciortino 2013; Malik 2013)  
 
There have been problems noted in use of ATP monitoring including 
unexpected and unusual results that often presented, such as 
readings of ATP which were higher following cleaning than 
measurement prior to cleaning being conducted. (Cooper 2007) The 
correlation between contamination due to microorganisms of concern 
often correlates poorly with ATP measurement which tend to be 
higher. (Smith et al., 2013; Boyce 2011) Unexplained variability has 
impeded efforts to identify a suitable benchmark.  (Lewis 2008, 
Moore 2010, Anderson 2011) Even collection of sufficient data and 
application of a receiver operating curve model has not resulted in a 
standardised and widely accepted definitional boundary on hygiene 
based on ATP measurements expressed as Relative Light Units 
(RLU). (Mulvey 2011, Smith 2013)  
 
In response to these attempts at solidifying a suitable cleanliness 
benchmark using rapid ATP bioluminescence, conceptual concerns 
have been highlighted with ATP as a surrogate for surface hygiene 
assessment, particularly noting the issues arising from variability. 
(Malik & Shama “20 pence” JHI 2011) The coefficient of variation has 
been noted as an problem with ATP monitoring, subsequently poor 
correlation (r2 was 0.078). (Shama & Malik IJHEH 2013) 
 
A controlled laboratory model indicated that whilst rapid ATP 
bioluminometers could distinguish well between ten-fold dilutions, all 
of the systems tested struggled with a 20% dilution series. (Whiteley 
2012) Coefficient of Variance (CoV) used to normalise data sets has 
shown variance as a substantial issue in using rapid ATP monitoring. 
(Whiteley 2013) 
 
Uncontrolled variability in data sets is a major problem for statistical 
applications. (Lautenbach 2012)  
 
In this work, the variability of 4 commercial brands of rapid ATP 
bioluminometers were tested in a series of laboratory studies using a 
standardised pharmaceutical industry approach (ICH 2005). The four 
brands of ATP bioluminometers and their consumables used in this 
work were 3M – Cleantrace; Kikkoman – Lucipac-pen; Hygiena – 
Ultrasnap; and Charm – Pocket Swab Plus. A calibrated HPLC using 
a fully validated method for ATP detection was used as a control for 
variability.  
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Cleaning is a process that when conducted efficiently and effectively 
can reduce the risk of cross infection via surfaces within healthcare 
settings (Popp 2013). The four monitoring tools available for 
monitoring of environmental cleaning are:  (i) visual inspection; (ii) 
microbial recovery; (iii) Fluorescent Marker products (FM); and (iv) 
rapid ATP (Adenosine Triphosphate) bioluminescence (Carling 2013, 
Mitchell 2013). 
  
Australia has moved to a quality driven process through the adoption 
of the National Service and Healthcare Quality Standards (NSHQS) 
introduced in 2012, which have the two pronged goal of 
standardisation and continuing improvement (ACSHQ 2012) 
including the risk of infection associated with environmental cleaning 
failure. This study investigated the use of Failure Mode Events 
Analysis (FMEA) as a risk analysis tool in the monitoring of cleaning 
processes using rapid ATP and FM. 
 
When conducted thoroughly, the cleaning process has been shown 
to reduce environmental contamination and also to reduce risks of 
cross infection (Hota 2009, Dancer 2009, Friedman 2013). When 
cleaning is conducted poorly, inefficiently or ineffectively, the 
outcome will produce a hazard element and provide a risk platform 
for cross infection within healthcare settings (Dancer 2012).  
 
The difficulty in developing a clinical approach to cleaning verification 
is highlighted by the recent comment that that ‘cleaning is a “weak 
science” based usually on a poetic theory not grounded in fact’ 
(Harbath 2013). This highlights the need to take a risk based 
methodology to link the underlying and sometimes disjointed 
sciences into a cohesive “process control” approach. 
The significant problem with environmental “cleaning” is twofold. 
 
 Firstly it is a relatively straightforward process of wiping and 
removing soils from a surface. Secondly however, cleaning is also a 
multi-faceted process and not just one science or a single scientific 
discipline. It is a complex array of linked activities that involve many 
scientific inputs to arrive at a single desired output (a clean surface). 
Human factors add a tertiary layer of complexity in the application of 
the task of cleaning (Jackson 2014).  
 
The total approach to cleaning validation remains poorly studied or 
little understood (Gillespie 2013). In Australia, various auditing 
approaches and measurements have been used to indicate cleaning 
performance incorporating the verification tools available (Victorian 
Government 2005, NHMRC 2010, Murphy 2011). Moving to a 
“process control approach” within a standards framework is required 
to achieve management control overall cleaning process outcome.  
 
The analysis of how bring these diverse issues together and to insert 
the use of the cleaning verification tools into the cleaning process 
was considered as per Australian Standard AS/NZS 31000:2009, 
“Risk Management – Principles and Guidelines” (Standards 
Australia, 2009). This standard outlines the principles for conducting 
an overall risk management process. For cleaning, the primary risk is 
failure of the process. For this study we focused solely on the 
cleaning verification tools on the basis that if the verification tools fail 
to work, then underlying cleaning failure will not be identified and 
corrected, leading to overall process failure.  
 
The use of FM is a validated method of checking that surface 
cleaning/wiping has occured (Carling 2008). The use of ATP has 
been shown to correlate well with high levels of bacterial pathogens 
on the surfaces found within healthcare settings (Smith 2014).  
 
Our team selected FMEA as the most appropriate tool for our study 
FMEA as a risk assessment tool has been used or suggested on a 
number of occasions in the field of infection prevention but has not 
gained any wide spread acceptance (Monti 2009, Chiozza 2009).  
 
The greatest use of FMEA as a semi-quantitative risk assessment 
tool is in the pharmaceutical and medical device sectors (van 
Leuwwan 2009).  
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Figure 3: Identified failure profile with FM Figure 4: Identified failure profile with ATP 
Results of FM laboratory studies  
 
 
REPEAT 
CLEANING 
PROCESS 
Results of FMEA (structural) failures  
The results of the first stage of failure mode are shown in Figures 1 and 2 below, in regards to drying of the FM. Results of the 
validation work on ATP systems are shown separately (Poster 3133).  
 
DAZO original and DAZO (e) both take several minutes to dry. In the period of time when drying is underway, the risk of inadvertent 
removal is quite high as the intention is to apply the FM dots to High Touch Objects or surfaces. Early removal other than by 
intentional cleaning cannot be detected and allows for a false reading. Our work identified this failure as a False Positive result (the 
intention is to remove the FM through a cleaning/wiping process). This is a high risk failure as it is not able to be mitigated in the 
normal course of cleaning activity. FM is noted to only provide qualitative information on cleaning efficiency and not cleaning efficacy. 
This failure is noted in Figure 3.   
 
For ATP the significant failure risk identified is that the ATP is read and the RLU outcome is below the intended threshold. But if 
pathogenic organisms remain on the surface, or the  ATP reads low due to a lack of detection then the low RLU is a false indication 
of surface cleanliness. Our work identified this failure as a False Negative result (the intention is to detect unclean surfaces through 
high RLU readings and a low RLU reading when surfaces remain contaminated with pathogenic and multi-drug-resistant-organisms 
[MDRO] is a false negative result).   This failure is noted in Figure 4 below.  
Figure 1: Drying of DAZO original Figure 2: Drying of DAZO (e)  
Photo 1: DAZO original Photo 2: DAZO (e)  
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The risk assessment of any cleaning process should 
consider not just the overall risk, but each of the 
individual sub-tasks and the risks attached to each. 
For our study we focused solely on the cleaning 
verification tools and the risks associated with each 
tool, on the basis that no matter what the cleaning 
materials and methods chosen, if the verification tools 
fail to work, then underlying failure will not be 
identified and corrected, leading to overall process 
failure.  
 
This FMEA indicates that use of FM has a low risk of 
failures but also is qualitative and does not indicate 
the quantitative efficacy achieved through the cleaning 
process. Whilst ATP bioluminescence measurements 
can indicate the quantitative level of surface hygiene, 
the failure modes identified suggest that it should be 
carefully managed within a risk based system (Malik 
2003, Malik 2012). 
 
The results presented indicate that the FM and the 
ATP should be used both in parallel and in sequence 
to mitigate the substantial failure risk associated with 
these cleaning monitoring tools.  
 
This study has focused on the overall failure risk as 
informed by FMEA. A full study has been submitted 
for publication and is currently in peer review. The 
results here are the preliminary and overall impacts of 
the two most significantly identified failure modes foe 
both FM and ATP. 
 
The overall impact of using both FM and ATP to 
mitigate each other provides a new approach for 
cleaning monitoring within healthcare settings. Further 
studies are currently underway to further investigate 
the potential of overcoming the well recognised flaws 
in hygiene science within hospitals globally.  
Figure 5: a revised approach to use of FM and ATP in cleaning monitoring  
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The two identified cleaning verification methods of rapid ATP and FM 
were assessed by the Risk Assessment team members to identify the 
structural or procedural failure modes.  
 
FMEA is a structured methodology which provides a quantitative 
predictive assessment of a process so as to prevent problems or 
failures before they occur (McDermott 2009). FMEA looks at the 
process and predicts possible failure modes. This identification of 
failure mode is by type so that subtle variations can be assessed 
together as they will provide a similar failure outcome. 
 
A small multi-disciplinary team was convened to consider and risk 
assess failure modes of the two cleaning monitoring tools, ATP and 
FM.  
 
FMEA also allows for the team members to note both the existence 
of underlying redundancy in the risk assessment (i.e. is the risk 
already overcome by an existing factor not clearly seen in the risk 
assessment for the characteristics). The possibility of further 
intervention can also be noted to indicate any observations as to the 
best way to lower or mitigate the identified risks. 
 
The method used by the risk assessment team considered the major 
clinical failures a structured approach to consider worst possible 
failure event outcomes.  
 
Mitigation was actively considered following identification of key 
failure modes and interaction with possible redundancy factors.    
Method 
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Introduction
Cleaning within healthcare 
settings is an intervention that is 
both practical and cost effective.  
Quality assurance over cleaning 
remains problematic with four 
monitoring methods being visual 
inspection, microbial recovery, 
Fluorescent Markers (FM) and 
ATP bioluminometry (ATP) 
(Mitchell 2013).
When conducted thoroughly, the 
cleaning process has been 
shown to reduce environmental 
contamination and also to reduce 
risks of cross infection (Hota
2009, Dancer 2009, Friedman 
2013). When cleaning is 
conducted poorly, inefficiently or 
ineffectively, the outcome will 
produce a hazard element and 
provide a risk platform for cross 
infection within healthcare 
settings (Dancer 2012). 
In Australia, various auditing 
approaches and measurements 
have been used to indicate 
cleaning performance 
incorporating the verification 
tools available (Victorian 
Government 2005, NHMRC 
2010, Murphy 2011). Moving to a 
“process control approach” within 
a standards framework is 
required to achieve management 
control overall cleaning process 
outcome. 
The use of FM is a validated 
method of checking that surface 
cleaning/wiping has occured
(Carling 2008). The use of ATP 
has been shown to correlate well 
with high levels of bacterial 
pathogens on the surfaces found 
within healthcare settings (Smith 
2014). The variability identified 
with ATP use can be overcome 
through appropriate sampling 
methodology (Whiteley 2015). 
Our team selected FMEA as the 
most appropriate tool for our 
study as it allowed a comparison 
based on the risks of failure, 
rather than a direct association 
(Whiteley 2015). 
This poster demonstrates the 
results of investigations into the 
cleaning monitoring processes. A 
new method of integrated 
assessment for cleaning 
monitoring is proposed. 
Method & Results
ATP Testing
In this series of experiments, a known source of ATP (Sigma Aldrich, Castle Hill, Australia) was used to assess ATP device response. The
quantitative aspects of the concentration of the ATP were confirmed using HPLC (Shimadzu, Japan) in a validated method. The method of
application followed the prior published method using direct application by micro-titre pipette . (Whiteley 2012) At each dilution point a minimum
of three swabs (usually four swabs) were used for each device. The ATP work was repeated on multiple occasions, with multiple operators
present. All swabs were used prior the recommended expiry period. All swabs were stored in below 5oC until prior to use when they were
allowed to reach room temperature. Multiples of differing batch lots were tested. The Charm device and consumables were obtained for
testing towards the end of the study, and so the number of sample points (runs) and total number of swabs used is somewhat less than the
other three brands.
Statistics and Graphs
The ATP readings are made in Relative Light Units (RLU). Each branded device has its own unique numerical presentation and scaling for
RLU. No two units share a common scaling. In these studies the RLU were noted for each data point and the mean, standard deviation and
Coefficient of Variance (Cv) were re-calculated using MS Excel (Microsoft Corp, Seattle, USA). The graphs were drawn using MS Excel. Cv
was preferred for the normalisation of the data given that each concentration was individual and not comparable.
FMEA Key Failures identified
Fluorescent Markers (FM)
For the purposes of the FMEA study, our work focused on the 
DAZO system developed by Dr Phillip Carling. The drying time 
was identified as a important characteristic for field based use so 
a series of laboratory based drying studies were undertaken to 
establish the drying characteristics to be used for the FMEA 
comparison. Drying with the second generation series (DAZO –
Ecolab) are shown. 
Conclusions
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OPTIONAL
LOGO HERE
Cleaning is a feature of hospital 
infection control but lacks a 
robust mechanism to achieve 
the desired quality assurance 
over cleaning outcomes. The 
Australian Healthcare System 
endorses a risk based approach 
to the prevention of healthcare 
associated infections, including 
surface hygiene within hospitals 
(ACSQH 2011). Our study 
focused on the cleaning 
verification tools and the risks 
associated with each tool, on 
the basis if the verification tools 
fail to work, then underlying 
failure will not be identified and 
corrected, leading to overall 
process failure. 
Further studies are currently 
underway to further investigate 
the potential of concomitant use 
of the four cleaning monitoring 
methods. The results presented 
indicate that the four cleaning 
monitoring methods should be 
used synergistically to mitigate 
the substantial failure risk 
associated with any one of the 
individual cleaning monitoring 
tools when those tools are used 
in isolation. 
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Failure Mode Risk Class Mitigation suggestions Mitigation 
Option
V
is
u
a
l 
In
s
p
e
c
ti
o
n
Surface looks clean but 
is contaminated with 
pathogenic microbes or 
other soils
High
Testing of surfaces with a quantitative 
method for determining surface hygiene 
may indicate contamination e.g. ATP 
testing or Microbial Recovery ATP or 
Micro
Surface looks clean but 
has not been subject to 
routine cleaning 
process12
Medium
Use of an FM technology will indicate 
surface cleaning frequency rate.
FM
M
ic
ro
b
ia
l 
re
c
o
v
e
ry
Result from sampling is 
delayed by 48 hours or 
more29
High
Testing of surfaces with a rapid method 
(e.g. ATP testing) can inform and guide 
the sampling processes by indicating any 
loci of contamination through use of ATP
ATP  
Pathogenic microbes 
are not detected on 
swab but are present on 
HTOs10
Medium
Validation of the sampling methods can 
improve microbial recovery rates - check 
cleaning with FM
FM
A
T
P
 b
io
lu
m
in
o
m
e
tr
y
ATP Detection failure 
(Possible lysis system 
failure), or insufficient 
bacteria recovered
Medium
Microbial recovery can be used for 
confirmatory quality control where FM 
indicates inadequate cleaning but ATP 
readings are inconclusive FM or 
Micro
Failure to detect viruses 
due to absence of ATP
Medium
Use of an FM technology is low cost and 
will indicate surface cleaning frequency in 
additon to use of rapid ATP detection. A 
suitable microbial recovery method for 
virus detection could also be used. FM or 
Micro
F
M
 t
e
c
h
n
o
lo
g
ie
s
FM spots are visible to 
cleaning staff and are 
preferentially removed
Medium
Testing of surfaces prior to use of FM and 
coincidental use of ATP will indicate 
surface hygiene
ATP
FM assessment does 
not enable 
measurement of the 
level of effectiveness of 
the cleaning process
Medium
ATP measurement will provide an adjunct 
measurement of surface cleanliness 
ATP or 
Micro
FMEA is a structured methodology which provides a 
quantitative predictive assessment of a process so as to 
prevent problems or failures before they occur (McDermott 
2009). FMEA looks at the process and predicts possible 
failure modes. This identification of failure mode is by type 
so that subtle variations can be assessed together as they 
will provide a similar failure outcome.
A small multi-disciplinary team was convened to consider 
and risk assess failure modes of the two cleaning 
monitoring tools, ATP and FM. 
FMEA also allows for the team members to note both the 
existence of underlying redundancy in the risk assessment 
(i.e. is the risk already overcome by an existing factor not 
clearly seen in the risk assessment for the characteristics). 
The possibility of further intervention can also be noted to 
indicate any observations as to the best way to lower or 
mitigate the identified risks.
This table presents a snapshot of the two worst failure 
modes for each of the monitoring methods (Whiteley 2015).
Answering the key validation questions
Has the cleaning 
method and 
materials been 
validated?
Has the cleaning 
process ensured 
suitable surface 
cleanliness
Has a cleaning 
process been 
attempted on this 
HTOs
HTOs to be 
cleaned
Identify the 
HTOs to be 
cleaned
Yes
No
Is the method 
of cleaning 
effective?
Are the 
materials used 
efficacious?
Yes
HTOs is Ok for 
continued use
No Re-clean
Reassess 
HTOs hygiene
Cleaning Monitoring        FM ATP Micro
The FM drying is achieved within a 
practical times of less than 2 minutes, 
although full drying can take up to 12 
minutes depending on the brand. Newer 
brands dry virtually instantly. The ATP tests 
lack precision but are robust when 
considered over a wide range of 
contamination. Each of the four cleaning 
monitoring methods has risks which, in 
isolation, limit their usefulness. FMEA 
highlights overlapping of weaknesses with 
strengths, suggesting a new integrated 
approach to cleaning monitoring within 
healthcare.
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